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Molecular Subtyping and Antibiotic Resistance Analysis of Salmonella Species 
 
Aparna Tatavarthy 
 
ABSTRACT 
 
The genus Salmonella, comprised of 2400 serotypes, is one of the leading causes of 
foodborne illnesses in the US and has been used for the deliberate contamination of food.  
A rapid system for detection, isolation, typing and antibiotic susceptibility profiling is 
essential for diagnosis and source tracking in natural outbreaks or a bioterrorism event. 
Pure culture is essential for molecular typing and antibiotic resistance testing. The 
virulence and the resistance mechanisms of Salmonella are rapidly evolving and many 
are still unexplained. The first aim of the study was to rapidly detect and isolate 
Salmonella from intentionally contaminated food. The second aim was to build a DNA 
fingerprinting database for accurate identification of the subtype. The third objective was 
to study the antibiotic susceptibility patterns and the underlying mechanisms of 
resistance.   A correlation between the DNA subtypes and antibiograms was 
hypothesized. An association between the resistance determinants and pathogenicity 
genes was expected. A total of 114 isolates including environmental and clinical sources 
were tested. General and selective enrichments and immunomagnetic separation (IMS) 
were tested for rapid detection and isolation of Salmonella from eight food groups. 
Isolates were subtyped by pulsed field gel electrophoresis (PFGE) and automated 
RiboPrinter®.  Resistance to 31 drugs was tested by the Sensititre® system and integrons 
were identified by PCR. The association between virulence and resistance was verified 
by Southern hybridization.  Of the three genes tested, ompF was found to be the most 
x 
reliable target for identifying Salmonella subspecies I, III and IV. Detection by real time 
PCR after enrichment in buffered peptone water and isolation by IMS provided the 
fastest results. Sixty two ribotypes and 74 pulsotypes were observed for the 100 isolates 
subtyped. Sixty isolates were resistant to one or more antimicrobials and 12 had class-1 
integrons. In conclusion, pure culture was achieved in 25 hours by IMS. Ribotyping, a 
comparatively rapid technique was found to be ideal for initial identification. PFGE, 
which was more discriminatory, was appropriate for source tracking.  Contrary to the 
original hypothesis, no correlation between subtyping and antibiograms was observed 
and no association of integrons with the virulence genes tested was demonstrated
xi 
Chapter One - Introduction 
 
The Genus Salmonella 
Various agents including bacteria, viruses and parasites cause foodborne diseases. 
According to a FoodNet survey about 38.6 million illnesses are caused by known 
pathogens every year of which 36% are due to foodborne organisms (141). Bacterial 
infections account for approximately thirty percent of the total foodborne illnesses of 
which, non- typhoidal Salmonella infections contribute to the highest percent of the 
mortality (141).  
 
Salmonella is a Gram negative, rod shaped, motile member of the Enterobacteriaceae. 
The genus Salmonella is comprised of over 2400 different serotypes that infect a wide 
range of hosts including poultry, cattle, rodents and humans (20). Salmonella is divided 
into two species: Salmonella enterica also called Salmonella choleraesuis and Salmonella 
bongeri. Salmonella enterica is further divided into five subspecies (I, II, IIIa, IIIb, IV, 
VI) (23). The nomenclature of Salmonella is extremely complex and tends to be 
confounding because of the lack of uniformity. Kauffmann and White proposed the initial 
nomenclature based on the O (somatic) and H (flagellar) antigens (20). Every serotype 
was considered as a species according to this system; however, with more than 2400 
recognized serotypes this nomenclature system is not feasible. Based on DNA-DNA 
hybridization it was observed that all subspecies (I, II, III, IV, VI) were closely related 
except for subspecies V (Salmonella bongeri) (23). Salmonella choleraesuis is sometimes 
used in the place of Salmonella enterica as the first species but its usage could be 
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confused with the serotype Choleraesuis. For subspecies I, the name of the serotype is 
used, for example Salmonella enterica serotype Typhimurium, but for the other 
subspecies (isolated after 1966) the antigenic formula is used. Table 1 shows the current 
nomenclature of the genus Salmonella and their common habitat. 
 
Table 1. Salmonella Nomenclature 
Salmonella species Salmonella Subspecies Habitat 
enterica (I) Salmonella enterica Warm blooded animals 
salamae (II)  Cold blooded animals, 
environment 
arizonae (IIIa)  Cold blooded animals, 
environment 
diarizonae (IIIb)  Cold blooded animals, 
environment 
hountenae (IV)  Cold blooded animals, 
environment 
indica (VI)  Cold blooded animals, 
environment 
bongeri (V) Salmonella bongeri Cold blooded animals, 
environment 
 
The current nomenclature of Salmonella followed by the Centers for Disease Control and 
Prevention (CDC) (23) 
 
Ninety-nine percent of clinically significant serotypes belong to subspecies I (Salmonella 
enterica subspecies enterica). According to a Centers for Disease Control and Prevention 
(CDC) survey the most frequently reported serotypes in the year 2002, all belonging to 
subspecies I, were Salmonella enterica serotype Enteritidis (S. Enteritidis), S. 
Typhimurium, Salmonella enterica serotype Javiana (S. Javiana) and Salmonella enterica 
serotype Newport (S. Newport) 
2 
(http://www.cdc.gov/ncidod/dbmd/phlisdata/salmtab/2002/SalmonellaAnnualSummary2002.pdf). Two of 
these serotypes, S. Typhimurium and S. Enteritidis are the most well studied serotypes of 
the subspecies Salmonella enterica. Salmonella enterica serotype Typhi (S. Typhi) is 
very host specific and infects only humans.  S. Typhimurium infection in a mouse model 
is assumed to be very similar to S. Typhi infection in humans (186). Although, other 
studies have shown that the mechanism of infection of S. Typhi in humans and S. 
Typhimurium in mice are slightly different (204).    
 
Salmonella Infection 
Salmonella species cause a variety of illnesses including nausea, vomiting, abdominal 
cramps and diarrhea. The infective dose of Salmonella is usually about 1000 colony 
forming units (CFU) (http://textbookofbacteriology.net/Salmonella.html) but it depends on 
various factors including the serotype and the pH of the stomach. If the pH of the 
stomach is high a low dose is sufficient to cause infection (74). A high stomach pH can 
also accelerate Salmonella invasion and allow the organism to spread into the circulatory 
system, liver and gall bladder causing further complications. After the initial invasion of 
the epithelial cells, the bacteria are engulfed by the host phagocytes where they replicate 
(188). Intracellular replication is important for the virulence of S. Typhimurium in a 
mouse model according to Leung and Finley (111). It was observed in that study that 
replication defective mutants did not kill the mice even after 21 days whereas the control 
strains killed the mice in five days. The primary infection site of Salmonella is the distal 
ileum (30). The invasion and replication strategies of Salmonella depend upon the 
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serotype and the nature of the host. For example the invasion of S. Typhimurium in swine 
is rapid and is non-cell specific. The organism preferentially adheres to sites of epithelial 
cell extrusion (144).  Many serotypes of Salmonella produce two kinds of toxins 
cytotoxin and enterotoxin apart from the endotoxin(196). The enterotoxin produced by 
Salmonella has a similar action to the cholera toxin (CT).  The Salmonella toxin (Stn) 
elevates the levels of cyclic adenosine monophosphate (cAMP) like CT, however 
structurally the two toxins are different (41). Stn is homologous to the toxins produced by 
Pseudomonas aeruginosa and Corynebacterium diptheriae (41). 
 
Salmonella in Foodborne Outbreaks 
Salmonella is one of the ancient pathogens and it still continues to confound scientists.  In 
the early twentieth century Salmonella was the only known foodborne pathogen and was 
thought to cause 90% of the gastroenteritis cases (88). In the past 20 years however, 
scientists began to recognize other bacteria including E. coli O157:H7, Listeria 
monocytogenes and Campylobacter species and viruses as potential foodborne agents 
(190). S. Typhi infections were controlled in the beginning of the twentieth century by 
disinfection of drinking water, sewage treatment and pasteurization of milk; however, 
infections caused by non-typhoidal serotypes of Salmonella began to increase. Eggs were 
implicated in several S. Enteritidis outbreaks in the 1980s. From 1985 –1999, 80% of S. 
Enteritidis infections were due to eggs (162). Surveillance of Salmonella in eggs and 
improved food handling practices led to the eventual decline in the foodborne disease 
caused by S. Enteritidis. However, increased consumption of fresh produce in the 1990s 
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compared to the 1970s led to the increased incidence of foodborne illnesses (15). Fresh 
produce could be contaminated at the stage of pre-harvesting due to various factors 
including infected irrigation water, soil or manure. Post-harvest contamination could be 
due to human handling, improper storage and packaging. Identifying the exact source of 
the pathogen in a foodborne outbreak is an extremely complex task because various 
ingredients of the food can be from several different sources and sometimes even 
different countries (190). 
 
Salmonella has been implicated in several foodborne outbreaks in the US. One of the 
biggest outbreaks that caught the attention of the food regulatory agencies was the S. 
Typhimurium outbreak in Chicago, IL in 1985. This involved the contamination of 
pasteurized milk that led to 23,000 confirmed cases of S. Typhimurium. Several of the 
patients who were infected in this outbreak have since developed long term arthritis (61). 
Since then, Salmonella species have caused a number of outbreaks involving a variety of 
foods. In  1995, a S. Newport outbreak transmitted by contaminated alfalfa sprouts 
affected over 100 persons in six different states in the US (197). Another outbreak of 
Salmonella enterica serotype Mbandaka leading to 89 confirmed salmonellosis cases was 
linked to alfalfa sprouts in Oregon in 1999 (80). The epidemiological investigations 
traced the pathogen to two sprout growers that did not follow the U.S. Food and Drug 
Administration’s (FDA) seed disinfection guidelines. Commercially packaged egg salad 
was implicated in a S. Typhimurium outbreak that led to 18 illnesses in Oregon and 
Washington states in 2003 (35). A multistate outbreak of S. Typhimurium in 
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unpasteurized milk affected four states and 62 people in 2002 (32). Roma tomatoes were 
associated in a more recent outbreak affecting over 400 persons in two countries and 11 
states in the US and Canada in 2004 (33). In this outbreak over five serotypes were 
implicated including Salmonella enterica serotype Muenchen, S. Javiana, S. 
Typhimurium, Salmonella enterica serotype Anatum and Salmonella enterica serotype 
Thompson. Two of the five serotypes were traced to a supplier in Florida.  
 
Foodborne outbreaks due to Salmonella are common in other parts of the world. An 
international outbreak of Salmonella enterica serotype Oranienburg affecting Germany, 
Sweden and Canada caused several hospitalizations due to bloody diarrhea in 2001 (205). 
The organism in this outbreak was traced to chocolates but no source was identified.  Egg 
fried rice was implicated in the outbreak of S. Enteritidis infecting 31 persons in 2002 
who dined at a Chinese restaurant in the U.K. (10). S. Enteritidis infection causing 
gastroenteritis and hospitalizations in Taiwan in 2001 was traced to a bakery product 
made with eggs (126). 
 
Although there is a decline in the overall frequency of Salmonella infections since 1970s, 
all the above mentioned outbreaks suggest that certain food groups including fresh fruits, 
vegetables and ready to eat foods seem to be potential targets for Salmonella 
contamination. The increasing dependency of consumers on commercially prepared food 
could be one of the reasons for the rise in Salmonella infections in the recent past. 
Availability and increased consumption of fresh fruits and vegetables could also be the 
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cause for the rise in the foodborne illnesses in fresh produce in the recent past. Lack of 
education about hygiene and food imported from countries where the regulation is not 
very stringent (e.g., Mexico, Guatemala) could also be the contributing factors. 
 
Food as a Bioterrorism Agent 
The deliberate use of microorganisms or toxins from living organisms to cause death or 
disease of humans, animals and plants is known as bioterrorism (BT) 
(www.sciencecoalition.org/glossary/glossary_main.htm). According to the CDC, a BT event can 
be distinguished from natural outbreaks by the sudden or unusual increase in the illnesses 
including two or more unrelated cases with unusual age distribution (34). The pathogen 
has to meet certain criteria for it to be used as a BT agent.  First of all, it needs to produce 
temperature stable products that could be dispersed over a large area. Secondly, it should 
allow aerosolization and production on a large scale. It should be difficult to diagnose 
and be transmitted from person to person to rapidly spread the disease. It should allow the 
terrorist to escape the scene by having a high incubation period. It should create panic 
and overwhelm the public health system (176). A number of pathogens fit one or more of 
the above descriptions and could be potentially used as BT agents. For example, the 
lethal dose of Bacillus anthracis spores is one millionth of a gram. Bacillus anthracis 
spores can be dispersed over a large area and affect thousands of people. The other 
organisms that are likely candidates are Francisella  tularensis, a Brucella species that is 
common in contaminated dairy products, Variola major that causes smallpox and  is 
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highly contagious and Clostridium botulinum that releases botulinum toxin that can kill a 
person by contact or ingestion.  
 
Though not conventional BT agents, foodborne pathogens that belong to category B 
agents, could be used in a small scale BT event to overwhelm the public health system. In 
fact, S. Typhimurium and Shigella dysenteriae have been used for the intentional 
contamination of food in the past (103, 193). S. Typhimurium was used in the intentional 
contamination of salad bars in Dalles, Oregon, by a religious cult group in 1985 to 
influence elections (193). This incident led to 751 cases of gastroenteritis and the fact that 
it was a BT event was not obvious at the time of the event. A similar case of intentional 
contamination of pastries and donuts by Shigella dysenteriae affected 12 laboratory 
workers who developed diarrheal disease (103). The use of enteric bacteria for the 
purpose of bioterrorism may not be discovered immediately as it is difficult to distinguish 
intentional contamination with the many natural outbreaks that occur each year around 
the world. Therefore, a rapid detection and characterization system for identification and 
source tracking of the organism is crucial to control both natural and deliberate outbreaks. 
 
Detection of Salmonella 
The conventional methods of identification of Salmonella including the one used by the 
FDA are time consuming and labor intensive. According to the Bacterial Analytical 
Manual (BAM) used routinely by FDA to test foods suspected to be contaminated with 
Salmonella, the food sample is first enriched in general enrichment media for 24 hours 
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(http://www.cfsan.fda.gov/~ebam/bam-5.html). The enriched sample is then selectively enriched 
for 24 hours and then inoculated in selective and differential agar media for 
identification. Suspected Salmonella colonies are then further tested with biochemical 
and serological methods for final identification. This identification process takes about 3-
5 days. Although the conventional identification and characterization process is still the 
gold standard, most laboratories are adapting molecular techniques for rapid 
identification and characterization. Several techniques including polymerase chain 
reaction (PCR) and immunoassays are currently complementing the conventional 
methods for rapid identification of Salmonella in food or in clinical samples.  
 
The advantages of using DNA based assays for detection of a pathogen are many. 
Nucleic acid assays can provide information about the virulence of the pathogen as well 
its relatedness to other organisms. They offer information about the genome of the 
organisms and are very useful for epidemiological investigations (13). Many studies have 
shown that Salmonella species can be identified rapidly using conventional PCR.  PCR 
was used to detect S. Enteritidis and S. Typhimurium in chicken meat samples spiked 
with 10 –7 CFU/ml after 24 hour enrichment in chicken meat using invA primers (62).  
Multiplex PCR with invA gene and slt gene primers was used for detecting 10 to 102 
CFU/ml of Salmonella in a mixture of Salmonella and E. coli after 9 hour pre-enrichment 
(38). Another study involved a very sensitive assay for detection of S. Typhimurium in 
artificially inoculated poultry samples, milk and fresh vegetables. In that study, using the 
hin/H2 primers 3 CFU/gm of food were successfully detected (1). PCR was shown to be 
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more sensitive compared to conventional culture techniques in a study where Salmonella 
was found in 19% of naturally contaminated poultry sample when tested by PCR, while 
only 16% of the samples, were positive when tested by culture techniques (207). A 
combination of the two techniques provided better results demonstrating 23% of the 
samples to be positive.  
 
Currently, conventional PCR is being replaced by real time PCR for identification of a 
pathogen. The real time PCR technique takes advantage of the 5’ nuclease activity of the 
taq polymerase to generate a positive signal (91). Typically, a probe that is 
complementary to the target DNA and anneals to it is designed. During the PCR reaction 
as the primers extend, the 5’ nuclease activity of the taq polymerase cleaves the probe, 
which produces a fluorescent signal detected by the computer. This automated version of 
the real time PCR has many advantages over traditional PCR technique. The new and 
improved version eliminates the post PCR gel processing so that the data can be 
monitored in real time (98). The rapid heating and cooling system ensures that there is 
quick temperature alteration and the closed system eliminates the possible amplicon 
contamination. Three kinds of probes have been developed for the real time PCR system: 
TaqMan probes, florescent resonance energy transfer (FRET) probes and molecular 
beacons (183). The TaqMan probe has a reporter dye at the 5’ end and a quencher dye at 
the 3’ end. The quencher dye suppresses the reporter dye from fluorescing when in close 
proximity.  When the primer extends, the taq polymerase cleaves the probe separating the 
reporter from the quencher to give a detectable signal. If the target DNA is absent the 
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probe cannot bind to the DNA and therefore the reporter and the quencher dyes are in 
close proximity giving no signal.  
 
There are numerous applications of real time PCR in patient diagnosis and environmental 
sampling.  It can be used for detection of virulence genes including E. coli and Vibrio 
cholerae (55, 75) and antibiotic resistance genes (116). This technique can be used for 
quantification of genes, for example the viral load of an immunocompromised individual 
can be tested. It can be applied to trace bioterrorism and also check food and water safety 
(98). It can be applied for the detection of spores (129). The efficiency, specificity and 
speed of real time PCR has made it popular for clinical and environmental sample testing. 
 
A number of studies have demonstrated the worth of real time PCR for rapid bacterial 
detection. Belgrader et al. detected Erwinia herbicola (a surrogate for Yersinia pestis) 
using the portable system advanced nucleic acid analyzer (ANAA) (13). In that study, 
DNA from 500 cells were detected in seven minutes, fifty in 8 minutes and five cells 
were detected in 9 minutes. The molecular beacon probe technology was used to detect 
two CFU of S. Typhimurium from pure culture DNA using the himA gene as a target 
(40). 
 
Several groups have detected Salmonella species from naturally and artificially 
contaminated food samples using various genes as targets. Knutsson et al. reported that 
pre-enriching the sample before DNA extraction increases the sensitivity (102). Ten ml 
of sterile buffered peptone water (BPW) was inoculated with 1 CFU of S. Enteritidis and 
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incubated for 36 hours in their study. Samples were taken for DNA extraction every 4 
hours and tested using primers against the invA gene. An eight hour enrichment was 
enough to detect one CFU of S. Enteritidis in clean broth in that study. The efficiency of 
real time PCR was demonstrated in detecting several Salmonella serotypes in naturally 
and artificially contaminated poultry samples enriched in tetrathionate (TT) broth for 18 
hours at 37 °C (70). Artificially contaminated Salmonella-free chicken samples with S. 
Enteritidis were enriched and tested after 18 hours with invA specific primers in that 
study. Salmonella positive flocks were successfully identified in 30 minutes after 18 hour 
enrichment compared to two days using conventional culture techniques. For the 
artificially contaminated samples the detection limit was six CFU/ml. By using real time 
PCR with invA gene as a target, the source of a gastroenteritis outbreak in Texas was 
identified to be barbequed chicken (54). invA was used as target, in another study for the 
detection of 50 strains of Salmonella belonging to Salmonella subspecies I, II, III, IV and 
Salmonella bongeri (177). A study tested the utility of four DNA extraction kits for 
detection of S. Enteritidis by real time PCR using sefA primers (58).  The detection limit 
was in the range of 108 to 103 CFU in that study for artificially contaminated poultry 
samples after 24 hours of pre-enrichment at 37 °C. Heller et al. compared four 
commercial kits for the detection of E. coli in artificially contaminated samples and 
concluded that the ABI PrepMan Ultra was the easiest to use and very efficient compared 
to others (90). The application of real time PCR was tested on fresh fruits and vegetables 
that were intentionally contaminated with 4 CFU/gm using molecular beacon probes 
(122). Positive results were obtained by using real time PCR in one day after 20-hour 
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enrichment compared to three to four days using the BAM methodology in that study. A 
very sensitive assay targeting the sipB and sipC genes was developed for the detection of 
one CFU/ml of Salmonella enterica serotype Abaetatuba in artificially spiked ready to eat 
meats after six hours of enrichment (67). In another study, the tetrathionate respiratory 
gene (ttRA) was targeted, and a detection limit of 103 CFU/ml with 70% probability and 
105 CFU/ml with 100% confidence, was achieved in artificially inoculated chicken, fish 
and meat samples (133). The technique was sensitive and could detect as low as three 
CFU/ml after 20 hour enrichment. The application of real time PCR in clinical samples 
was tested in artificially inoculated stool samples with food or waterborne pathogens 
including S. Enteritidis, Campylobacter jejuni and Vibrio cholerae (77). They could 
detect 105 CFU/gm of stool in two hours, the sensitivity was higher with an sample 
overnight enrichment.  All the studies suggest that real time PCR is a very powerful 
technique that is easy to use compared to the conventional techniques and can be used for 
testing food samples as well as clinical samples. However, there are several drawbacks of 
PCR. PCR requires pure sample that is free of any inhibitors. It is a good tool that allows 
molecular identification, however, needs technical expertise and can be expensive. 
Unlike conventional methods, PCR cannot differentiate between live and dead organisms.   
Most of the studies have demonstrated that it is possible to detect Salmonella from 
artificially contaminated food samples with longer pre-enrichment or with high 
inoculums. There are not many reports of a sensitive and rapid real time PCR assay that 
can detect very low CFU (1-10) of Salmonella species from 25 gm of food samples 
particularly with mixed backgrounds. 
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 Isolation of Salmonella from food 
Numerous techniques have been developed for the rapid detection of Salmonella species 
in food including biosensors, real time PCR and microarrays (99, 159, 187). However, 
studies on the rapid isolation of Salmonella species from mixed cultures are limited. 
Isolation of pure cultures of Salmonella from mixed samples or from food is equally 
important for further characterization including serotyping, biochemical analysis and 
DNA based typing. Detection is important for identification of the pathogen and 
diagnosis, whereas subtyping by serotyping or DNA fingerprinting is essential for 
tracking down the source of the contamination in an outbreak. Source tracking is 
especially relevant if the outbreak is food associated so that the corresponding food can 
be recalled to prevent further illnesses. Though the FDA BAM protocol is extremely 
sensitive and detects one CFU of Salmonella species per 25 gm of food, it is time 
consuming and labor intensive. Therefore there is a need for studies involving 
development of techniques to accelerate the isolation of Salmonella from food.  
 
A number of studies have attempted to isolate Salmonella rapidly from food using 
immunomagnetic separation (IMS) or shorter selective enrichment compared to 
conventional techniques. Isolation of pure organism from food is a complicated process 
because it not only contains components including fats, starches etc. but also could 
contain a considerable amount of resident flora and preservatives (49). The IMS 
technique has been relatively successful in limiting the time required for achieving pure 
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culture because it physically separates the specific bacteria targted by the assay from a 
complex matrix (49).  IMS is based on the use of species-specific antibody coated beads 
to separate the organism of interest from a complex mixture of organisms. This technique 
was first applied by Luk and Lindberg to detect Salmonella enterica serogroup C by 
using a mouse monoclonal antibody (mAb) against Salmonella (128). The antibodies 
used in that study were specific for the O antigen of serogoup C.  Polysterene beads were 
precoated with the Salmonella IgG (sheep antimouse immunoglobins) antibodies. These 
beads were then coated with mAb. A detection limit of 4 CFU/ml of blood or TT broth 
was achieved using this technique in the study. The beads were found to be specific to 
Salmonella when tested against other bacteria including Pseudomonas species, 
Staphylococcus species and Streptococcus species. In a study involving intentionally 
contaminated meat and milk samples, a detection limit of 20 CFU/gm of E. coli O157:H7 
was achieved after 24 hour incubation using IMS (210).  The advantage of IMS over 
conventional enrichment techniques in terms of recovery was demonstrated in a study 
with naturally contaminated samples using the anti-Salmonella Dynabeads (49). In that 
study, swab samples were enriched in BPW for 16-20 hours before employing IMS and 
plated on selective agar plates. They demonstrated that IMS could identify more 
Salmonella positive samples compared to the conventional selective enrichment with 
selenite cystine broth or rappaport vassiliadis (RV) medium.  Application of IMS for the 
rapid detection of Salmonella in combination with enzyme linked immunosorbent assay 
(ELISA) in food samples was demonstrated in a study where the sensitivity was 107 
CFU/ml in artificially contaminated egg and chicken samples after 20 hour BPW 
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enrichment (47).  Another study based on spiked food samples as well as naturally 
contaminated samples compared six different methods, including IMS, conventional and 
ELISA based techniques for isolation of Salmonella (84) . The specificity of beads was 
studied by spiking Citrobacter species and Proteus species that resemble Salmonella on 
selective agar plating. They were able to isolate 103 CFU in 30 hours using IMS and 
found it to be most rapid compared to other techniques however, it was non-specific.  To 
improve the specificity of the protocol, the IMS method was modified in a later study by 
adding a post-IMS enrichment step in RV soy peptone broth for isolation of bacteria in 
artificially contaminated food samples (48). Although the process was lengthy (48 hours 
to obtain pure culture) and the sensitivity (100-1000 CFU/25 gram) lower, compared to 
the conventional methods, the non-specificity issue was eliminated. A very large study 
involved the testing of environmental samples from animal feeds, cheese samples, egg 
products and environmental swabs from food manufacturing plants (182). The samples 
were incubated in pre-enrichment broth for 16 hours, were selectively enriched in TT 
broth or RV medium and were purified by IMS. They found a good correlation between 
the standard culture techniques and IMS; the latter was 24h faster. In another study, 
artificially inoculated liquid eggs were tested for S. Enteritidis after 24 hour pre-
enrichment using various techniques including TT broth, RV broth, and IMS enrichment 
(87). BPW followed by TT broth enrichment was the best technique in terms of 
identifying the highest percentage of S. Enteritidis positive samples (97% to 100%) in 
that study. 
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IMS has been used by a number of groups to concentrate samples in preparation for 
detection of Salmonella species by PCR or bacteriophage assays (72, 93, 95, 175). IMS 
also aids in the removal of food debris and concentrating the target bacteria to perform 
molecular analysis by PCR (95). An automated version of the IMS process known as the 
automated immunomagnetic separation (AIMS) exists. Lynch et al. tested AIMS for 
detection of S. Typhimurium in artificially contaminated poultry samples (130). It was 
shown to have a higher sensitivity for isolation and was more rapid in identifying 
Salmonella species when compared to conventional culture techniques.    
 
These studies suggest that IMS with anti-Salmonella antibody beads is rapid and specific 
for isolation of certain Salmonella species from food samples. Furthermore, it is apparent 
that a longer pre-enrichment before IMS improves the sensitivity of the assay.  Some 
studies suggested that a post-IMS enrichment yielded better results for isolation of 
Salmonella compared to direct plating after IMS (48). However, the development of rapid 
detection and isolation protocol for Salmonella diagnosis and source tracking is still 
needed. The sensitivity of the assay needs to be improved so that less than 100 CFU/25 
gm of foods can be detected and isolated using shorter enrichments compared to the 
conventional techniques. The specificity of the assay needs to be tested on samples 
containing mixed backgrounds.  
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Subtyping of Salmonella Species 
Salmonella subtyping is required for source tracking for epidemiological investigations of 
outbreaks and for general surveillance of the pathogen in the environment. Subtyping is 
also essential to distinguish outbreak strains from existing endemic strains, therefore a 
good subtyping technique should be very discriminatory. Salmonella can be typed based 
on phenotypic or genotypic methods. The common phenotypic techniques used for typing 
Salmonella are biochemical characterization (biotyping), serotyping, antibiotic 
susceptibility profiling and phage typing. Biochemical profiling involves reaction of the 
organism to a series of biochemical tests including hydrogen sulfide production, glucose 
and lactose fermentation, and lysine decarboxylation.  Serotyping of Salmonella is based 
on somatic (O), flagellar (H) and capsular (Vi) antigens (20). Phage typing relies on the 
ability of bacteriophages to lyse Salmonella and their host specificity to certain serotypes 
(31). Although routinely used for typing Salmonella, phenotypic typing methods are time 
consuming and extremely labor intensive. Therefore, genotyping methods that are more 
rapid and specific offer an attractive alternative to phenotypic methods, including plasmid 
profiling, ribotyping, pulsed field gel electrophoresis (PFGE), randomly amplified 
polymorphic DNA (RAPD), multilocus sequence typing (MLST), repetitive extragenic 
pallindromic PCR (REP-PCR) and multiple locus variable number tandem repeat analysis 
(MLVA) (71, 104, 123, 147, 168, 174, 203). Plasmid profiling is based on the presence or 
absence of plasmids in an organism and their restriction digestion pattern. The 
disadvantage of plasmid profiling is that several Salmonella strains may lack plasmids 
therefore this technique does not provide good discrimination (148). Therefore subtyping 
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based on chromosomal DNA is a better option. Ribotyping is based on the ribosomal 
operons that are conserved among bacteria. It relies on the principle of Southern 
hybridization where the probe recognizes some combination of 16S, 23S and 5S 
ribosomal operons. The ribosomal genes show high homology in various bacteria, which 
allows hybridization. However, the regions flanking the genes are heterogeneous, which 
is the basis for fingerprinting (16). 
 
PFGE is based on restriction digestion of the whole bacterial genome. Since the 
fragments obtained by the macrorestriction digestion of DNA can be up to several 
megabases (Mb), specialized electrophoresis equipment is needed that can resolve large 
DNA fragments. In this technique an electric field is alternately applied in several 
directions. Longer pulses of current are applied in the forward direction and short pulses 
are used in the reverse and sideways direction to resolve the large DNA fragments and to 
accommodate relatively smaller DNA (202).  
 
Various new techniques have been recently developed to subtype Salmonella. MLST is a 
relatively recent technique that is based on sequencing of genes of housekeeping, 
ribosomal or virulence traits (104). MLVA compares the number of tandem repeats 
between isolates (168). A number of PCR techniques including RAPD (123), REP-PCR 
(203) and enterobacterial intergenic repetitive consensus (ERIC) PCR have been applied 
to fingerprint Salmonella species (27). The issue of non-typeability that is associated with 
phenotyping is usually eliminated when dealing with chromosomal DNA based typing. 
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 Many groups have compared molecular typing methods with phenotypic typing 
techniques for subtyping Salmonella species. Before the molecular era, phage typing was 
the method of choice for further subtyping Salmonella serotypes. Phage typing was used 
to identify Salmonella and other members of Enterobacteriaceae (89). Phage typing was 
more discriminatory compared to serotyping and was determined to be a good tool for 
epidemiological investigations in a study of isolates from contaminated food, human 
clinical samples and naturally contaminated waters (31). However, molecular techniques 
including ribotyping and PFGE have a better discriminatory power (71, 147). 
 
Comparison of Phenotypic and Genotypic Chracterization 
 
 
As mentioned before there are various ways to characterize Salmonella based on 
phenotypic methods including serotyping, biotyping, phage typing and antibiotic 
susceptibility testing. A number of studies have compared the phenotypic subtyping to 
molecular methods (73, 120, 173). One hundred twenty environmental isolates belonging 
to three serotypes were characterized by ribotyping (69). It was shown in that study that 
ribotyping that produced 12 types was clearly more discriminatory than serotyping. In 
another study, 56 S. Typhimurium isolates were subtyped by biotyping, antibiotic 
susceptibility profiling, plasmid profiling and ribotyping (148). Ribotyping and plasmid 
profiling that generated nine and eight types and were more discriminatory than biotyping 
that produced only four types. In a Brazilian study of 105 S. Enteritidis isolates from 
clinical and environmental sources, ribotyping was shown to be more discriminatory (14 
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profiles) compared to phage typing (2 types) (73). Ribotyping that generated 22 types 
was demonstrated to be more discriminatory compared to phage typing that generated 10 
types in characterizing 104 poultry S. Enteritidis isolates (118). The discriminatory 
ability of molecular typing by insertion sequence 200 (IS 200) typing (11 types) was 
evident in a study that also characterized 99 S. Typhimurium isolates also by phage 
typing (4 types) (96). In a study of 199 S. Typhimurium isolates, four phage types were 
divided into 34 ribotypes and 23 pulsotypes (120). Molecular typing methods including 
PFGE, ribotyping, amplified fragment length polymorphism (AFLP) were more 
discriminatory compared to antibiotyping in characterizing ten outbreak isolates of S. 
Havana (173).  
Molecular Typing  
 
As previously mentioned molecular typing methods including ribotyping and PFGE are 
good tools for the discrimination of closely related Salmonella strains. Ribotyping 
generated more profiles in comparison to phage typing in a study of S. Enteritidis isolates 
from human clinical, food and water samples (107). Six different enzymes including 
EcoRI, HindIII, SmaI, Sau3AI, HaeIII and XhoI were compared in a study to ribotype 
three Salmonella serotypes: S. Typhimurium, S. Reading and Salmonella enterica 
serotype Seftenburg from a variety of sources. EcoRI generated the most clear and 
distinctive patterns (69). Ribotyping with SphI was found to be more discriminatory than 
PFGE in typing S. Enteritidis strains isolated from clinical and poultry sources (191). 
Ribotyping with two enzymes used together, for example PstI and SphI ribotyping (PS 
ribotyping) was demonstrated to be more discriminatory compared to phage typing, 
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PFGE and plasmid profiling for characterization of S. Enteritidis and S. Typhimurium in 
several other studies (118-120, 147). Since ribotyping using EcoRI is less discriminatory 
compared to PS ribotyping, it is suggested that EcoRI be used for serovar level of 
identification and PS ribotyping for further discrimination (56). Ribotyping using the 
automated version was the preferred method compared to PFGE in terms of 
discrimination, speed and increased standardization in a study that involved typing of a 
number of organisms including E. coli, Hafnia, Proteus and Staphylococcus aureus (92), 
whereas PFGE was demonstrated to be more discriminatory compared to ribotyping, 
phage typing and biotyping in typing S. Typhimurium, S. Enteritidis and S. Thompson in 
another study (153). The discriminatory ability of PFGE compared to plasmid profiling 
and ribotyping was also shown in another study of S. Enteritidis isolates (174). The 
discriminatory power of PFGE was demonstrated to be better compared to several other 
techniques including ribotyping, phage typing, fluorescent amplified fragment length 
polymorphism (FAFLP), insertion sequence typing and MLST in typing Salmonella 
serotypes by a number of groups (71, 81, 120, 121, 160, 189). 
 
Although PFGE is considered the gold standard for typing Salmonella, several studies 
have shown that other techniques including plasmid profiling, RAPD, MLST, MLVA 
further resolved PFGE groups (36, 104, 108, 123, 125, 178). Application of PFGE to 
differentiate drug resistant Salmonella isolates from the sensitive ones was demonstrated 
in several studies (76, 184, 213). The ability of PFGE technique to separate S. 
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Typhimurium direct phage type 104 (DT104) from the non DT104 isolates was also 
demonstrated in another study (66). 
 
Based on the above studies it is clear that molecular typing techniques that are based on 
chromosomal DNA analysis have an advantage over phenotypic typing methods for 
subtyping Salmonella species. Molecular techniques could successfully type almost all 
serotypes of Salmonella studied so far. For certain serotypes including S. Enteritidis it 
appears that ribotyping provides better discrimination than PFGE (118, 148, 191). 
However, for most serotypes including S. Typhimurium, S. Derby and S. Dublin, PFGE 
was more discriminatory compared to ribotyping (120, 121, 189). Based on the above 
observations it is clear that the discriminatory ability of a technique relies upon the nature 
of the genome of the Salmonella serotype. Therefore, an ideal typing system should 
include more than one technique.  A comparison of the common techniques used for 
typing Salmonella is summarized in Table 2. 
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 Table 2. Salmonella Subtyping 
Typing Technique Principle Advantages Disadvantages 
Biotyping Biochemical 
reactions 
Standard 
identification in 
laboratories 
Time consuming, 
laborious, expensive 
Serotyping Serological 
reactions against 
Somatic (O) and 
Flagellar antigens 
(H) 
Well known typing 
system for 
Salmonella species 
Not discriminatory 
for epidemiological 
analysis 
Not all Salmonella 
species are typeable 
using this method 
Phage typing Ability of 
bacteriophages to 
lyse specific 
Salmonella types 
More discriminatory 
compared to 
serotyping 
Plasmid Profiling Presence or absence 
of plasmids 
Discriminatory 
when comparing 
two isolates with 
presence of 
plasmids 
Chances of loosing 
the plasmid with the 
lack of selective 
pressure are very 
high. Not all 
Salmonella species 
are typeable using 
this method 
Ribotyping Hybridization to 
rRNA operons 
Conserved among 
species allowing 
species 
identification, very 
rapid with 
automated system 
Not discriminatory 
for all Salmonella 
serotypes, expensive
PFGE Macro restriction 
profiling of the 
entire genome 
Gold standard for 
typing Salmonella, 
Pulsenet database 
established for 
comparison between 
health laboratories 
in the US and other 
countries 
Laborious, not 
discriminatory for S. 
Enteritidis, 
expensive 
MLST Typing based on 
sequence analysis of 
housekeeping genes 
Analyses conserved 
areas of the genome, 
shown to be more 
discriminatory than 
PFGE in some 
Time consuming, no 
standardized 
protocol for 
Salmonella  
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Typing Technique Principle Advantages Disadvantages 
studies 
MLVA Typing based on 
sequencing of 
tandem repeats in 
the genome 
Shown to be more 
discriminatory than 
PFGE 
Still in the 
preliminary stages, 
needs validation and 
standardization 
 
Common techniques to subtype Salmonella and their advantages and disadvantages. 
PFGE- pulsed field gel electrophoresis, MLST- multi locus sequence typing, MLVA- 
multiple locus variable number tandem repeat analysis 
 
Molecular Typing for Epidemiological Investigations 
 
Subtyping with either phenotyping or genotyping could provide very valuable 
information regarding the epidemiology of the pathogen. This information assists in 
tracking down the source of the contamination and make needed changes and prevent 
further spread of the epidemic clone. A number of studies have shown the efficacy of 
molecular typing data for source tracking and general surveillance of Salmonella species. 
In a lengthy study of over six years, S. Enteritidis isolates collected from patients, 
chicken meat and chicken feces were characterized by phage typing and PFGE analysis 
and the outbreak strain was traced to chicken meat (19). In a similar study, an identical 
clone of Salmonella enterica serotype Indiana was identified in human patients, poultry 
meat and pet food by PFGE typing (165). A common link of S. Typhimurium infections 
was established between two children’s centers based on the ribotyping, PFGE and 
RAPD data (145). Clones of S. Newport were observed in humans and food animals in a 
study that characterized isolates by PFGE (213). Several other studies have determined 
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the circulation of identical clones between humans, foods, food animals and their 
environment by molecular typing techniques including PFGE, ribotyping, RAPD or 
phenotypic typing techniques including, phage typing and antibiotyping (14, 43, 82, 117, 
147, 154).  A number of studies have demonstrated that molecular typing was useful in 
establishing an epidemiological link between outbreak strains and their sources. For 
example cuttle-fish chips were determined to be the source of S. Oranienburg infections 
by PFGE, ERIC-PCR and in a study that involved isolates from patients and recalled 
food samples (105). An outbreak strain of S. Livingstone was traced to animal feed based 
on molecular typing data of animal food and human clinical isolates (68). Likewise, at 
times, phenotypic data was also successful in determining the source of outbreak. This 
was shown in a study where biotyping based on the ability of the isolates to ferment 
melibiose was helpful in tracking down the source of a S. Enteritidis outbreak to chicken 
portion of the lunch (3).   
Molecular typing methods also helped in demonstrating absence of an epidemiological 
link between different sources in several studies (37, 79). Molecular typing methods are 
not only useful in source tracking but also valuable in surveillance of Salmonella species 
in a particular environment (21). All the above studies suggest that molecular typing 
methods combined with phenotypic techniques are valuable in source tracking and 
establishing an epidemiological link, which is vital in an event of an outbreak or 
bioterrorism.  
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Pathogenicity Islands in Salmonella 
Salmonella possesses five large pathogenicity islands known as Salmonella Pathogenicity 
Islands (SPI) and a number of smaller pathogenicity islets (196). These large DNA 
fragments contain genes required for virulence mechanisms including invasion, 
macrophage survival, iron uptake and survival in low magnesium conditions (137). All 
the SPI except for the SPI-1 are inserted near tRNA loci (86). The SPI are horizontally 
acquired and have features of mobile elements including low G+C percentage compared 
to the rest of the genome, presence of integrases, presence of insertion sequences and 
direct repeats (DR) flanking on either of their sides (137, 149). 
 
SPI-1 and SPI-2 are the two islands that have been extensively studied in Salmonella. 
The SPI-1 is a 40 Kb element located at 63 minute centisome of Salmonella 
Typhimurium (149) and is present in all subspecies of Salmonella (157). The major 
function of the SPI-1 that harbors iron uptake genes is to encode the proteins required for 
invasion into the host epithelial cells. The iron uptake locus of SPI-1 has a different G+C 
content compared to the rest of the island proving that it was acquired independently of 
the SPI-1 (161). SPI-2, which is absent in Salmonella subspecies V is also a 40 Kb 
element located at 31 minute centisome near Val tRNA. Normal functioning of SPI-2 has 
been shown to be important for expression of SPI-1 genes (59).  Its functioning is 
important for the survival of Salmonella in macrophages and for defense against host 
reactive oxygen species (97, 158). The function of SPI-2 depends on various 
environmental cues including ion limitation and osmomolarity and was considered to be 
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regulated by the two component regulatory system phoP/phoQ. Some studies in 
Salmonella enterica Gallinarum have shown that SPI-2 but not SPI-1 is required for 
virulence (97). In a recent study it was demonstrated that SPI-2 is required for virulence 
in the colon and cecum in a mouse model (44). These two studies emphasize the role of 
SPI-2 and survival in macrophages in causing infection in the host (44, 97). Hensen-
Wester et al. have shown that SPI-2 could be transferred into a non- SPI-2 containing 
species, Salmonella bongeri (85). This functional transfer led to increased colonization 
and secretion of effector proteins by S. bongeri. However, these changes were not 
sufficient to cause any systemic infection, demonstrating that factors outside SPI-2 
influence the virulence of the organism. 
 
The less well-studied SPIs of Salmonella are SPI-3, 4 and 5. SPI-3 has been found only in 
Salmonella suspecies, I, II, IIIb and V. It is 17 Kb long and has a mosaic structure and 
encodes magnesium transporters. It is important for survival in macrophages, virulence in 
mice and survival in low Mg++ conditions (18). It is inserted near the selC tRNA locus 
and is regulated by the phoP/phoQ system. SPI-4 is also required for survival in 
macrophages and is 27 Kb long. SPI-5 is located near the serT tRNA locus and is unique 
to Salmonella species (209). It contains genes coding for Salmonella outer protein B 
(sopB) and other putative membrane proteins required for cellular responses. The cause 
of insertion of most of the SPIs near tRNA loci is not clear. However, it is possible that 
mobile elements that are horizontally transferred get inserted near a conserved locus 
similar to tTNA. It is also possible that the mobile elements that are inserted near the 
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conserved locus are retained in the course of evolution. Therefore, the SPIs that are 
inserted near tRNA loci are conserved and have been vertically transmitted, although 
SPI-1 that is not inserted near a tRNA is an exception.  
 
Both SPI-1 and SPI-2 harbor genes required for the type three secretion system (TTSS) 
(137, 146).  The TTSS is responsible for producing the proteins essential for bacterial 
internalization by the host, macrophage apoptosis and the production of effector proteins 
that interfere with the host cellular system and cause systemic disease. TTSS genes 
include spiC that encodes proteins required for intramacrophage survival and sseF and 
sseG that encode proteins for replication in the macrophage.  sifA and sseJ which are 
located on SPI-2 have been implicated in virulence and replication in macrophages (201).  
 
Knodler et al. observed an interesting phenomenon of cross talk between various SPIs 
(101). They established that the SPI- 5 genes are regulated by the two large pathogenicity 
islands (PI), SPI-1 and SPI-2. The genes of SPI-1 are the most conserved in all the 
Salmonella subspecies whereas the genes of SPI-2, SPI-3, SPI-4 and SPI-5 are not highly 
conserved, according to a microarray analysis (164).  A study based on pathogenic 
isolates of Salmonella subspecies I by Southern blotting and restriction fragment length 
polymorphism (RFLP), revealed that the SPI-1, SPI-2, SPI-4 and SPI-5 have a very 
conserved structure but SPI-3 has a high degree of variation between serotypes (5).  The 
structure and functions of the SPIs are summarized in Table 3. 
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Table 3. Salmonella Pathogenicity Islands 
Size/Co-location with tRNA 
gene 
Pathogenicity Island Major role/genes 
SPI-1 40 kb, unknown Invasion, Iron uptake 
genes, sit, invA 
40 Kb, val tRNA SPI-2 Survival in 
macrophages, 
replication, omp 
17 Kb, selC tRNA SPI-3 Magnesium uptake 
system, virulence genes, 
mgtC  
27 Kb, putative tRNA genes SPI-4 Macrophage survival 
SPI-5 serT tRNA Salmonella outer protein 
gene (sopB), virulence 
 
Structure and major function of Salmonella pathogenicity islands (SPI) 
 
Besides the five PI, Salmonella has other virulence factors including virulence plasmids, 
fimbriae and flagella (196).  The virulence plasmids in Salmonella are present in only six 
serotypes of Salmonella enterica including: S. Typhimurium, S. Enteritidis, S. Dublin, S. 
Pullorum, S. Choleraesuis and S. Gallinarum. These plasmids contain the spvRABCD 
locus. spvB is important for virulence and actin depolymerization. The spv (Salmonella 
virulence plasmid) locus is chromosomal in location in other subspecies of Salmonella, 
including subspecies II, IIIa and IV (115). Fimbriae and flagella have been shown to be 
required for colonization and motility respectively (196). 
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Antibiotic Resistance in Salmonella 
The prevalence of Salmonella in animal products including uncooked meat, eggs and 
milk is not surprising because it is endemic in food animals. To control the spread of 
infection in animals, antibiotics have been used in the past and are still being used.  
Although not proven, the increase of antibiotic resistance in Salmonella in developed 
countries could be mainly due to the administration of antibiotics in food animals for 
growth and treatment (192).  The increase of antibiotic resistance in developing countries 
is due to the widespread usage of antibiotics for human treatment (45). Salmonella 
evolved into a pathogen by acquiring pathogenicity determinants through horizontal gene 
transfer; similarly, it developed antibiotic resistance by virtue of mobile DNA elements. 
 
Salmonella is resistant to a variety of antimicrobials including ampicillin, broad-spectrum 
cephalosporins, aminoglycosides, quinolones, tetracycline, trimethoprim and 
chloramphenicol. Cabrera et al. characterized 62 Salmonella isolates causing travelers 
diarrhea that were collected from the Indian subcontinent and Western Africa during 
1995-2002 (28). Overall, 45% of the isolates were resistant to at least one drug including 
tetracycline, ampicillin and nalidixic acid. A very high increase (60%) in resistance to 
nalidixic acid was observed in 2003 compared to 1991. 
 
Resistance to two or more classes of drugs (MDR phenotype) is becoming increasingly 
widespread in Salmonella species.  Several studies have demonstrated the increasing 
prevalence of multidrug resistance in Salmonella (110). An increase in multidrug 
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resistant Salmonella was observed in a 1989-1990 study based on human clinical isolates 
in the US (110).  Similar observation was made in Greece in a survey during 1990-1997 
where increased resistance to tetracycline, ampicillin and piperacilin in non-typhoidal 
Salmonella isolates of humans, food animals and environment was observed (198). S. 
Typhimurium was found to be the most resistant in that study. Out of 113 isolates 
collected from poultry slaughterhouses, 65% were found to be multiply resistant to 
antibiotics including tetracycline, neomycin and streptomycin in a study in Spain (29). In 
a similar study, 90% of the S. Enteritidis isolates collected from humans, food and 
poultry samples were resistant to at least one antimicrobial and 61% were multidrug 
resistant (60).  Kariuki et al. observed a trend showing an increase in multiple resistance 
to chloramphenicol, streptomycin and tetracycline in human clinical Salmonella isolates 
collected from 1994 to 2003 (100).  
 
The prophylactic use of antibiotics in food animals is a major contributing factor for the 
increase in resistance in the US and Europe. In 1997, the World Health Organization 
(WHO) reported that the selection of antibiotic resistance in non-typhoid Salmonella is 
due to the use of antimicrobials in food animals (6). The increase of antibiotic resistance 
in the US is mainly due to the spread of resistant organisms in food animals. It is not due 
to increased antimicrobial use in humans in US or in any other country (45). Numerous 
studies have also verified the spread of resistance from food animals to humans. Chen at 
al. have observed that 82% of the isolates obtained from retail meat samples including 
chicken, turkey and pork were resistant to one or more drugs (39). An identical clone of 
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S. Typhimurium was observed in nine isolates collected from pork products and an 
outbreak of gastroenteritis in Portugal (7). This clone was pentadrug resistant to 
ampicillin, chloramphenicol, sulfomethoxizole, streptomycin and tetracycline (ACSuST) 
and the resistance was plasmid encoded. A high prevalence of tetA encoding resistance to 
tetracycline, strA and strB encoding resistance to streptomycin was observed in a study in 
Italy (163). Out of 58 multidrug resistant isolates from swine, turkey, chicken and duck 
samples 84% of the isolates carried str genes and 68% harbored tetA genes. An increased 
resistance to quinolones and fluoroquinolones was observed in food animals in a thirteen 
year study in Germany (134). A number of other recent studies have shown an alarming 
increase in the resistance to fluoroquinolones in food animals. In a lengthy study of 22 
years, Salmonella isolates from patients and food sources collected from 1981-2003 were 
tested for the presence of nalidixic acid resistance (138).  During the period of 1981-1991 
0.3% of the isolates showed resistance to nalidixic acid whereas, from 1992-2003, 24.8% 
of the isolates were resistant to nalidixic acid. Mutations in the quinolone resistance 
determining region of gyrA genes were seen in organisms from both food and human 
sources and increase in the resistance to nalidixic acid was attributed to the use of the 
antibiotics in food animals. The increase in the antibiotic resistance in Salmonella can 
also be attributed to the spread of MDR S. Typhimurium DT104 showing the 
characteristic pentadrug resistant phenotype ACSuST.  In a study of Salmonella isolated 
from raw foods of animal origin, animal feed and animal feces, 52% of all S. 
Typhimurium were found to be multiply resistant to chloramphenicol, tetracycline, 
sulfonamides and β-lactamases (135). This study confirms that food animals are 
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responsible for the increased resistance to various antibiotics in Italy. The above studies 
indicate that there has been an increase in multi-antimicrobial resistance over the past 
decade in Salmonella species especially in S. Typhimurium and S. Enteritidis. 
 
A number of factors have led to antibiotic resistance in bacteria. One of the major causes 
is the acquisition of resistance determinants and their retention even in the absence of 
antibiotics. Improper use of antimicrobials as in animal feed particularly at the 
subtherapeutic levels favors selection and eventual propagation of the resistant strains. 
Some bacteria are intrinsically resistant to antibiotics based on their genetic and structural 
organization while others acquire resistance by mutations or by horizontal gene transfer.  
A number of mechanisms are responsible for decreased susceptibility in bacteria (Table 
4) (166, 211). Some of them are due to chromosomal mutations leading to the low intake 
of the drug and increased efflux or alteration of the target. Others could be due to genes 
encoding for enzymes that inactivate the drug. A number of pumps or porins are involved 
in the uptake of antibiotics by bacteria. Mutations in the genes encoding these porins 
often lead to decreased permeability of the antimicrobial and hence increased resistance. 
For example mutations altering the expression of the genes encoding the outer membrane 
porins ompF and ompC result in decreased uptake of β-lactams in E. coli (166) . A 
similar situation was observed in clinical isolates of Salmonella enterica serotype Wein 
where absence of ompF led to imipenum resistance (9). acrAB efflux pumps have been 
demonstrated to be responsible for the increased resistance of S. Typhimurium to 
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penicillin, tetracycline and chloramphenicol (156). High expression of arcB gene was 
observed in post therapy resistant organism compared to pre-therapy susceptible ones.  
 
Mutations in the gyrA gene often lead to decreased susceptibility to quinolones in 
Salmonella (200). A number of studies have shown that the presence of β - lactamase 
genes confer resistance to various β lactams (172). Most of the resistance determinants 
are mobile and are usually harbored by plasmids, phages and integrons.  
 
Table 4. Antibiotic Resistance Mechanisms 
 
Antimicrobial Mode of Action  Resistance 
Mechanisms  
Genes 
responsible 
bla, ampC Inhibition of 
enzymes required 
for peptidoglycan 
synthesis, alterations 
in penicillin binding 
proteins 
β-lactams (penicillins, 
cephalosporins, carbapenums) 
Production of β-
lactamases, 
changes causing 
reduced uptake 
of the drug and 
active efflux 
 Quinolones (nalidixic acid, 
ciprofloxacin, levofloxacin) 
Inhibit DNA 
synthesis by acting 
on DNA gyrase and 
topoisomerase IV 
Mutations in 
genes encoding 
gyrase or 
topoisomerase, 
decreased 
permeability 
and active efflux 
tet (A-E), tet 
(M,O,P,Q,S) 
Tetracycline Prevents protein 
synthesis by binding 
reversibly to 30 S 
ribosomal subunit 
Altered 
permeability, 
active efflux or 
ribosome 
protection  
sul I & II Sulfonamides and 
Trimethoprim 
Inhibit conversion of 
p-amino benzoic 
acid (PABA) into 
dihydrofolate or 
Decreased 
permeability 
and 
overproduction 
35 
Antimicrobial Mode of Action  Resistance 
Mechanisms  
Genes 
responsible 
inhibit dihydrofolate 
reductase (DHFR) 
respectively 
of PABA 
cat genes Chloramphenicol Prevents peptide 
elongation by 
binding to 50 S 
ribosomal subunit 
Inactivation of 
the drug by 
chloramphenicol 
acetyl 
transferases  
aac, aad Aminoglycosides (gentamicin, 
amikacin, 
tobramycin,kanamycin,strepto
-mycin, spectinomycin 
Inhibit protein 
synthesis by binding 
irreversibly to 30 S 
ribosomal subunit 
Decreased 
uptake of drug 
or enzymes 
modification 
 
Some of the common antimicrobials to which Salmonella is resistant and their mode of 
action (166, 211) 
 
 
Plasmids as Antibiotic Resistance Determinants 
  
Plasmids are one of the most common vectors of antibiotic resistance genes in Gram 
negative organisms. Numerous studies based on conjugation experiments have shown 
that this resistance is transferable from one species to another facilitating the spread of 
antibiotic determinants (42, 208). Plasmids harboring resistant genes to a number of 
antibiotics have been reported. A transferable but non-conjugative plasmid carrying a 
blaCMY gene and conferring resistance to cephalosporins was observed in Salmonella 
species isolated from animals (208). Evidence of antibiotic resistance genes on a serotype 
specific virulence plasmid was first seen in clinical isolates of S. Choleraesuis where a 
smaller plasmid with drug resistance genes integrated into the virulence plasmid giving 
rise to a bigger plasmid (42). A very recent study also demonstrated the propagation of 
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virulence genes and antibiotic resistance genes in a plasmid (199). An integron carrying 
resistance genes to ampicillin, streptomycin and kanamycin was demonstrated in a 
virulence plasmid on S. Typhimurium in that study.  This situation is particularly 
alarming since it allows the dissemination of resistance and virulence determinants 
together and may favor selection. Circulation of plasmids with antibiotic resistance genes 
is a common feature in Enterobacteriaceae. For example a gene conferring resistance to 
florphenicol sequenced from MDR S. Newport showed 100% identity to the floR gene of 
R55 plasmid of Klebsiella pneumoniae (142). 96% of all S. Mbandaka clinical isolates 
were found to be resistant to broad-spectrum cephalosporins encoded by plasmids in a 
Tunisian study (132). A plasmid  conferring resistance to all β-lactams and β -lactam 
combinations, streptomycin, trimethoprim and sulfamethoxazole was observed in a 
clinical isolate of Salmonella Cubana (150). All the above studies show that plasmid 
mediated multiple drug resistance is widespread in Salmonella and is very prevalent in 
both human and animal isolates. 
 
Integrons as Antibiotic Resistance Determinants 
 
Integrons are mobile genetic elements containing antibiotic resistance genes. These 
integrons belong to a family of transposable elements, Tn21, and were first described by 
Schmidt and Kaul in 1984 (181). The name integron was first proposed by Stokes and 
Hall in 1989 (185). Integrons are found in chromosomal and extrachromosomal DNA in 
mostly in Gram negative bacteria (180). They consist of a 5’ conserved sequence (CS), a 
middle variable region and a 3’CS. The antibiotic resistance genes are generally 
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incorporated into the variable region by site-specific recombinations. The integrase gene 
(intI) of the 5’CS encodes enzymes essential for these recombinations. It mediates 
recombinations between a primary recombination sequence (attI) and a secondary site 
(attC or 59 base element) (46). The secondary site is associated with the gene cassettes of 
the variable region. A typical integron structure is shown in Figure 1. 
 
Figure 1. Integron Structure 
 
Variable Region
 
 
 
 
General structure of class-1 integron with 5’ conserved sequence, 3’ CS and a middle 
variable region with gene cassettes (112).  intI-integrase gene that mediates 
recombination in class-1 integron, Pant – anterior promoter required for expression of 
gene cassettes, sulI- sulfonamide resistance encoding gene typically present in the 3’ CS 
of an integron 
 
Integrons are divided into four classes and can be distinguished by their intI genes. The 
int1 gene was first described in an E. coli K12 strain in 1988 (139). The 3’CS is usually 
associated with genes encoding resistance to quaternary ammonium compounds (QAC) 
and sulfonamides. Integrons found in Salmonella species have the standard integron 
structure. Brown et al. characterized integrons in S. Enteritidis by using primers targeting 
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the conserved integron sequences (26). They observed four different integron profiles in 
11 isolates proving a great degree of diversity.  
 
Class-1 integrons are the most common ones that are associated with the multidrug 
resistant phenotype. Guerra et al. observed that 20% of all the MDR Salmonella 
serotypes isolated from patients and foodborne outbreaks in Spain were positive for class-
1 integrons (83). In an Irish study on clinical and food isolates of Salmonella 
Typhimurium, 90% were seen resistant to sulfonamides and 85% of those harbored class-
1 integrons (52). This supports the previously known concept that sulfonamide resistance 
is a good marker for class-1 integrons. The fact that sul genes are good markers for the 
presence of class-1 integrons was recently demonstrated (8).  
 
The presence of integrons was noted in clinical as well as environmental Salmonella 
isolates (124). Integrons are frequently associated with multidrug resistance phenotype 
(65, 116, 169).   Class-1 integrons were detected in 38% of MDR S.  Gallinarum isolated 
from chicken in South Korea (106). 34% of animal isolates and 71% Salmonella 
Typhimurium contained class-1 integrons in a study based in England and Wales (116). 
Class-1 and class-2 integrons were observed in a variety of serotypes that were resistant 
to three or more drugs including S. Emek, S. Newport, S. Stanley and S. Ohio (169). 
Multiplex PCR revealed the presence of class-1 integrons in 30% of 104 veterinary 
isolates that were MDR (65). It was also observed in the study that isolates showing 
resistance to tetracycline, chloramphenicol and kanamycin had a higher probability of 
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harboring integrons compared to others. In a recent study integrons were detected on 
conjugative plasmids in S. Agona isolates from pigs that were resistant to multiple 
antibiotics including tetracycline and chloramphenicol (24). In another study integrons 
were noted in Salmonella isolates from non-symptomatic carriers (212) .  Overall, these 
studies prove that class-1 integrons conferring multidrug resistance are ubiquitous in 
animal and human isolates of Salmonella. A very high prevalence is observed in S. 
Typhimurium isolates. This could be because of the wide host range and hence increased 
exposure to antibiotics and it could also be because of successful clonal spread.  
 
It is unknown as to where the integrons harboring multiple gene cassettes originated and 
what their original function was. A number of scientists have speculated that they have 
originated from the super integrons (SI) of Vibrio cholerae. The SI are large elements 
integrated into the chromosome of V. cholerae and harbor up to seventy gene cassettes 
(155). Magnus et al. have shown that the integrase activity of SI and class-1 integrons is 
similar and also sequence similarity exists between attC and Vibrio cholerae repeats. 
They have also shown that SI is required for metabolic activities and is not limited to just 
the virulence or antibiotic resistance functions. The fact that integrons were isolated from 
environmental samples further supports the theory that integrons do not have to be 
associated with pathogenicity or antibiotic resistance (179). 
 
Many recent studies have described the presence of novel integrons or integrons carrying 
novel resistance genes. A novel integron with β lactam and aminoglycoside resistance 
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genes was reported in S. Agona isolates from human clinical sources (152). A new class-
2 integron was identified in S. Enteritidis isolates in another recent study (2). A new gene 
aacA5 encoding resistance to aminoglycoside in a S. Kentucky strain isolated from spices 
was recently described (114). 
 
Integrons can be located on plasmids or chromosomes in Salmonella (25, 194). Class-1 
integrons coupled with plasmids in clinical were noted strains of Salmonella 
Typhimurium (194). Many scientists have observed the chromosomal integration of 
integrons in the pentadrug resistant strain S. Typhimurium DT104 isolates. This strain, 
which is avian in origin, has caused an immense increase in the multidrug resistant of 
Salmonella species (208). The 10 KB resistance gene cluster was characterized by Briggs 
et al. and contains two class-1 integrons separated by a resistance plasmid (R plasmid) 
(25). The characteristic two integron (1.0 Kb and 1.2 Kb) pattern of S. Typhimurium 
DT104 and S. Typhimurium non-DT104 isolates showing pentadrug resistance was noted 
in a number of studies (11, 131).  Boyd et al. further characterized the antibiotic 
resistance gene cluster and found it to be a part of a bigger island (22). They named this 
Salmonella genomic island 1 (SGI 1). SGI 1 is a 43 KB element with a different G+C 
ratio than the rest of the genome and it is usually flanked by DR establishing its 
horizontal acquisition (63). SGI 1 was later found in S. Albany, S. Paratyphi, and S. 
Agona with minor sequence variations (63, 64, 143). In a recent study, SGI 1 was 
identified in 46% of S. Paratyphi isolates tested (151).  Levings et al. in a very recent 
study identified SGI in a variety of other Salmonella serotypes including S. Emek, S. 
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Derby, S. Infantis and S. Kiambu (113).  This widespread presence of SGI in non S. 
Typhimurium isolates as well as non DT104 strains suggests that SGI confers some 
advantage to the organism and is spreading rapidly either by horizontal transfer or by 
plasmids. A third integron of 1.6 Kb carrying additional genes dfrA1 and aadA1 
conferring resistance to trimethoprim and aminoglycosides respectively was recently 
found in two S. Typhimurium DT104 bovine (51).  
 
Hypothesis 
Both the antibiotic resistance and virulence factors are required by the organism for 
survival against the host defenses. However, the correlation between antibiotic resistance 
and virulence in Salmonella or any other organism has never been extensively studied. 
There have been few reports of such association in Salmonella, for example the 
integration of both the serotype specific virulence plasmid and antibiotic resistant 
plasmid or integron in S. Choleraesuis, S. Typhimurium (42, 199). Similarly, Rahman et 
al. observed that the multidrug resistant S. Typhi caused more severe illness and 
prolonged fever than the susceptible ones due to possible association of the resistance 
plasmid with the virulence genes (167). This kind of association is very plausible as the 
bacteria that are pathogenic are more likely to encounter antibiotics than the less virulent 
organisms. For non-typhoidal Salmonella and other foodborne pathogens this might not 
be entirely true because of the administration of antibiotics for growth and prophylaxis in 
food animals. The pathogen does not have to be particularly virulent to have encountered 
antibiotics. However, the fact that it survives illustrates its ability to invade and propagate 
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amidst host defenses and antibiotics.  Some scientists might not agree with the above 
coselection concept on the basis that the presence of antibiotic genes cause target 
alterations and hence reduces the overall virulence of the bacteria (140). This could be 
true for maybe the first few growth cycles but the eventual survival and multiplication 
proves that the bacteria have compensatory mechanisms. In fact, it has been shown that 
compensatory mutations arise to support the growth of antibiotic resistant organisms (17). 
This further supports the opinion that the organisms that have both antibiotic resistance 
and virulence thrive better in hostile conditions. A number of subtle associations between 
antibiotic resistance and virulence have already been recognized in some studies. The 
occurrence of multiple antibiotic resistant operon marRAB in Salmonella subspecies I 
was observed by Randall and Woodward (170). The marA locus upregulates efflux 
pumps (example acrAB) that pump out antibiotics and marB downregulates outer 
membrane porin including ompF and therefore resulting in the decreased permeability of 
the outer membrane to antimicrobials. In addition, they found that the mar system was 
absent in Klebsiella, Streptococcus and Staphylococcus (mar). In a later study, Randall 
and Woodward have shown that the mar mutant of S. Typhimurium DT104 has reduced 
adherence and lower survival in macrophages in chickens (171). Similarly the 
upregulation of genes encoding iron uptake systems (fecA) and antioxidant defense 
enzymes (sodA, soxRS) was observed when marA was constitutively expressed in E. coli 
(12). The importance of iron as a virulence factor in Salmonella species and its presence 
on SPI-1 has already been established (94, 214). 
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The fact that antibiotic resistance persists even in the absence of selective pressure 
implies that the resistance factors are incorporated in the genome. This is more probable 
if the antibiotic gene clusters are carried by an integron since they have the integrase gene 
that mediates site-specific recombinations. The hypothesis of this study is that the 
antibiotic resistance determinants present on an integron are likely to be integrated into 
the chromosome as seen in the case of the S. Typhimurium DT104. This trend may be 
more common in the Salmonella serotypes that are more widespread and therefore likely 
exposed to antibiotics, for example S. Typhimurium, S. Enteritidis, S. Newport, and S. 
Agona and other common serotypes associated with food animals. The expected 
integration site for the integron on the Salmonella chromosome is a conserved location as 
seen in most horizontal gene transfers. A resistance gene cluster in PI encoding iron 
uptake systems has been recently found in Shigella flexneri but not in Salmonella species. 
Therefore the potential incorporation sites for the resistance genes in Salmonella species 
are SPI-1 (encodes for iron uptake proteins and is highly conserved), SPI-5 (encodes for 
Mg++ uptake systems and putative membrane proteins) or SPI-3 (has a mosaic structure 
with varying G+C content and recombination hot spots in addition to encoding Mg++ 
uptake systems and putative membrane proteins). Both PI and antibiotic gene clusters 
have the features of mobile elements (IS, DR and integrases) and are required for the 
survival of the bacterium against host defenses. Based on this and the above studies it is 
reasonable to hypothesize that selective pressure would bring SPI and antibiotic 
resistance elements together. It is possible that they are physically interrelated to each 
other and are co-expressed collectively. 
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Aims of the Study 
The overall aims of the project are to develop a protocol for rapid isolation of Salmonella 
from food, to build a molecular typing database and study the antibiotic resistance 
mechanisms of Salmonella species. The specific aims of the project are as follows:   
• To rapidly detect and isolate Salmonella species from food, as pure culture is 
required for molecular typing as well as antibiotic resistance analysis 
• To build a fingerprinting database with known serotypes and to identify unknown 
Salmonella species by comparing them to the database 
• Apply the DNA fingerprinting database to see differences in the typing patterns of 
the clinical and environmental Salmonella isolates  
• To compare the discriminatory ability of PFGE and ribotyping  
• To determine whether the DNA typing patterns correlate with the antibiotic 
resistance profiles as observed in other studies (76, 184, 213) 
• To understand the molecular basis of antibiotic resistance in Salmonella based on 
DNA profiles, plasmids and integrons 
• To determine if antibiotic resistance determinants and pathogenicity genes are co-
located in Salmonella species as seen in Shigella flexneri (127) 
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Chapter Two - Material and Methods 
Bacterial Isolates 
A total of one hundred fourteen Salmonella isolates consisting of 33 serotypes and three 
subspecies were used in this study. One hundred wild type isolates were used of which 
sixty are clinical and forty are from environmental sources. Thirty out of forty 
environmental isolates obtained from two midwestern turkey farms were kindly donated 
by Dr. Catherine Logue of North Dakota State University (NDSU); 10 were obtained 
from Washington State Department of Health (WADOH). Forty eight of the sixty clinical 
isolates were collected from various hospitals in Tampa, FL including Tampa General 
Hospital (TGH), Saint Joseph’s Hospital (SJH) and University Community Hospital 
(UCH). These Tampa clinical isolates were obtained through the Florida Department of 
Health (FLDOH) and will be referred to as FLDOH isolates. Twelve clinical isolates 
were donated by the WADOH. Twelve Salmonella strains were used as controls for real 
time PCR, ribotyping, PFGE and the antibiotic susceptibility testing. Seven of the control 
strains were obtained from American Type Culture Collection (ATCC, Manassa, VA); 
six were from CDC and one was from DuPont Qualicon (Wilmington, DE). All the 
isolates were characterized biochemically by API 20E® panel, analyzed with the APILAB 
Plus® Identification Program v.3.3.3/4.0 (bioMerieux, Inc., Hazelwood, MO) by Mrs. 
Kealy Peak. Serotyping of clinical isolates was performed by the Salmonella reference 
laboratory of the FLDOH, Bureau of Laboratories, Jacksonville, FL. Strains obtained 
from WADOH and Dr. Logue were serotyped by the contributors prior to inclusion in 
this study. E. coli, Proteus mirabilis and Citrobacter freundii obtained from ATCC were 
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used for specificity testing for the food detection and isolation. Shigella sonnei, Listeria 
monocytogenes and Bacillus cereus were used for the specificity testing of the primers 
and probes for the detection by real time PCR. The isolate number, serotype and source 
are shown in Table 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Isolates Used in the Study 
Strain number Serotype Clinical/ Environmental Source Source Isolation Date
CBD 032 S.Nima Clinical Unknown TGH 7/1/2001 
CBD 033 S.Aberdeen Clinical Rectal swab, Human TGH 9/30/2001 
CBD 067 S.Newport Clinical Unknown UCH 12/20/2001 
CBD 069 S.Javiana Clinical Unknown UCH 12/20/2001 
CBD 213 S.Newport Clinical Stool, Human FLDOH 11/18/2002 
CBD 222 S.Javiana Clinical Stool, Human FLDOH 11/26/2002 
CBD 425 S.Newport Clinical Stool, Human WADOH 8/10/2001 
CBD 426 S.Newport Clinical Stool, Human WADOH 2/5/2002 
CBD 427 S.Newport Clinical Stool, Human WADOH 3/31/2002 
CBD 428 S.Newport Clinical Stool, Human WADOH Unknown 
CBD 429 S.Oranienburg Environmental Bearded Dragon WADOH 7/22/2002 
CBD 430 S.Apapa Environmental Lizard WADOH 2/5/2003 
CBD 431 S. Saintpaul Environmental Alfalfa sprouts WADOH 3/14/2003 
CBD 432 S. arizonae Environmental Snake WADOH 2/5/2003 
CBD 433 S. arizonae Clinical Stool, Human WADOH 5/29/2003 
CBD 434 S.Brandenburg Clinical Stool, Human WADOH Unknown 
CBD 435 S.Westhampton Clinical Stool, Human WADOH 6/4/2003 
CBD 436 S.Paratyphi A Clinical Blood, Human WADOH 6/5/2003 
CBD 437 S.Saintpaul Clinical Stool, Human WADOH 6/6/2003 
CBD 438 S.Typhimurium Clinical Stool, Human WADOH 6/4/2003 
CBD 439 S.Enteritidis Clinical Stool, Human WADOH 6/6/2003 
CBD 440 S.Muenchen Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 441 S.Muenchen Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 442 S.Muenchen Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 443 S.Hildgo Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 444 S. Alamo Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 445 S. Javiana Environmental Unpasteurized OJ outbreak WADOH 6/1/1999 
CBD 446 S. Typhimurium Environmental Stool, Human WADOH Unknown 
CBD 569 S.Alachua Environmental Turkey Plant-2, Day-1 NDSU 2000 
CBD 570 S. Anatum Environmental Turkey Plant-1, Farm-A NDSU 2000 
CBD 571 S.Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 572 S.Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 573 S.Istanbul Environmental Turkey Plant-1, Farm-B NDSU 2000 
CBD 574 S.Istanbul Environmental Turkey Plant-1, Farm-B NDSU 2000 
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Strain number Serotype Clinical/ Environmental Source Source Isolation Date
CBD 575 S.Istanbul Environmental Turkey Plant-1, Farm-B NDSU 2000 
CBD 576 S.Kentucky Environmental Turkey Plant-1, Farm-B NDSU 2000 
CBD 577 S.Kentucky Environmental Turkey Plant-1, Farm-A NDSU 2000 
CBD 578 S. Mbandaka Environmental Turkey Plant-1, Farm-A NDSU 2000 
CBD 579 S. Montvideo Environmental Turkey Plant-2, Day-2 NDSU 2000 
CBD 580 S. Muenster Environmental Turkey Plant-1, Farm-C NDSU 2000 
CBD 581 S.Muenchen Environmental Turkey Plant-1, Farm-C NDSU 2000 
CBD 582 S. Reading Environmental Turkey Plant-1, Farm-B NDSU 2000 
CBD 583 S. Reading Environmental Turkey Plant-1, Farm-B NDSU 2000 
CBD 584 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 585 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 586 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 587 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 588 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 589 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 590 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 591 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 592 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 593 S. Newport Environmental Turkey Plant-2, Day-3 NDSU 2000 
CBD 594 S. Newport Environmental Turkey Plant-2, Day-4 NDSU 2000 
CBD 595 S. Newport Environmental Turkey Palnt-2, Day-5 NDSU 2000 
CBD 596 S. Newport Environmental Turkey Plant-2, Day-5 NDSU 2000 
CBD 597 S. Newport Environmental Turkey Plant-2, Day-6 NDSU 2000 
CBD 598 S. Newport Environmental Turkey Plant-2, Day-6 NDSU 2000 
CBD 603 S. Javiana Clinical Stool, Human FLDOH 8/2003 
CBD 604 S. Newport Clinical Stool, Human FLDOH 8/2003 
CBD 746 S. Typhimurium Clinical Stool, Human UCH 3/2004 
CBD 747 Clinical Stool, Human UCH 3/2004 S. IV 50:z4,z23:-- 
CBD 757 S. Typhimurium Clinical Stool, Human UCH 4/2004 
CBD 759 S. Newport Clinical Stool, Human SJH 4/2004 
CBD 775 S.Typhimurium Clinical Stool, Human SJH 3/2004 
CBD 776 S. Sandiego Clinical Body Fluid  from thyroid SJH 4/2004 
CBD 777 S.Typhimurium Clinical Stool, Human SJH 4/2004 
CBD 778 S. Typhimurium Clinical Stool, Human SJH 4/2004 
CBD 779 S. Enteritidis Clinical Stool, Human SJH 4/2004 
CBD 780 Clinical Stool, Human UCH 4/2004 S. IV 50:z4,z23:--  
CBD 781 S. Enteritidis Clinical Stool, Human UCH 4/2004 
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Strain number Serotype Clinical/ Environmental Source Source Isolation Date
CBD 782 S. Stanley Clinical Stool, Human UCH 4/2004 
CBD 805 S. Berta Clinical Stool, Human UCH 6/2004 
CBD 806 S.species Clinical Stool, Human UCH 6/2004 
CBD 807 S.Javiana Clinical Rectal swab, Human SJH 6/2004 
CBD 808 S.Muenchen Clinical Rectal swab, Human SJH 6/2004 
CBD 809 S.Muenchen Clinical Stool, Human SJH 6/2004 
CBD 810 S. Heildelberg Clinical Stool, Human SJH 6/2004 
CBD 811 Clinical Rectal swab, Human SJH 6/2004 S.  I  4,12:i:-- 
CBD 813 S. Javiana Clinical Stool, Human SJH 7/2004 
CBD 814 S. Anatum Clinical Stool, Human SJH 7/2004 
CBD 815 S. Newport Clinical Stool, Human SJH 7/2004 
CBD 816 S.Typhimurium Clinical Body fluid, Human SJH 7/2004 
CBD 817 S.Typhimurium Clinical Unknown UCH 7/2004 
CBD 818 S.Enteritidis Clinical Stool, Human UCH 7/2004 
CBD 819 S.Javiana Clinical Stool, Human SJH 8/2004 
CBD 820 S.Typhimurium Clinical Stool, Human SJH 8/2004 
CBD 821 S.Sandiego Clinical Stool, Human SJH 8/2004 
CBD 822 S.species Clinical Stool, Human SJH 8/2004 
CBD 823 S.Typhimurium Clinical Stool, Human SJH 8/2004 
CBD 824 S.Tallahassee Clinical Stool, Human SJH 8/2004 
CBD 825 S.Paratyphi A Clinical Blood, Human UCH 8/2004 
CBD 826 S.Javiana Clinical Unknown UCH 8/2004 
CBD 827 S.Newport Clinical Stool, Human UCH 9/2004 
CBD 828 S.Typhimurium Clinical Stool, Human UCH 9/2004 
CBD 829 S.Newport Clinical Stool, Human SJH 9/2004 
CBD 830 S.Javiana Clinical Stool, Human SJH 9/2004 
CBD 831 S.Muenchen Clinical Stool, Human SJH 9/2004 
CBD 832 S.Enteritidis Clinical Stool, Human UCH 10/2004 
CBD 833 S. IV 50:z4,z23 :- Clinical Stool, Human UCH 10/2004 
CBD 020 S. Infantis   Dupont Dupont 103   
CBD 024 S.Enteritidis   ATCC ATCC 13076   
CBD 025 S.Choleraesuis   ATCC ATCC 13312   
CBD 026   ATCC ATCC 13314   S. arizonae 
CBD 027 S. Pullorum   ATCC ATCC 19945   
CBD 028 S. Typhimurium   ATCC ATCC 23564   
CBD 030 S. Newport   ATCC ATCC 6962   
CBD 031 S. Derby   ATCC ATCC 6960   
50 
51 
Strain number Serotype Clinical/ Environmental Source Source Isolation Date
CBD 236 S. Typhimurium   CDC DOH-D-13   
CBD 321 S. Braenderup   CDC CDC H 9812   
CBD 387 S. arizonae  CDC CAP D-05  
CBD 599 S. Typhimurium   CDC CDC 61-99   
CBD 600 S. Typhimurium   CDC CDC 78-99   
CBD 1058 S. Newport   ATCC ATCC 27869   
CBD 52 E. Coli   ATCC ATCC 25922   
CBD 553 Citrobacter freundii   ATCC ATCC 8090   
CBD 554 Proteus mirabilis   ATCC ATCC 35659   
CBD 006 Bacillus cereus   ATCC ATCC 11778   
CBD 009 Listeria monocytogenes   ATCC ATCC 9525   
CBD 002 Shigella sonnei   ATCC ATCC 9290   
 
Isolate number, serotype, source and date of isolation of bacteria used in the study. UCH-University Community Hospital, 
Tampa, FL, SJH- St. Joseph’s Hospital, Tampa, FL, TGH- Tampa General Hospital, WADOH- Washington Department of 
Health, FLDOH- Florida Department of Health, NDSU- North Dakota State University, O.J- orange juice. The turkey carcass 
strains were isolated from two Plants, 1 and 2. Plant-1 isolates were from three different farms, A, B and C. Plant-2 isolates 
were collected in a course of six days. The specific days, farms and plants are indicated in the table. 
 
DNA Extraction 
DNA was extracted from pure cultures by using the MagNA Pure® LC instrument and kit 
(Roche Applied Sciences, Indianapolis, IN) or the Epicenter Masterpure DNA isolation 
kit (Epicenter Biotechnologies, Madison, WI). All the buffers except for Tris EDTA (TE) 
buffer (10mM Tris; 100mM Ethylenediamine tetraacetic acid) were provided in the kits. 
A 1: 20 ratio of, DNA to molecular biology grade water (Sigma Aldrich, St. Louis, MO) 
was used for all PCR reactions. 
 
 
®DNA Extraction by MagNA Pure
 
®MagNA Pure  is designed to purify DNA from bacteria and fungi. Bacterial isolates from 
freshly sub-cultured plates were grown in 4 ml of trypticase soy broth (TSB, REMEL, 
Inc., Lenexa, KS) for 18 hours at 37 °C. One ml of the TSB culture was centrifuged at 
8000 X g for 10 minutes and 900 μl of the supernatant was discarded. One hundred thirty 
μl of bacterial lysis buffer was added to the remaining 100 μl containing the pellet and 
mixed well. Twenty μl of proteinase K (50mg/ml) was added and incubated at 65 °C for 
10 minutes and at 95 °C for 10 minutes. The above 250 μl of the lysed sample was loaded 
into the machine along with buffers and disposables. The buffers are subsequently added 
automatically into the sample by the MagNa Pure® instrument. The first buffer to be 
added is 300 μl of lysis binding buffer, which lyses the cells and releases the DNA. Then, 
150 μl of magnetic glass particle is added to which DNA is bound. Four hundred fifty μl 
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of wash buffers I and II are then added to remove any unbound particles. One hundred μl 
of elution buffer is finally added to elute the DNA. 
 
DNA Extraction by Epicenter Kit 
 
Bacterial colonies from freshly sub-cultured plates were grown for 18 hours in TSB. 1 ml 
of the above culture was centrifuged for 5 minutes at 12,000 X g. The pellet was 
resuspended in 1 μl of proteinase K (50 μg/μl) and 150 μl of 2X tissue and cell lysis 
solution (2 X T+C). The sample was mixed well by vortexing and then was incubated at 
65 °C for 30 minutes. The sample tubes were transferred to a 95 °C heat block, incubated 
for 10 minutes, and then placed on ice for 5 minutes. One hundred fifty μl of protein 
precipitation reagent provided in the kit was added and the mixture was vortexed. The 
samples were centrifuged at 10,000 X g for 10 minutes and the supernatant was 
transferred to a fresh microfuge tube. Five hundred μl of 75% isopropanol was added to 
the pellet, tubes were inverted 30 to 40 times and centrifuged at 12,000 X g for 10 
minutes at 4 °C. The pellet containing DNA was rinsed twice with 75% ethanol. Finally, 
the pellet was resuspended in 200 μl of TE.  
 
Real time PCR- Primer and Probe Testing 
Three primers and probe sets representing the genes Salmonella outer protein B (sopB), 
outer membrane porin F (ompF) and Salmonella virulence plasmid A (spvA) were 
designed. sopB is required for virulence and fluid secretion but not invasion (78). The 
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main function of spvA is virulence since spvA mutants show lower virulence in mice 
(115). ompF is a porin, present on SPI-2 and is required for Salmonella virulence (109). 
The TaqMan probes were labeled with the reporter dye, 6 – carboxyfluorescein (FAM) 
on the 5’ end and the quencher dye, Black Hole Quencher (BHC) on the 3’ end. The 
primer and probe sequences are listed in Table 6. 
 
Table 6. Primers and Probes for Real Time PCR 
 
Gene Primer or probe Sequence (5’ to 3’) 
sopB Forward TGGCGGCGAACCCTATAAA 
sopB Reverse CGCGTCAATTTCATGGGC 
sopB TaqMan probe  TCGCACAACGCCTTGCCATGTT 
spvA Forward CGGTATTTGCTGGTTAATGGC 
spvA Reverse GAGCGTCGGCCGGAC 
spvA TaqMan probe TCATTAACCACCATCAGGGTGGCCA 
ompF Forward CCTGGCAGCGGTGATCC 
ompF Reverse AAATTTCTGCTGCGTTTGCG 
ompF TaqMan probe TGCCCTGCTGGCTGCTGCA 
 
The primer and probes sequences used for real time PCR in the study. All the above 
primers were designed using Primer Express® Oligo design software, version 1.5 
(Applied Biosystems, Foster City, CA) for this study.  
 
For the real time PCR, 50 μl reaction was set up consisting of 25  μl of TaqMan universal 
master mix (Applied Biosystems, Foster City, CA), 0.45  μl forward primer, 0.45  μl 
reverse primer (100 pmol/μl stock each), 0.125  μl of probe (100 pmol/μl stock), 18.975 
 μl of molecular biology grade water (Sigma Aldrich, St. Louis, MO) and 5 μl of the 
template DNA (40-50 μg/ml). All the primers used in this study were purchased from 
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Integrated DNA Technologies (IDT DNA, Coralville, Iowa).  PCR amplification and 
detection was carried out using ABI Prism 7700 sequence detection system using the 
default parameters (Applied Biosystems, Foster City, CA). Each sample was run in 
duplicate and the mean Cycle Threshold (CT) value was calculated.  CT value represents 
the cycle number at which the florescence of the reaction crosses the threshold (102). CT 
value shows the stage of the PCR reaction at which there is enough amplified product to 
give a positive result. Therefore, the lower the CT value the higher is the likelihood of the 
reaction to be positive. CT value of 40 or above was considered to be a negative reaction 
based on the criteria set by Heller et al. (90). 
 
Detection and Isolation of Salmonella from Artificially Contaminated Food Samples 
 
Ready to eat food samples were used in this study, as they are potential candidates for 
natural or intentional contamination. The food was from local grocery stores and was 
divided into 25 gm aliquots and frozen at –30 °C until needed. These foods are listed in 
Table 7. The background flora that is represented in CFU per gram of each food is also 
shown in the table.  The media used in this study were purchased from REMEL  
(REMEL, Inc., Lenexa, KS).  The background flora for each food was calculated by 
using the heterotrophic plate count (HPC) method as follows. Twenty five gm of food 
was homogenized with 225 ml of sterile phosphate buffered saline (PBS) in a stomacher 
(Seward Medical, London, UK) for 2 minutes at 230 RPM.  The homogenized sample 
was serially diluted to 10-2 -3 and 10  dilutions. Ten ml of the sample as well as the 
dilutions were poured onto a petri dish. Then, 12-15 ml of plate count agar (cooled to 45 
55 
± 1°C) was poured into the petri dish and allowed to solidify at room temperature. The 
plates were then incubated at 37 °C for 48 hours and the colony counts were recorded. 
Table 7. Food Samples for Analysis 
 
Food Sample Background (CFU/gm) 
Chicken cuts 15 
Egg salad 500 
Hamburger 5050 
Sushi 100 
Blueberries 420 
Cheese 2550 
Mayonnaise <10 
Orange juice 0 
 
Ready to eat food samples used in the study and their background flora calculated 
according to HPC protocol. The background is represented in colony forming units 
(CFU) per gram of food. 
 
 
For isolation and detection, 25 grams of each food sample was artificially inoculated with 
low spike (1- 10 CFU of S. Enteritidis, ATCC 13076 or S. Typhimurium, ATCC 23564) 
or mixed spiked (1-10 CFU of Salmonella species along with 5-200 CFU E.coli, Proteus 
mirabilis and Citrobacter freundii). The spiking amounts for each experiment and the 
organisms is shown in the Appendix, Table A1.  The negative control was unspiked. The 
standard spiking amount was maintained through frozen glycerol dilution stocks kept at –
80 °C. One hundred μl of frozen dilution stock of each organism, which was the amount 
used for the intentional contamination of the food samples, was plated on three TSA 
plates for viability count and quality control for each experiment performed. For 
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Salmonella, 100 μl of the frozen dilution was also inoculated on three xylose lysine 
desoxycholate  (XLD) plates. The mean viable count from the three XLD plates was 
considered as the spiking amount of Salmonella for each experiment. The mean viable 
count from the three TSA plates was considered the spiking amount for E. coli and 
Citrobacter. For the Proteus species individual colonies were not counted, but a lawn of 
growth on TSA plate was considered as the ideal spiking amount. 
 
The artificially contaminated food samples were homogenized within a sterile filter bag 
(Interscience laboratories, Weymouth, MA) using the stomacher (Seward medical, 
London, UK) for 90 seconds at 230 RPM with 225 ml of buffered peptone water (BPW, 
pH 7.2) containing bacto peptone.  The homogenate was incubated at 37 °C for 6 hours 
and 100 μl of the same was plated on TSA and XLD agar respectively and then incubated 
at 37 °C for 18 hours. For orange juice the inoculated BPW was shaken in a jar and was 
not homogenized. Salmonella species can be differentiated from other enterics based on 
three reactions, xylose fermentation, lysine decarboxylation and hydrogen sulfide (H2S) 
production on XLD agar.  Xylose is fermented by most enterics but not Shigella, this 
differentiates Shigella from Salmonella. Salmonella, which has lysine decarboxylase 
enzyme, reverts the pH back to alkaline conditions after the xylose fermentation. 
Coliforms are lysine positive but the presence of excess sucrose and lactose prevent these 
from reverting to alkaline conditions. Sodium thiosulphate and ferric ammonium citrate 
lend Salmonella to produce H2S that turns the colony black whereas E. coli, Citrobacter 
and Proteus produce yellow colonies. Deoxycholate is the selective agent and inhibits the 
growth of Gram positive organisms. 
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One ml of the BPW enriched samples was selectively enriched by IMS and tetrathionate 
(TT) broth. Organisms that can reduce TT survive and flourish in this medium while 
others are inhibited. Therefore, growth of fecal organisms will be inhibited. Bile salts and 
sodium thiosulfate inhibit Gram positive organisms and some Enterobacteriaceae. For 
IMS, 1 ml of the sample was mixed with 20 μl of anti Salmonella antibody beads (Dynal 
Biotech, Brown Deer, WI). The beads and the sample were mixed for an hour using the 
sample mixer (Dynal Biotech) and washed three times for 10 minutes in 400 μl of sterile 
PBS (with 10% Tween). Finally the beads were suspended in 100 μl of sterile PBS and 
50 μl was plated onto each of TSA and XLD agar plates.  For TT broth enrichment, 1ml 
of the BPW enriched sample was mixed with 10 ml of TT broth and incubated for 4 
hours, then 100 μl of the sample was plated onto TSA and XLD plates. The XLD and 
TSA plates from IMS and TT broth enrichment were incubated for 18 hours at 37 °C.  
The schematic of the isolation is represented in Figure 2. 
Figure 2. Isolation and Detection of Salmonella 
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Schematic of detection and isolation protocol; BPW=buffered peptone water, 
TT=tetrathionate broth, IMS=immunomagnetic separation, RT PCR=real time PCR 
 
Plate counts were recorded and the morphology of the colonies was determined.  All 
colonies that were black on XLD and resembled the control plates were considered to be 
Salmonella species. Each experiment was repeated for two or three times and the average 
was calculated.  DNA was extracted by using the ABI PrepMan® kit (Applied 
Biosystems, Foster City, CA) from one ml of each the BPW and the TT broth enriched 
samples.  Real time PCR (ABI 7700, Applied Biosystems, Foster City, CA) with 
Salmonella specific ompF gene was used to test the DNA extracted from the food 
samples. 
 
Statistical Analysis 
Students T test was calculated by comparing the averages of two sets of isolation. 
Isolation results from each enrichment technique: BPW, BPW+IMS and BPW+TT were 
compared against the others to get the P value. The data for low and mixed spiking was 
analyzed separately.  
 
Ribotyping 
 
Automated ribotyping was performed on the RiboPrinter® (Dupont Qualicon, 
Wilmington, DE) with the restriction enzyme EcoRI according to manufacturers’ 
instructions. All the reagents were supplied by the manufacturer. Briefly, 2-3 isolated 
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colonies from freshly inoculated TSA plates were suspended in 200 μl of sample buffer 
and heated to 80 oC for 15 minutes. 5 μl each of lysis agent A and B were added to 30 μl 
of the above sample and were placed in sample carrier tray. The sample carrier tray was 
loaded into the RiboPrinter® along with the gel cassette, membrane, purified water, 
restriction enzyme and other disposables including probe, substrate and conjugate. All the 
steps are automatically performed by the RiboPrinter® including the restriction digestion, 
separation of the DNA fragments on the gel and transfer of the fragments onto a 
membrane and its subsequent hybridization with the rDNA probe. The results were 
exported into the BioNumerics® (Applied Math, Sint-Martens Latem, Belgium) program 
in QNX (text file) format.  
 
Pulsed Field Gel Electrophoresis (PFGE) 
Macrorestriction digestion of genomic DNA was performed using the CDC standardized 
laboratory protocol for molecular subtyping of E.coli O157:H7.  All reagents were 
obtained from Sigma (Sigma Aldrich, St. Louis, MO) unless otherwise specified. Briefly, 
Salmonella colonies from freshly inoculated TSA plates (incubated for 18-20 hours) were 
suspended in 1 ml of cell suspension buffer (100 mM Tris: 100 mM EDTA, pH 8.0) to 
obtain an optical density of 1- 1.4 absorbance units at 610 nm. Two hundred μl of the 
above cell suspension, 0.2 mg of proteinase K and 200 μl of 1% molten agarose (Seakem 
Gold, Cambrex Bio Science, Rockland, ME) were dispensed into disposable plug molds 
(BioRad, Hercules, CA) and allowed to solidify for 10 minutes at 4 °C. The plugs were 
lysed in cell lysis buffer (50 mM Tris: 50 mM EDTA, pH 8.0 and 1 % Sarcosyl) with 0.5 
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mg of proteinase K for 2.5 hours at 54 °C in a shaking waterbath and were then washed 
twice in preheated water (50 °C) and four times in Tris EDTA buffer (50 °C) at 10 
minute intervals.  Plug slices of 2 mm width were digested with 50 units each of SpeI and 
XbaI (Promega, Madison, WI) separately for two hours. XbaI digested S. Braenderup 
H9812 plug slices were used as molecular weight standards.  The electrophoresis was 
carried out on the CHEF Mapper (BioRad, Hercules, CA) with an initial switch time of 
2.16 seconds and final switch time of 63.8 seconds for 18 hours. The running buffer as 
well as the buffer used for the gel was 0.5X Tris Boric acid EDTA (TBE) 
(Tris 0.04M, Boric acid 0.04M, EDTA, disodium 0.001M).  The gel was stained in 
ethidium bromide (0.4 mg/ 400 ml of deionized water) for 20 minutes, destined twice for 
10 minutes in deionized water for and visualized by using the GelDoc (BioRad, Hercules, 
CA). TIFF images were exported into the BioNumerics® program for analysis.  
 
PFGE for Non- Typeable Strains 
 
S.  Saintpaul is one of the serotypes that is known to be untypeable by PFGE under 
normal conditions. This serotype requires addition of thiourea in the TBE running buffer.  
Thiourea neutralizes a nucleolytic peracid derivative of Tris that is formed at the anode 
during electrophoresis. S. Saintpaul isolates were typed by the addition of 1600 μl of 
10mg/ml thiourea to 2100 ml of the TBE running buffer. 
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Antibiotic Resistance Testing 
Antibiotic resistance profiles were determined by using the Sensititre® system (Trek 
Diagnostics, Cleveland, OH). All the reagents were provided by the manufacturer.  The 
Sensititre® system consists of a panel of precision dosed antibiotics at different dilutions 
in a 96 well plate and is equivalent to the classic macrobroth dilution method. It provides 
an autoread system that utilizes fluorescence technology to detect the bacterial growth 
after 18 hours. The technology monitors the activity of specific surface enzymes and 
hence the fluorescence substrate generated is directly related to the growth of the test 
organism. Resistance to a total of 31 different antibiotics or antimicrobial combinations 
was tested using manufacturers’ instructions with two panels comprised of 23 and 16 
antibiotics each. Briefly, 1-2 pure colonies of the bacteria were resuspended in a saline 
tube to obtain a 0.5 McFarland density. Ten μl of this solution was placed into a Mueller 
Hinton broth tube. This mixture was then automatically dispensed in 50 μl aliquots into 
the 96 well plate by the machine. 
 
Intraplate reliability testing was done to see if the results vary based on time or day. A 
fresh TSA plate was inoculated with a sterile loop touching a colony of the mother plate 
of Salmonella enterica serotype Infantis (DuPont # 103) and incubated for 18 hours at 37 
°C. Five different reactions were set up using the same plate but touching different 
colonies for each. This was done five times using the same incubated plate but with five 
different saline and broth tubes. Then the broth tubes were used to automatically 
inoculate the 96 well plates consisting of the antibiotics. The same test was repeated 
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twice on two different days using the same colony from the mother plate to inoculate a 
fresh plate.  
 
The isolates were tested for various antibiotics including β lactams: ampicillin (Amp), 
piperacillin (Pip), ticarcillin (Tic); β-lactam/β-lactamase inhibitor combinations: 
amoxicillin/clavulanic acid (Aug), ampicillin/sublactum (A/S), piperacillin/tazobactum 
(P/T), ticarcillin/ clavulanic acid (Tim); Aminoglycosides: amikacin (Ami), gentamicin 
(G), kanamycin (K), streptomycin (Str), tobramycin (Tob); Cephams: ceftriaxone (Axo), 
cephalothin (Cep), cefoxitin (Fox), ceftiofur (Tio), aztreonam (Azt), cefepime (Fep), 
cefoperazone (Fop), cefotaxime (Fot), ceftazidime (Taz); Quinolones: nalidixic acid 
(Nal); fluoroquinolones: ciprofloxacin (Cip), levofloxacin (Levo), lomefloxacin (Lome);  
Others: chloramphenicol (Ch), tetracycline (Tet), trimethoprim/sulfamethaxazole (Cot), 
sulfamethoxazole (Smx), sulfizoxazole (Fis), imipenem (Imi). Results were interpreted 
according to the National Committee for Clinical Laboratory Standards (NCCLS, 2002) 
guidelines. The minimum inhibitory concentration (MIC) values in μg/ml of the isolates 
were compared to the NACCLS breakpoints. An isolate was considered to be resistant 
(R), intermediately resistant (I) or susceptible (S) based on the NCCLS breakpoints. An 
isolate was considered to be multidrug resistant if it was R or I to two or more classes of 
antibiotics. E. coli (ATCC 25922) was used for quality control. 
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 Dendrogram Construction 
Tagged image file format (TIFF) images of PFGE and ribotyping and the MIC values of 
antibiotic resistance were analyzed by BioNumerics® software, version 3.0 using the Dice 
coefficient. For PFGE, four molecular weight standards were run on each gel for 
normalization and bands below 54 kilobases (Kb) were not considered for analysis.  For 
ribotyping, the data was analyzed in two different ways. In the first method, data 
normalized by the RiboPrinter® was exported into the BioNumerics® database. In the 
second method TIFF images obtained from the RiboPrinter® were manually analyzed 
using the BioNumerics® software. The phylogenetic relationship between isolates was 
studied by dendrograms constructed with unweighted pair group method using arithmetic 
averages (UPGMA) with 1% position tolerance.  Strains that showed 93% or more 
similarity were considered identical for PFGE based on cluster analysis of molecular 
weight standards from various gels (Figure 3a). For the RiboPrinter®, comparison of 
molecular weight standards’ between gels showed 99.99% similarity, therefore strains 
showing less than 99.99% similarity were considered different for both automated 
normalization as well as the TIFF based manual analysis (Figure 3b). 
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Figure 3. Molecular Weight Standard Analysis 
 
Figure 3a. 
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Analysis of molecular weight standards of PFGE gels digested with XbaI. Eleven 
standards analyzed showed 93% similarity. 
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Figure 3b. 
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Analysis of molecular weight standards of ribotyping with EcoRI. The standards 
analyzed showed 99.99% similarity.  
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Integron PCR  
Integrons were amplified using the primers (Table 8) and conditions described by 
Levesque et al. (112). The primers are directed to amplify the entire length of the 
integron; therefore, the expected product size can be variable. For amplification of 
integrase gene (intigene) primers were designed based on previous studies are shown in 
Table 8 (212). All the reagents were purchased from TaKaRa Bio Inc. (Otsu, Shiga, 
Japan) PCR was performed in 50 μl reaction with 4 μl of 10X PCR buffer, 0.8 μl of 
deoxynucleotide triphosphate mix (2.5 mM/μl), 0.6 μl each of forward (18.8 pM/μl) and 
reverse primer (18.5 pM/μl), 6 μl of magnesium chloride (25 mM/μl), 35.6 μl of 
molecular biology grade water, 0.4 μl of Taq DNA Polymerase and 2 μl of DNA 
template. PCR was set up using the hot start method using the Whatman Biometra 
thermocycler (Horsham, PA). The initial denaturing was done at 94 °C for 5 minutes 
followed by 34 cycles of denaturation (94 o oC, 30 seconds), annealing (55 C for 30 
seconds), extension (72 oC for 2 minutes 30 seconds) and a final extension. Twenty μl of 
the amplified product was electrophoresed on 1% agarose gel using the Benchtop ladder 
(Promega, Madison, WI) as a size standard and stained in ethidium bromide. The stained 
gel was visualized using the GelDoc (BioRad, Hercules, CA) 
 
Table 8. Integron Primers 
Gene Primer  Sequence (5’ to 3’) Reference 
int Forward  GGC ATC CAA GCA GCA AG Levesque et al.
int Reverse AAG CAG ACT TGA CCT GA Levesque et al.
intigene Forward GTT CGG TCA AGG TTC TG Zhang et al. 
intigene Reverse  GCC AAC TTT CAG CAC ATG Zhang et al. 
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 Sequences of forward and reverse primers for integron (int) and integrase gene (intigene) 
PCR. 
 
DNA Sequencing 
 
The amplified product was purified using the QIAquick gel extraction kit (Qiagen, 
Valencia, CA) for sequencing using manufacturers’ protocol. Briefly, QG buffer was 
added to the fragments of interest that were cut from the agarose gel after PCR. The 
sample was incubated for 10 minutes at 50 oC and vortexed.  The sample was then placed 
in QIAquick spin column and centrifuged at 12,000 X g for 1 minute. The flow- through 
was discarded and 500 μl of buffer QG was added and centrifuged for 1 minute. The 
filtrate was discarded and 750 μl of PE buffer was added and centrifuged for 1 minute. 
The filtrate was discarded and the sample was spun dry for 1 minute. Finally, the DNA 
was eluted in 50 μl of molecular biology grade water (preheated to 65 oC). Five 
microliters of the eluted DNA was electrophoresed on 0.7% agarose gel for calculating 
the concentration of DNA for sequencing. Lambda DNA HindIII marker (Promega, 
Madison WI) was used as the molecular weight and concentration standard. 
 
Sequencing was done using the CEQ 8000 (Beckman Coulter, Fullerton, CA) following 
the manufacturer’s protocol and reagents. A total of 20 μl sequencing reaction was set up 
with 5 μl of the DNA template, 1.5 μl of primer (18.5 pM), 8 μl of DTCS and 5.5 μl of 
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molecular biology grade water. The thermal cycling was carried out for 30 cycles at 96 
°C for 20 seconds, 50 °C for 20 seconds and 60 °C for 4 minutes. The DNA was 
concentrated by precipitation in 1.5 ml microfuge tubes. Four μl of stop solution (equal 
volumes of 1.5 M NaOAc pH 5.2 and 50 mM EDTA pH 8.0) and 1 μl of glycogen (20 
mg/ml) was added to the cycle sequencing product. Sixty μl of cold 95% ethanol was 
added and mixed well. The sample was then centrifuged at 12,000 X g at 4 °C for 15 
minutes. The supernatant was then carefully removed without disturbing the pellet. The 
pellet was then washed twice in 200 μl of cold 70% ethanol by centrifuging at 12,000 X g 
for 10 minutes. The sample was then dried using the DNA 110 SpeedVac (Thermo 
Savant, Holbrook, NY) for 10 minutes. The sample was resuspended in 40 μl of sample 
loading solution and transferred to the 96 well sequencing plate. One drop of mineral oil 
was added to each well and then the plate was loaded onto the sequencer. The results 
were analyzed using the Lasergene software, version 5.6 (DNAstar Inc., Madison, WI) 
and compared with the National Center for Biotechnology Information database 
(http://www.ncbi.nlm.nih.gov/BLAST/). 
 
 
Plasmid Extraction 
Plasmids were extracted using the Qiagen plasmid midi kit (Qiagen, Valencia, CA).  The 
isolates were first grown on TSA plates and then an isolated colony was inoculated in 25 
ml TSB broth. The 25 ml culture was pelleted down and the pellet was resuspended in 4 
ml of buffer P1 and vortexed.  Then, 4 ml of buffer P2 was added and mixed gently and 
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incubated for 5 minutes at room temperature. Buffer P3 was then added and mixed gently 
and incubated on ice for 20 minutes. The sample was then centrifuged at 10,000 X g for 
30 minutes. The supernatant was filtered through a pre wet paper towel to eliminate extra 
debris. Four milliliters of buffer QBT was allowed to flow through the spin column to 
equilibrate the column. The supernatant was then placed in the spin column and allowed 
to flow through. The DNA in the column was washed twice with buffer QC. The DNA 
was then eluted in a fresh tube with 5 ml of preheated (50 0C) buffer QF. The DNA was 
then precipitated by adding 3.5 ml of isopropanol and centrifuged for 30 minutes at 
10,000 X g. The supernatant was discarded and the pellet was washed twice with 70% 
ethanol. The pellet was air dried and resuspended in 50 μl of TE buffer. Five microliters 
of the plasmid prep was electrophoresed on a 0.7% agarose gel.  
 
Membrane Transfer 
DNA was fractionated according to the PFGE protocol. The gel was soaked in several 
volumes of depurination solution (0.2 N hydrochloric acid) for 15 minutes. The gel was 
then soaked in denaturation solution (1.5 M sodium chloride. 0.5 N sodium hydroxide) 
for 20 minutes. The gel was rinsed in deionized water and then soaked in neutralization 
solution (1 M Tris pH 7.4, 1.5 M sodium chloride) for 30 minutes. The gel was again 
soaked in neutralization solution for an additional 15 minutes and the DNA was 
transferred from the gel to the membrane by capillary action. Briefly, a plexiglass 
container was wrapped in Whatmann 3 MM paper and placed in a large baking dish. The 
dish was filled with transfer buffer (10X SSC; 175.3 gm sodium chloride, 88.2 gm 
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sodium acetate per L of deionized water, pH 7.0). The gel was inverted and placed on the 
plexiglass support; a pre wet membrane (Roche Applied Sciences, Indianapolis, IN) was 
cut similar to the dimensions of the gel was placed on the gel. Two Whatmann filter 
papers were cut to match the gel size and placed on the membrane. The baking dish was 
filled with more transfer buffer and paper towels were stacked on the arrangement. 
Finally, a weight of about 500 gm was placed on this and the DNA was allowed to 
transfer for 48 hours. The arrangement was then disassembled and the DNA was 
crosslinked on the membrane using the UV Strata Linker® (Spectronics Corporation).  
 
Hybridization of Southern Blots 
The primers used to make the probe for Southern blotting are listed in Table 5. Probe 
bound to DNA fragments was detected by chemiluminescence. The probes were designed 
for variety of virulence and antibiotic resistance genes based on the Salmonella 
Typhimurium LT2 genome. sitA and sitB are iron transporter genes and are important 
virulence factors . phoP and phoQ are part of two component regulatory system. invA is 
the gene encoding the invasion protein and magA is the putative magnesium transporter. 
fecA encodes an iron carrier protein in Shigella flexneri that is present on a pathogenicity 
island and is associated with multiple antibiotic resistance genes.   ampC and ampH 
encode penicillin binding proteins conferring resistance to β- lactams. blaSHV and tem1 
encode resistance toβ- lactams. aadA2 is aminoglycoside resistance gene; tetR is the gene 
conferring resistance to tetracycline. sul1, dfr1 and cat genes confer resistance to 
sulfonamides, trimethoprim and chloramphenicol respectively. All the reagents were 
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purchased from Roche (Roche Applied Sciences, Indianapolis, IN) except for the primers 
and SSC solution. Primers were labeled using the digoxygenin (DIG) 3’ oligonucleotide 
tailing 2nd generation kit using the manufacturer’s protocol to make the hybridization 
probe. Briefly, 1 μl (100 pmol/ μl) of the forward or reverse primer shown in Table 9 was 
added to 8 μl of molecular biology grade water. This solution was then mixed with 4 μl 
of reaction buffer, 4 μl of cobalt chloride solution, 1 μl of DUG-dUTP solution, 1 μl of 
dATP solution and 1 μl of U terminal transferase. The sample was then mixed well and 
centrifuged briefly. The solution was then incubated for 15 minutes at 37 °C and placed 
on ice for 5 minutes. Finally 2 μl of 0.2 M EDTA was added to stop the reaction. The 
labeled probe was then added to 25 ml of hybridization solution. This probe was stored at 
–20 °C prior to use.  Hybridization was carried out using the CDP Star kit. The 
membrane was prehybridized in the pre heated DIG Easy Hyb solution for 1 hour at 35 
°C in a hybridization oven (VWR international, West Chester, PA).  This was replaced 
with preheated hybridization solution containing the probe. The membrane was allowed 
to hybridize for 18 hours at 35 °C. The blot was then washed twice for 5 minutes each in 
2X SSC and 0.5X SSC at appropriate temperature (5 °C less than melting temperature of 
the primer).  The blot was then washed on a rocker in 100 ml of washing buffer for 15 
minutes followed by blocking for 1 hour in 10% blocking buffer. The blot was then 
incubated in 20 ml of antibody solution (1 μl of anti-digoxigenin-AP Fab fragments in 20 
ml of blocking buffer) for 30 minutes. The blot was then washed in washing buffer twice 
for 15 minutes each. The membrane was then equilibrated in 20 ml of detection buffer for 
5 minutes. Finally, 2 ml of CDP star working solution was spread onto the membrane and 
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covered with transparency. The blot was then visualized in the ChemiDoc (BioRad, 
Hercules, CA) with appropriate exposure time. The membrane was then stripped by 
rinsing twice in 1X stripping solution (10X stock; 2M sodium hydroxide, 1% sodium 
didocyl sulfate). The stripped membrane was viewed in the ChemiDoc to make sure there 
was no signal. The stripped membrane was reused 2-3 times. 
 
Table 9. Probes for Southern Hybridization 
 
Gene Primer Sequence (5’ to 3’) Reference/Gene id 
fecA Forward GTT GTC GTC ATA AGA GCG G Luck et al. 
fecA Reverse GCT CCC ATT TCG CTC GGC Luck et al. 
sitA Forward GTC AGC TCG ATT ACC AAA CC STM2861*  
sitA Reverse CGC CGA TCA GCG CTG GTT STM2861*  
sitB Forward GGT TCA ATC GCC GCG CTG STM2862 * 
sitB Reverse GAG CTG TCC GGC GGG CA STM2862*  
phoP Forward GGT CTG CCG GAT GAA GAC G STM1231*  
phoP Reverse GTT CTC ATG GGG CGT CTG C STM1231*  
phoQ Forward GAC GCA GCG CAA CAT TCC STM1230 * 
phoQ Reverse CGC GAG CTT GAA GAT CAT C STM1230*  
magA Forward GCT GGC GTC GCG CGA TC STM3763 * 
magA Reverse CGG CGC GAT GGA TGT GCT STM3763*  
invA Forward GCG GAT GCC GCG CGC G STM2896*  
invA Reverse GGC GTG CGC CTG CCG G STM2896*  
ampC Forward TGG GGC TAT GCG GAC A 948669  
ampC Reverse ACG CCT GGG GAT ATC G 948669  
ampH Forward GCG CGC ATG TCC CGA 1246887  
ampH Reverse GCG GCG GAG TCT ATT C 1246887  
blaSHV Forward CA CGCTGACCGCCTG 1446571  
blaSHV Reverse GGTG GACGATCGGG TC 1446571  
tem1 Forward TCC CGT GTT GAC GCC G 2716540  
tem1 Reverse AGC CCT CCC GTA TCG TA 2716540  
aadA2 Forward CGA GCA TTG CTC AAT GAC 1450505  
aadA2 Reverse GGC CTC ACG CGC AGA 1450505  
tetR Forward GGT GTA GAG CAG CCT AC 1446691  
TetR Reverse GCA CTC AGC GCT GTG G 1446691  
Sul1 Forward GCC GGC CGA TGA GAT 1263138  
Sul1 Reverse TCT CGG TGT CGC GGA 1263138  
Dfr1 Forward CTG CCT TGG CAT TTG CC 933011  
Dfr1 Reverse CCT ATT TCC CTG AAG AGC 933011  
cat Forward GGC ATT TCA GTC AGT TGC 1251342     
cat Reverse AAG GCG ACA AGG TGC TG 1251342     
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Probes designed for various virulence and antibiotic resistance genes based on The 
Institute for Genomic Research (TIGR) or National Center for Biotechnology 
Information (NCBI) database. The gene id number is depicted;  * indicates that the 
primers were designed using TIGR website. fecA probe was designed based on Luck et 
al. (127) 
 
Southern Blotting with 1.0 Kb Integron Fragment 
 
For the detection of integrons in the PFGE gels in order to see the location of the 
antibiotic resistance determinants in relation to pathogenicity island genes Southern 
hybridization using the High Prime DNA Labeling and Detection Starter Kit II (Roche 
Applied Sciences, Indianapolis, IN) was used. The protocol is essentially similar to the 
above described DIG oligonucleotide tailing kit except that pure DNA extracted by using 
the QIA Quick kit after cutting the integron band was used as a probe. Approximately 1 
μg of template DNA was denatured by boiling for 10 minutes and chilled briefly on ice. 
Four microliters of DIG high prime solution was added to the above sample was 
incubated for 1 hour at 37 °C. The reaction was stopped by adding 2 μl of 0.2 M EDTA 
and heated at 65 °C. The sample was added to 25 ml of pre hybridization solution (Roche 
Applied Sciences, Indianapolis, IN) and stored at –30 °C before use. The hybridization 
was carried exactly as described above with minor variations. After the hybridization, the 
membranes were washed twice with 2 X SSC solution at 28 °C and twice with 0.5 X SSC 
solution at 68 °C.  
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Dot Blots for Southern Hybridization 
 
Dot blots were prepared to be as controls for the Southern hybridization. Approximately, 
2 μg of DNA was placed on a small piece of membrane (Roche Applied Sciences, 
Indianapolis, IN) and allowed to dry for 10 minutes at room temperature. After 10 
minutes, 2 μg of template was added again on the membrane and allowed to dry for one 
hour.  Both the positive control (CBD 746, S. Typhimurium) and negative control (CBD 
554, Proteus mirabilis) were placed on the two corners of the membrane as shown in 
Figure 4. 
 
Figure 4. Dot Blots 
 
 
+ Control    - Control 
Preparation of dot blots for positive and negative control. S. Typhimurium (CBD 746) 
was used as a positive control and Proteus mirabilis (CBD 554) was used as a negative 
control for integron and Salmonella virulence gene testing  
 
Whatman filter papers were cut to fit the size of the dot blots and placed in three trays. 
The filter paper was soaked with NaOH (0. 5M) in tray #1, Tris (1 M) in tray #2 and Tris 
(1 M) with NaCl (1.5 M) in tray #3. The dot blot membranes were then placed on each 
tray #1 for 10 minutes, tray #2 for three minutes and tray #3 for 10 minutes and allowed 
to dry and were crosslinked in the Stratalinker and visualized using the Chemidoc.   
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Chapter Three – Results 
 
Primer and Probe Testing of Salmonella species by Real Time PCR 
Three primers and probes targeting the genes sopB, spvA and ompF were tested on the 
DNA extracted from pure culture obtained from the 114 isolates listed in Table 5. A 
mean CT value of 40 or more was considered negative; the results were also analyzed 
based on the amplification plot generated for each well. An example of the amplification 
plot produced by the system is given in Figure 5.  A well defined peak showing a plateau 
stage represents a positive reaction whereas a scattered and disorganized plot depicts the 
absence of amplification. In the Figure 5, wells A3, A4; A5, A6 and A7 with Salmonella 
species were positive whereas the negative controls including a no template control, E. 
coli, Bacillus cereus, Shigella sonnei and Listeria monocytogenes did not produce a 
curve. 
Figure 5. Real Time PCR 
 
 
 
 
 
 
 
Amplification plot showing the CT value or the cycle number at which the fluorescence 
of the reaction crosses the threshold. A well-defined peak indicates that that the reaction 
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is positive, whereas smaller peaks indicate no reaction. The sample lanes and the graph 
are color-coded. A1, A2-no template control, A3, A4-Salmonella Pullorum, A5, A6-
Salmonella spp., A7, A8-Salmonella spp. A9, A10-Shigella sonnei, A11, A12-E.coli, B1, 
B2-E.coli, B3, B4-E.coli, B5, B6-E.coli, B7, B8-Bacillus cereus, B9, B10-Listeria 
monocytogenes 
 
Table 10 represents the CT values of the isolates for the three primers sets. All the isolates 
belonging to Salmonella enterica subspecies I were positive for the sopB gene, whereas 
only three out of seven isolates belonging to subspecies III and IV possessed the sopB 
gene. The spvA reaction was positive for only four serotypes of subspecies I including 
Pullorum, Choleraesuis, Typhimurium and Enteritidis. The spvA locus was also seen in 
some of the isolates belonging to subspecies III and IV. Overall, four out of six S. 
Enteritidis isolates, 13/16 S. Typhimurium isolates and four out of eight isolates 
belonging to subspecies III and IV were positive for the spvA gene. The ompF gene was 
detected in all of the 114 Salmonella isolates belonging to all of the three subspecies I, III 
and IV tested. The negative controls including E. coli, Shigella sonnei, Listeria 
monocytogenes, Proteus mirabilis, Citrobacter fruendii and Bacillus cereus were 
negative for all the three primer sets. 
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Table 10. Real Time PCR Results 
sopB gene spvA gene ompF gene CBD  # Genus Name Serotype/Subspecies Source 
CBD 0020 Salmonella Infantis ATCC +,16.06 -,40 +,19.2 
CBD 0024 Salmonella Enteritidis ATCC +,17.01 +,18.79 +,18.7 
CBD 0025 Salmonella Choleraesuis ATCC +,15.31 +,14.59 +,17.8 
-,40 +,17.88 +,18.0 CBD 0026 arizonae, subspeciesIIIATCC Salmonella 
CBD 0027 Salmonella Pullorum ATCC +,16.47 +,19.57 +,20.4 
CBD 0028 Salmonella Typhimurium ATCC +,15.35 +,17.30 +,18.6 
CBD 0030 Salmonella Newport ATCC +,18.82 -,40 +,18.5 
CBD 0031 Salmonella Derby ATCC +,16.47 -,40 +,17.1 
CBD 0032 Salmonella Nima FLDOH +,17.4 -,40 +,18.4 
CBD 0033 Salmonella Aberdeen FLDOH +,15.34 -,40 +,17.9 
CBD 0067 Salmonella Newport FLDOH +,16.11 -,40 +,17.4 
CBD 0069 Salmonella Javiana FLDOH +,15.89 -,40 +,21.9 
CBD 0213 Salmonella Newport FLDOH +,15.2 -,40 +,17.10 
CBD 0222 Salmonella Javiana FLDOH +,14.5 -,40 +,22.8 
CBD 0236 Salmonella Typhimurium CDC +,17.34 +,17.54 +,16.45 
CBD 0321 Salmonella Braenderup CDC +,16.92 -,40 +,16.9 
-,40 +,17.32 +,17.34 CBD 0387 arizonae, subspeciesIIICDC Salmonella 
+,18.53 -,40 +,16.73 CBD 0425 Newport WADOHSalmonella 
+,16.74 -,40 +,16.04 CBD 0426 Newport WADOHSalmonella 
+,16.82 -,40 +,16.63 CBD 0427 Newport WADOHSalmonella 
+,18.34 -,40 +,15.96 CBD 0428 Newport WADOHSalmonella 
+,19.6 -,40 +,16.05 CBD 0429 Oranienburg WADOHSalmonella 
+,18.0 -,40 +,16.14 CBD 0430 Apapa WADOHSalmonella 
+,16.6 -,40 +,16.34 CBD 0431 Saintpaul WADOHSalmonella 
+,27.99 -,40 +,16.03 CBD 0432 arizonae, subspeciesIII WADOHSalmonella 
-,40 +,17.7 +,20.56 CBD 0433 arizonae. subspeciesIIIWADOHSalmonella 
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sopB gene spvA gene ompF gene CBD  # Genus Name Serotype/Subspecies Source 
+,22.2 -,40 +,17.84 CBD 0434 Brandenburg WADOHSalmonella 
+,18.18 -,40 +,16.38 CBD 0435 Westhampton WADOHSalmonella 
+,24.1 -,40 +,25.22 CBD 0436 Paratyphi A WADOHSalmonella 
+,17.47 -,40 +,17.9 CBD 0437 Saintpaul WADOHSalmonella 
+,15.60 +,17.72 +,16.7 CBD 0438 Typhimurium WADOHSalmonella 
+,17.71 +,18.95 +,17.12 CBD 0439 Enteritidis WADOHSalmonella 
+,16.47 -,40 +,17.09 CBD 0440 Muenchen WADOHSalmonella 
+,14.98 -,40 +,18.51 CBD 0441 Muenchen WADOHSalmonella 
+,17.03 -,40 +,15.69 CBD 0442 Muenchen WADOHSalmonella 
+,18.34 -,40 +,18.19 CBD 0443 Hildgo WADOHSalmonella 
+,16.87 -,40 +,18.02 CBD 0444 Alamo WADOHSalmonella 
+,16.39 -,40 +,19.46 CBD 0445 Javiana WADOHSalmonella 
+,15.4 +,16.94 +,17.09 CBD 0446 Typhimurium WADOHSalmonella 
CBD 0569 Salmonella Alachua Turkey +,15.82 -,40 +,17.54 
CBD 0570 Salmonella Anatum Turkey +,16.30 -,40 +,18.01 
CBD 0571 Salmonella Newport Turkey +,15.29 -,40 +,17.48 
CBD 0572 Salmonella Newport Turkey +,15.73 -,40 +,16.38 
CBD 0573 Salmonella Istanbul Turkey +,17.31 -,40 +,16.68 
CBD 0574 Salmonella Istanbul Turkey +,15.30 -,40 +,17.38 
CBD 0575 Salmonella Istanbul Turkey +,17.11 -,40 +,16.40 
CBD 0576 Salmonella Kentucky Turkey +,17.29 -,40 +,17.03 
CBD 0577 Salmonella Kentucky Turkey +,17.63 -,40 +,17.10 
CBD 0578 Salmonella Mbandaka Turkey +,17.06 -,40 +,16.61 
CBD 0579 Salmonella Montevideo Turkey +,17.84 -,40 +,16.34 
CBD 0580 Salmonella Muenster Turkey +,16.41 -,40 +,15.58 
CBD 0581 Salmonella Muenster Turkey +,16.87 -,40 +,15.99 
CBD 0582 Salmonella Reading Turkey +,16.95 -,40 +,27.96 
CBD 0583 Salmonella Reading Turkey +,17.12 -,40 +,17.27 
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sopB gene spvA gene ompF gene CBD  # Genus Name Serotype/Subspecies Source 
CBD 0584 Salmonella Newport Turkey +,17.05 -,40 +,16.13 
CBD 0585 Salmonella Newport Turkey +,17.19 -,40 +,16.68 
CBD 0586 Salmonella Newport Turkey +,16.85 -,40 +,16.60 
CBD 0587 Salmonella Newport Turkey +,16.67 -,40 +,16.70 
CBD 0588 Salmonella Newport Turkey +,17.21 -,40 +,16.33 
CBD 0589 Salmonella Newport Turkey +,16.90 -,40 +,16.77 
CBD 0590 Salmonella Newport Turkey +,16.52 -,40 +,16.87 
CBD 0591 Salmonella Newport Turkey +,16.88 -,40 +,16.79 
CBD 0592 Salmonella Newport Turkey +,15.92 -,40 +,17.3 
CBD 0593 Salmonella Newport Turkey +,16.17 -,40 +,16.96 
CBD 0594 Salmonella Newport Turkey +,17.28 -,40 +,17.98 
CBD 0595 Salmonella Newport Turkey +,15.96 -,40 +,18.23 
CBD 0596 Salmonella Newport Turkey +,14.64 -,40 +,18.97 
CBD 0597 Salmonella Newport Turkey +,16.00 -,40 +,18.19 
CBD 0598 Salmonella Newport Turkey +,14.61 -,40 +,19.76 
CBD 0599 Salmonella Typhimurium CDC +,16.15 +,16.90 +,18.39 
CBD 0600 Salmonella Typhimurium CDC +,15.98 -,40 +,16.2 
CBD 0603 Salmonella Javiana FLDOH +,15.33 -,40 +,22.15 
CBD 0604 Salmonella Newport FLDOH +,15.32 -,37.95 +,17.34 
CBD 0746 Salmonella Typhimurium FLDOH +,15.62 +,16.07 +,17.98 
-,40 -,40 +,16.92 CBD 0747 FLDOH Salmonella IV 50:z4,z23:-- 
CBD 0757 Salmonella Typhimurium FLDOH +,15.48 +,17.20 +,16.85 
CBD 0759 Salmonella Newport FLDOH +,14.89 -,40 +,15.90 
CBD 0775 Salmonella Typhimurium FLDOH +,15.79 +,17.26 +,16.78 
CBD 0776 Salmonella Sandiego FLDOH +,16.15 -,40 +,16.13 
CBD 0777 Salmonella Typhimurium FLDOH +,15.72 +,16.92 +,16.88 
CBD 0778 Salmonella Typhimurium FLDOH +,16.31 +,17.57 +,17.13 
CBD 0779 Salmonella Enteritidis FLDOH +,15.41 +,17.01 +,16.24 
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sopB gene spvA gene ompF gene CBD  # Genus Name Serotype/Subspecies Source 
+,35.5 -,40 +,16.45 CBD 0780 FLDOH Salmonella IV 50:z4,z23:-- 
CBD 0781 Salmonella Enteritidis FLDOH +,15.73 -,40 +,16.57 
CBD 0782 Salmonella Stanley FLDOH +,15.89 -,37.81 +,16.99 
CBD 0805 Salmonella Berta FLDOH +,16.28 -,40 +,16.47 
CBD 0806 Salmonella Species FLDOH +,16.17 -,40 +,16.87 
CBD 0807 Salmonella Javiana FLDOH +,15.70 -,40 +,20.12 
CBD 0808 Salmonella Muenchen FLDOH +,16.53 -,40 +,17.33 
CBD 0809 Salmonella Muenchen FLDOH +,16.14 -,40 +,18.36 
CBD 0810 Salmonella Heildelberg FLDOH +,16.25 -,40 +,17.13 
+,15.73 +,14.95 +,15.99 CBD 0811 FLDOH Salmonella I  4,12:i:-- 
CBD 0813 Salmonella Javiana FLDOH +,16.32 -,40 +,21.95 
CBD 0814 Salmonella Anatum FLDOH +,16.04 -,40 +,16.52 
CBD 0815 Salmonella Newport FLDOH +,16.67 -,40 +,17.15 
CBD 0816 Salmonella Typhimurium FLDOH +,16.16 +,16.63 +,17.05 
CBD 0817 Salmonella Typhimurium FLDOH +,16.51 +,16.34 +,16.83 
CBD 0818 Salmonella Enteritidis FLDOH +,15.63 +,14.85 +,15.88 
CBD 0819 Salmonella Javiana FLDOH +,18.58 -,40 +,20.33 
CBD 0820 Salmonella Typhimurium FLDOH +,16.93 -,40 +,17.24 
CBD 0821 Salmonella Sandiego FLDOH +,19.72 -,40 +,16.31 
CBD 0822 Salmonella Species FLDOH +,17.5 -,40 +,17.08 
CBD 0823 Salmonella Typhimurium FLDOH +,19.41 +,20.54 +,16.89 
CBD 0824 Salmonella Tallahasse FLDOH +,19.34 -,40 +,16.56 
+,20.05 -,40 +,16.99 CBD 0825 Paratyphi A FLDOH Salmonella 
CBD 0826 Salmonella Javiana FLDOH +,19.2 -,40 +,20.61 
CBD 0827 Salmonella Newport FLDOH +,17.46 -,40 +,16.49 
CBD 0828 Salmonella Typhimurium FLDOH +,16.68 -,40 +,16.66 
CBD 0829 Salmonella Newport FLDOH +,17.36 -,40 +,18.18 
CBD 0830 Salmonella Javiana FLDOH +,17.44 -,40 +,22.90 
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CBD  # Genus Name Serotype/Subspecies Source sopB gene spvA gene ompF gene 
CBD 0831 Salmonella Muenchen FLDOH +,17.46 -,40 +,17.24 
CBD 0832 Salmonella Enteritidis FLDOH +,17.13 +,22.62 +,18.13 
CBD 0833 Salmonella IV 50:z4,z23 :- FLDOH +,35.15 -,40 +,17.56 
CBD 0052 Escherichia Coli ATCC -,40 -,40 -,40 
CBD 0553 Citrobacter Freundii ATCC -,40 -,40 -,40 
CBD 0554 Proteus Mirabilis ATCC -,40 -,40 -,40 
CBD 0006 Bacillus Cereus ATCC -,40 -,40 -,40 
CBD 0009 Listeria Monocytogenes ATCC -,40 -,40 -,40 
CBD 0002 Shigella Sonnei ATCC -,40 -,40 -,40 
 
Mean CT values from two reactions of the isolates tested for the three primers targeting the genes, Salmonella outer protein 
(sopB), Salmonella virulence plasmid (spvA) and outer membrane porin (ompF). The serotype names and sources are 
indicated. – Indicates a negative reaction and + indicates a positive PCR reaction. Dark gray cells for sopB and ompF genes 
specify a negative reaction; light gray cells for spvA gene indicate a positive reaction. 
 
 
 
 
 
 
 
Detection and Isolation of Salmonella species from Artificially Contaminated Food 
Samples 
 
Detection of Salmonella species 
 
Eight ready to eat food groups shown in Table 7 were artificially seeded with low spike 
(1-10 CFU of S. Typhimurium or S. Enteritidis) or mixed spiked (1-10 CFU of 
Salmonella species along with 5-200 CFU E. coli, Proteus mirabilis and Citrobacter 
freundii) as shown in Figure 2. The DNA was extracted after enrichment in BPW and 
BPW + TT broths and tested using real time PCR with primers targeting the ompF gene. 
The consolidated results of the PCR for the low spiked foods are shown in Table 11 and 
Figure 6 and the raw data is given in the Appendix (Table A1). For sushi, mayonnaise 
and orange juice enrichment in BPW resulted in 100% positive results, whereas for 
hamburger and chicken cuts further enrichment in TT broth provided 100% positive 
results. None of the enrichments were 100% successful for egg salad or cheese. None of 
the unspiked food samples gave a positive signal. Overall, 19/25 reactions were positive 
after BPW enrichment and 18/25 were positive after BPW and TT broth enrichment 
showing that further enrichment in TT broth did not provide any significantly additional 
benefit for the detection of Salmonella species by real time PCR (P=0.5). 
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Table 11. Real time PCR Results-Low Spiked 
 
No. Of positive 
Reactions Food (Low Spike) No. Of ReactionsBroth 
BPW 2 Chicken Cuts 3 BPW+TT 3 
BPW 3 Egg Salad 4 
BPW+TT 3 
BPW 2 Hamburger Meat 3 
BPW+TT 3 
BPW 3 Sushi 3 
BPW+TT 2 
BPW 2 Cheese 5 BPW+TT 3 
BPW 3 Mayo 3 
BPW+TT 1 
BPW 3 Orange Juice 3 
BPW+TT 2 
BPW 1 Blueberries 1 BPW+TT 1 
 
Real time PCR results of food samples artificially inoculated with 1-10 CFU of S. 
Enteritidis or S. Typhimurium.  The total number of experiments carried out and the 
number of positive reactions are shown. BPW= 6 h enrichment in buffered peptone 
water, BPW+TT= 6 h enrichment in BPW and 4 h enrichment in tetrathionate broth 
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Figure 6. Real time PCR Results-Low Spiked 
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Real time PCR results of food samples artificially inoculated with 1-10 CFU of S. 
Enteritidis or S. Typhimurium.  The total number of experiments performed is shown on 
the X-axis and the percentage of positive reactions is indicated on the top of the bars for 
each food group. BPW= 6 h enrichment in buffered peptone water, BPW+TT= 6 h 
enrichment in BPW and 4 h enrichment in tetrathionate broth 
 
The results for the mixed spiked food samples are represented in Table 12 and Figure 7. 
Enrichment with BPW as well BPW and TT broths gave 100% positive results for foods 
including chicken cuts, blueberries and hamburger. BPW and TT enrichment was better 
than BPW for egg salad and BPW was slightly better than BPW and TT enrichment for 
the foods including cheese and mayonnaise. Only one test was carried out on the mixed 
spiked sample of sushi, and it did not provide a positive result. On the whole, 15/20 
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(75%) reactions were positive with BPW enrichment and 13/30 (65%) reactions were 
positive when the samples were further enriched in TT broth. These results again 
demonstrate that further enrichment in TT broth did not significantly increase the 
sensitivity (P=0.4) 
 
Table 12. Real time PCR Results-Mixed Spiked 
Food (Mixed Spike) No. Of Reactions Broth No. Of +Ve Reactions 
BPW 2 Chicken Cuts 2 
BPW+TT 2 
BPW 1 Egg Salad 2 BPW+TT 2 
BPW 3 Hamburger Meat 3 
BPW+TT 3 
BPW 0 Sushi 1 
BPW+TT 0 
BPW 4 Cheese 5 BPW+TT 2 
BPW 2 Mayo 3 
BPW+TT 1 
BPW 2 Orange Juice 3 
BPW+TT 2 
BPW 1 Blueberries 1 
BPW+TT 1 
 
Real time PCR results of food samples artificially inoculated with 1-10 CFU of S. 
Enteritidis or S. Typhimurium along with E. coli, Proteus mirabilis and Citrobacter 
freundii.  The total number of experiments carried out and the number of positive 
reactions are shown. BPW= 6 h enrichment in buffered peptone water, BPW+TT= 6 h 
enrichment in BPW and 4 h enrichment in tetrathionate broth. 
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Figure 7. Real time PCR Results-Mixed Spiked 
P e r c e nt a ge  of  P osi t i v e  Re a c t i ons f or  M i x e d S pi k e
100% 100%
50%
100% 100% 100%
0% 0%
80%
40%
67%
33%
67% 67%
100% 100%
2 2 3 1 5 3 3 1
Chi c k e n Cut s Egg S a l a d Ha mbur ge r
M e a t
S ushi Che e se M a y o Or a nge  J ui c e B l ue be r r i e s
BP W
BP W+T
 
Detection results of food samples mixed spiked with 1-10 CFU of S. Enteritidis or S. 
Typhimurium along with E. coli, Proteus mirabilis and Citrobacter freundii.  The total 
number of experiments performed is shown on the X-axis and the percentage of positive 
reactions is indicated on the top of the bars for each food group. BPW= 6 h enrichment in 
buffered peptone water, BPW+TT= 6 h enrichment in BPW and 4 h enrichment in 
tetrathionate broth 
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Isolation of Salmonella species 
 
Ready to eat foods that were artificially seeded with Salmonella species were subjected to 
general enrichment in BPW and selective enrichment as shown in Figure 2. The 
purification or selective enrichment was carried out by IMS and TT broth respectively to 
compare the two techniques. The foods were low spiked, mixed spiked or unspiked and 
enriched in BPW, BPW+IMS and BPW+TT.  One hundred μl of BPW and BPW+TT 
enriched samples were inoculated in both XLD and TSA plates. For the BPW+IMS 
technique, 50 μl of the final product was plated onto TSA and XLD agar plates. The 
mean results of repeat isolation experiments are represented in Table 13 and the raw data, 
including each spiking amount and isolation results is shown in the appendix (Table A1). 
The colony count on the XLD agar was used for analysis. To compensate for the 
difference in the final amounts of BPW+IMS (50 μl) and the two broths (100 μl) plated 
on the XLD agar, half the number of colonies isolated after enriching in BPW and 
BPW+TT broth were considered for analysis. 
 
Figure 8a shows an example of isolation of Salmonella from unspiked, low spiked and 
mixed spiked foods after BPW+IMS enrichment. The negative control, which was 
unspiked, had very little background flora on TSA agar and almost none on the XLD 
agar.  The low spiked XLD plate predominantly showed the presence of Salmonella 
species, whereas the mixed spiked had few colonies, possibly E. coli or Citrobacter 
freundii. The black colonies of Salmonella species were easily distinguishable from the 
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yellowish ones on the XLD plate. A comparison of the three isolation techniques, after 
general enrichment in BPW and selective enrichments in TT broth and IMS is depicted in 
Figure 8b. No colonies were seen in the unspiked chicken cuts using any of the three 
enrichments on the XLD plates. The low spiked food samples had colonies using the 
three enrichment techniques. The highest number of Salmonella was seen in the mixed 
spiked sample using the IMS technique with no E. coli or Citrobacter contamination. 
However, possible E. coli and Citrobacter species were seen in the mixed spiked samples 
after the BPW enrichment as well as the BPW+TT enrichment. This data suggests that 
IMS technique might offer a cleaner sample of Salmonella species in mixed cultures 
compared to TT broth. 
Figure 8. Isolation of Salmonella on Selective Plates 
Figure 8a 
                                       
Unspiked     Low Spiked            Mixed Spiked 
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Isolation results of unspiked, low spiked (1-10, Salmonella species) and mixed spiked 
(Salmonella species with E. coli, Citrobacter and Proteus) from chicken cuts, after 
selective enrichment in buffered peptone water and immunomagnetic separation on 
trypticase soy agar and xylose lysine desoxycholate (XLD) agar. Black colonies on XLD 
agar represent Salmonella species; yellow colonies are possible E. coli or Citrobacter 
species.  
Figure 8b 
 Unspiked 
Low spiked 
Mixed spiked 
 
 
 
 
 
 
 
 
 
 
BPW   BPW+IMS  BPW+TT 
Isolation of Salmonella species from low spiked and mixed spiked chicken cuts with 
Buffered Peptone Water (BPW), immunomagnetic separation (BPW+IMS) and 
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tetrathionate broth (BPW+TT) enrichments on xylose lysine desoxycholate (XLD) agar. 
Black colonies represent Salmonella species. 
 
Table 13 and Figure 9 show the mean data of repeat tests for the isolation of Salmonella 
species from low and mixed foods after six hour general enrichment and selective 
enrichments. The raw data with results from each experiment is in the Appendix (Table 
A1). The unspiked samples were consistantly negative for Salmonella and therefore are 
not shown in the table or the graph. The number of colonies isolated after selective 
enrichment in IMS was greater than the general enrichment in BPW for all the low spiked 
food samples except cheese. However, further enrichment in TT broth for four hours did 
not improve isolation over the general enrichment for most of the low spiked foods. For 
cheese, all the rapid enrichment techniques provided poor recovery. An overnight 
incubation in BPW was required for cheese to obtain any growth on the plates. Overall, 
isolation by BPW+IMS was significantly better than BPW (P=0.02) and BPW+TT 
(P=0.01) for the food samples that were spiked with low levels of Salmonella. 
Enrichment in BPW provided better recovery compared to BPW+TT (P=0.03) for the 
low spiked samples. The isolation data for low spiked food clearly shows that BPW+IMS 
is the best technique compared to the general enrichment in BPW or the selective TT 
broth enrichment. 
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For mixed spiked food samples, again for most food types, BPW+IMS was better than 
the other two methods. For foods including chicken cuts, egg salad and mayonnaise BPW 
provided better recovery than BPW+TT and the converse is true for the other foods. 
Although BPW+IMS technique facilitated the isolation of more Salmonella colonies 
compared to BPW+TT, the difference between the two techniques for mixed spiked food 
samples is not significantly different (P=0.95). However, isolation results of BPW+IMS 
are significantly different compared to BPW enrichment (P=0.01).  On the whole, it is not 
surprising that both BPW+IMS and BPW+TT improved the isolation of Salmonella 
species from mixed cultures compared to the general enrichment. In general BPW+IMS 
is the best technique for both the low and the mixed spiked food groups. 
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Table 13. Isolation of Salmonella from 25 gm of Spiked Food 
Food(25gm) Sample
Background 
(CFU/gm)
Mean CFU 
BPW
Mean CFU 
BPW+IMS
Mean CFU 
BPW+TT
# of 
Expts.
Low Spiked 15 30 170 8 3
Mixed Spiked 66 230 28 2
Low Spiked 500 28 80 9.5 3
Mixed Spiked 45 99 20.5 2
Low Spiked 5050 46.5 227 21 3
Mixed Spiked 68 165 102 3
Low Spiked 100 22.5 28 14 3
Mixed Spiked 9 5 22.5 1
Low Spiked 420 15.5 98 21.5 5
Mixed Spiked 6.5 79 86 2
Low Spiked 2550 0.1 0 0 4
Mixed Spiked 0 2 0
Low Spiked 2550 TNTC TNTC TNTC 1
Mixed Spiked 0 31 TNTC
Low Spiked <10 58 115 25.5 3
Mixed Spiked 92 255 83.5 3
Low Spiked 0 6.5 39 4.5 3
Mixed Spiked 9.5 21 10.5 3
Orange Juice
Blueberries
Cheese
Cheese O/N
Mayonnaise
Chicken Cuts
Egg Salad
Hamburger
Sushi
4
1
 
Isolation of Salmonella from 25 gm of food samples low spiked or mixed spiked and 
enriched in buffered peptone water (BPW), BPW+IMS (immunomagnetic separation) or 
BPW+TT (tetrathionate broth). The background flora of each food group is indicated. 
The mean colony count on xylose lysine desoxycholate (XLD) agar from repeat tests is 
shown. TNTC=too numerous to count. 
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Figure 9. Isolation of Salmonella from 25 gm of spiked food 
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Isolation of Salmonella from food samples enriched in buffered peptone water (BPW), 
BPW+IMS (immunomagnetic separation) or BPW+TT (tetrathionate broth). The mean 
colony count on xylose lysine desoxycholate (XLD) agar from repeat tests is shown. For 
the graph, too numerous to count colonies were represented as 500 
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Application of Colonies Isolated from Food for Typing and Antibiotic Susceptibility 
Testing 
 
Salmonella colonies isolated on XLD agar after general enrichment in BPW and selective 
enrichment in IMS and TT broth were subtyped by PFGE, ribotyping and antibiotic 
susceptibility profiles. S. Typhimurium with which the food samples were originally 
spiked was used as a positive control and was grown on a TSA plate. The organism 
isolated after the enrichments had identical ribotype, PFGE and antibiotic susceptibility 
patterns as the control (Figure 10, Table 14). This shows that pure culture was achieved 
after the enrichments and there was no possible contamination. These results demonstrate 
that Salmonella colonies isolated from the selective XLD agar can be used to subtyping 
pure culture from a TSA plate is not required. 
Figure 10. Molecular Typing on Salmonella Isolated from Food 
 
10a.       10b. 
M       +       B         M       BI      BT      M M           +               B               BI 
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Application of S. Typhimurium isolated from intentionally contaminated food after 
general and selective enrichment for molecular typing. The colonies isolated on xylose 
lysine desoxycholate (XLD) agar were used for typing. 10a. Ribotyping, 10b. Pulsed field 
gel electrophoresis; M=molecular weight standard, + = positive control, B=buffered 
peptone water, BI=B + immunomagnetic separation, BT=B + tetrathionate broth 
enrichment 
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Table 14. Antibiotic Susceptibility Testing of Salmonella Isolated from Spiked Food 
 AMI A/S AZT FEP FOP FOT TAZ AXO CH CIP G IMI LEVO LOM PIP P/T FIS TET TIC TIM TOB SXT
+ 4 S 2 S 2 S 2 S 4 S 4 S 1 S 4 S 4 S .25S 1 S 1 S .12 S .5 S 8 S 8 S 256S 1 S 8 S 16 S 1 S .5 S 
B 4 S 2 S 2 S 2 S 4 S 4 S 1 S 4 S 4 S .25S 1 S 1 S .12 S .5 S 8 S 8 S 256S 1 S 8 S 16 S 1 S .5 S 
BI 4 S 2 S 2 S 2 S 4 S 4 S 1 S 4 S 4 S .25S 1 S 1 S .12 S .5 S 8 S 8 S 256S 1 S 8 S 16 S 1 S .5 S 
BT 4 S 2 S 2 S 2 S 4 S 4 S 1 S 4 S 4 S .25S 1 S 1 S .12 S .5 S 8 S 8 S 256S 1 S 8 S 16 S 1 S .5 S 
 
Antibiotic susceptibility testing of S. Typhimurium isolated from artificially contaminated food samples. AMI- amikacin, A/S- 
ampicillin/sublactum, AZT- aztreonam, FEP- cefepime, FOP- cefoperazone, FOT- cefotaxime, TAZ-ceftazidime, AXO- 
ceftriaxone, CH- chloramphenicol, CIP- ciprofloxacin, G- gentamicin, IMI- imipenem, LEVO- levofloxacin, LOME- 
lomefloxacin, PIP- piperacillin, P/T- piperacillin/tazobactum, FIS- sulfizoxazole, TET- tetracycline, TIC- ticarcillin, TIM- 
ticarcillin/ clavulanic acid, TOB- tobramycin, SXT- trimethoprim/sulphamethoxazole. + = Positive control, B=buffered 
peptone water, BI=B + immunomagnetic separation, BT=B + tetrathionate broth enrichment, S= susceptible 
 
 
 
rDNA Analysis by Automated RiboPrinter®
The 100 wild type Salmonella isolates and the controls strains were subjected to rDNA 
analysis by automated ribotyping with the enzyme EcoRI. The results were analyzed by 
using BioNumerics® software. Figure 11a shows an example of the TIFF image obtained 
after the automated ribotyping. The results are obtained in eight hours and the 
RiboPrinter® identifies strains based on the ribotype patterns of the organisms in its 
database (Figure 11b). The first strain (S. Choleraesuis) in Figure 11b was placed in a 
group of five with 86% similarity, which included S. Choleraesuis.  The third strain (S. 
Typhimurium) was placed in a group of 55 with 96% similarity, which also consisted of 
S. Typhimurium. The fourth strain (unknown) was put in a group of 12 with 90% 
similarity. The sixth strain (S. Derby) was placed in a group of 3 with 90% similarity that 
included S. Derby. The fifth strain was identified correctly as S. Newport.  The 
RiboPrinter® database did not identify the second and eighth strains (unknown). The 
seventh strain CBD 32 was identified as Salmonella enterica serotype Give; however this 
identification was incorrect based on biochemical and serological results. Out of the eight 
strains analyzed, the RiboPrinter® correctly identified six as Salmonella species of which, 
S. Newport was correctly recognized at the serotype level. Two of the eight isolates were 
not grouped as Salmonella species, possibly due to the absence of these types in its 
database. One of the serotypes (CBD 32, S. Nima) was mistakenly identified as S. Give. 
These results show that the results analyzed by the RiboPrinter® may be correct at the 
species level for Salmonella but not always at the serotype level which is expected 
because the criteria used by the ribotyping and the serotyping are different. Serotyping 
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analyses the serological properties of the organism and ribotyping analyzes the rRNA 
operons, hence a correlation although possible is not always expected. Therefore, analysis 
and comparison of the fingerprints by creating a separate database is suggested. 
Figure 11. Ribotyping of Salmonella 
11a. 
 
 
      M      1   2    M   3      4    M   5      6   M     7    8    M 
Ribotyping of Salmonella species by automated RiboPrinter®.  1= CBD 25, S. 
Choleraesuis; 2=CBD 26, S. arizonae; 3= CBD 28, S. Typhimurium; 4= CBD 29, S. 
species; 5= CBD 30, S. Newport; 6= CBD 31, S. Derby; 7= CBD 32, S. species; 8=CBD 
33, S. species, M= Molecular weight standard 
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Figure 11b 
 
 
Identification of unknown Salmonella serotypes by the RiboPrinter® after auto 
normalization. Samples 1, 3, 4, 6 were placed in groups AE, AA, AB and AF respectively 
by the RiboPrinter®.  Samples 5 and 6 were identified as S. Newport and S. Give; 
samples 2 and 8 were not identified. 
 
DNA Fingerprinting by Macrorestriction Digestion (PFGE) 
The 100 wild type isolates were subtyped by PFGE with two enzymes, XbaI and SpeI, 
and were analyzed using BioNumerics® software. An example of a PFGE gel containing 
samples digested with XbaI is shown in Figure 12. Four standards were run with each gel 
for normalization.  The four environmental S. Newport isolates in lanes 1-4 are identical 
whereas the clinical S. Newport in lane 10 is slightly different (Figure 12). It is also clear 
that the unknown Salmonella serotype (CDC isolate sent for PulseNet certification) in 
lane eight has an identical pattern to the molecular weight standard S. Braenderup. The 
two isolates in lanes six and seven have completely different PFGE profiles although they 
are both of the same serotype (Typhimurium).  These results indicate that typing by 
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PFGE can be used for identification of an isolate if the strain is already present in the 
database. It is also clear that two isolates belonging to one serotype can have an identical 
pattern or very different profiles. It is important to know the percent relatedness of the 
isolates belonging to the same serotype to assess its clonality in the event of an outbreak; 
therefore visual observation of the fragments in the gel is not sufficient. 
 
Figure 12. PFGE of Salmonella with XbaI  
 
M       1   2     3    M      4    5     6    7    M     8     9   10    11    M
1135 Kb
668.9 Kb
452.7 Kb
336.5 Kb
173.4 Kb
54.7 Kb
 
 
 
 
 
 
 
 
 
 
 
Analysis of Salmonella species by macrorestriction profiling by XbaI. Lane 1= CBD 595 
(S. Newport), lane 2= CBD 596 (S. Newport), lane 3= CBD 597 (S. Newport), lane 4= 
CBD 598 (S. Newport), lane 5= CBD 599 (S. Typhimurium), lane 6= CBD 600 (S. 
Typhimurium), lane 7= CBD 601 (S. species), lane 8= CBD 602 (S. species), lane 9= 
CBD 603 (S. Javiana), lane 10= CBD 604 (S. Newport), lane 11= CBD 31 (S. Derby), 
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M= molecular weight standard (CDC H 9812, S. Braenderup). The molecular weights of 
the bands are shown in Kb 
 
Identification of Unknown Salmonella Serotypes by Molecular Typing 
The rDNA and PFGE fingerprint database of known Salmonella serotypes created by 
using the BioNumerics® software was used to identify the unknown Salmonella samples 
obtained from FLDOH. The unknown isolates were eventually serotyped by Bureau of 
Laboratories, Jacksonville, FL. but the molecular typing database was validated for initial 
identification. The results of ribotyping database for identification of selected unknown 
isolates are shown in Figure 13a and Table 15. By using the ribotyping and the PFGE 
database, isolates 213, 604, 759, 827 and 67 were identified as S. Newport (Figure 13b). 
Ribotyping gave a very close relatedness of 90 to 100%.  Whereas; by PFGE, the isolates 
were related by 65% to S. Newport. Isolates 832, 781, 779 and 818 showed a very close 
similarity of more than 80% to S. Enteritidis using both the ribotyping and PFGE 
database. All the S. Typhimurium isolates formed a close cluster of 90 to 100% similarity 
with the ribotyping. However, the PFGE analysis separated the S. Typhimurium isolates 
into three clusters at 55 to 80% relatedness. The S. Javiana isolates formed a cluster with 
the known S. Javiana in the database with PFGE. However, they did not show any close 
similarity with the ribotyping database. These results suggest that ribotyping patterns 
show a closer relatedness among serotypes, which could be used for initial identification. 
PFGE patterns among serotypes show more diversity and may not be appropriate for 
initial identification of the serotype. The results of both the typing techniques depend on 
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the serotype as well. For example, S. Enteritidis isolates showed very high similarity to 
the known S. Enteritidis strain using both the PFGE as well ribotyping. For S. Javiana, 
PFGE was better in identifying the serotype compared to the ribotyping database. These 
results also suggest that it is important to rely on two or more techniques for strain 
typing. 
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Figure 13. Identification of Unknown Salmonella by Molecular Typing 
 
Figure 13a 
60   65   70   75    80   85   90   95  100 
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Application of ribotyping database for identification of unknown Salmonella serotypes 
received from Florida department of health (FLDOH). The unknown isolates are 
compared to known serotypes obtained from Washington department of health 
(WADOH) or American Type Culture Collection (ATCC), Centers for Disease Control 
and Prevention (CDC) or environmental isolates from turkey carcasses. The numbers 
above the dendrogram represent the percent relatedness, the red blocks indicate that the 
serotype is known. 
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Figure 13b 
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Application of PFGE database for identification of unknown Salmonella serotypes 
received from Florida department of health (FLDOH). The unknown isolates are 
compared to known serotypes obtained from Washington Department of Health 
(WADOH) or American Type Culture Collection (ATCC), Centers for Disease Control 
and Prevention (CDC) or environmental isolates from turkey carcasses. The numbers 
above the dendrogram represent the percent relatedness, the red blocks indicate that the 
serotype is known. 
 
Table 15. Identification of Unknown Salmonella serotypes by Molecular Typing 
Isolate 
Numbers 
% Similarity by 
Ribotyping 
% Similarity by 
PFGE 
Final Id by 
Serotyping 
213, 604, 759, 
827, 829, 67 
90-100% to S. Newport 65% to S. Newport S. Newport 
832, 781, 779, 
818 
90-100% to S. 
Enteritidis 
80-95% to S. 
Enteritidis 
S. Enteritidis 
746, 823, 777 90% to S. 
Typhimurium 
72% to S. 
Typhimurium 
S. Typhimurium 
817, 828, 820, 
757, 775, 778 
90-100% to S. 
Typhimurium 
55-80% to S. 
Typhimurium 
S. Typhimurium 
830, 807, 819, 
603, 826, 69, 
222 
Closest match, 60% to 
S. Typhimurium 
60-60% to S. 
Javiana 
S. Javiana 
 
Comparison of ribotyping and PFGE patterns of known serotypes with unknown 
Salmonella serotypes for initial identification. The percent similarity as shown in the 
dendrograms of Figure 12 is indicated and the final identification by serotyping is shown 
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Discrimination of Salmonella Species by Molecular Typing and Antibiotic Susceptibility 
patterns 
 
The discriminatory ability of the two molecular typing techniques; PFGE and ribotyping, 
and the phenotypic method, antibiotic susceptibility profiling, was tested on the 100 wild 
type isolates. The ribotyping results were analyzed by both manual analysis of the TIFF 
images as well as by importing images already normalized by the RiboPrinter®. For 
PFGE, patterns above 93% similarity were considered identical and for ribotyping, 
patterns that showed below 99.99% similarity were considered different based on 
molecular weight standard analysis of repeated gels. The results of the molecular weight 
standard analysis are shown in Figures 3a and 3b. For the 100 isolates, the ribotyping 
based on auto normalization generated 58 profiles; whereas the manual analysis of the 
TIFF images obtained from the ribotyping produce 62 ribotypes (data shown in 
Appendix, Figure A1). The major difference was seen in the serotype Newport; 12 types 
were produced by the manual analysis, whereas only eight types were seen by the 
automated normalization for the 28 wild type isolates analyzed. Overall, PFGE typing 
produced 74 profiles using the XbaI enzyme (data shown in Appendix, Figure A2) and 70 
pulsotypes with the SpeI enzyme. The 100 isolates were divided into 42 profiles based on 
the antibiograms (data shown in Appendix, Figure A3). These results clearly demonstrate 
that both of the molecular fingerprinting methods were more discriminatory than the 
phenotypic typing method, for the set of isolates studied. 
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To study the discriminatory ability and correlation between the three techniques, 
ribotyping, PFGE and antibiotic susceptibility profiles, a set of 30 isolates belonging to 
one serotype (S. Newport) was selected for analysis. Twenty eight wild type isolates and 
two ATCC S. Newport strains were analyzed. When the ribotyping results were analyzed 
manually, three major clusters at 74% or more similarity were seen (Figure 14a). The 
three clusters were further divided into 14 unique ribotypes. Based upon 99.9% 
similarity, with the exception of CBD 584, the environmental isolates grouped into the 
largest cluster comprising 9 of the 14 ribotypes, whereas the clinical isolates were 
dispersed among the three major clusters. Four clinical isolates, CBD 604, CBD 213, 
CBD 829 and CBD 759, showed 100% identity with the environmental isolates. When 
the fragment patterns were normalized by the RiboPrinter® software, ten ribotypes at 
98% or less similarity were observed using the BioNumerics® software (Figure 14b). 
These ten ribotypes are essentially similar to the manually analyzed data with some 
exceptions. The major difference between the automated and the manual analysis was 
seen among the environmental isolates. Thirteen isolates that showed 100% similarity 
using the automated analysis were divided into 8 ribotypes using the manual analysis. 
Using 93% similarity as the threshold, 14 PFGE pulsotypes were observed at 93% 
similarity with the enzyme XbaI (Figure 15a) for the 30 S. Newport isolates. Similarly, 
14 subtypes were seen with the enzyme SpeI (15b). The environmental isolates formed 
one large cluster at 84% that could be further divided into 3 sub-groups and 4 pulsotypes 
with the enzyme XbaI. The 11 clinical isolates showed greater diversity, forming 8 
pulsotypes with all of the isolates from WADOH forming one cluster. The two ATCC 
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control strains were of two distinct pulsotypes. The PFGE results between the two 
enzymes correlated well and similar grouping was observed with XbaI and SpeI (Figure 
15a and 15b). Both PFGE and ribotyping further resolved groups not differentiated by the 
corresponding method. For example, ribotype cluster 2 (Figure 14a) was further 
discriminated by PFGE into two groups, B and C (Figure 15a). Likewise, PFGE cluster A 
(Figure 15a) was further divided into clusters 1 and 3 by ribotyping (Figure 14a). The 
clinical isolates from WADOH were identical by both ribotyping as well as PFGE. 
Cluster analysis of the antimicrobial susceptibility results showed 23 distinct profiles. 
Isolates resistant or intermediately resistant to six or more antibiotics formed a separate 
cluster clearly distinguishable from the susceptible or less resistant isolates (Figure 16). 
The clinical isolates from WADOH formed a cluster at 94% or more similarity. The 
environmental isolates were distributed among various clusters. This data shows that for 
the set of S. Newport isolates studied antibiograms were more discriminatory compared 
to the molecular typing techniques.  No correlation among the molecular typing patterns 
and the antibiotic susceptibility profiles was apparent for the 30 S. Newport isolates 
studied. Both susceptible and resistant isolates were spread among the various clusters 
and were not clearly distinguished by the ribotyping or the PFGE. 
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Figure 14. Ribotyping of S. Newport 
 
Figure 14a 
 
Dendrogram representing the ribotypes of the S. Newport isolates with the enzyme EcoRI 
using the manual analysis of RiboPrinter® images. The isolate number, corresponding 
source and resistance pattern are shown. The relatedness among the isolates is depicted 
by percentage similarity.  Cluster 2 depicts the group that was further divided by PFGE 
with XbaI; Cluster 1 and 3 refer to the PFGE group A that was subdivided by the 
ribotyping. S=susceptible, 1 class=R or I to only one class of antibiotic, MDR=Multidrug 
resistant to 2 or more classes of drugs 
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Figure 14b 
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Dendrogram of the ribotypes of the S. Newport isolates with the enzyme EcoR1 using the 
automated normalization. The isolate number, corresponding source and resistance 
pattern are shown. The relatedness among the isolates is depicted by percentage 
similarity.  S=susceptible, 1 class=R or I to only one class of antibiotic, MDR=Multidrug 
resistant to 2 or more classes of drugs 
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Figure 15. PFGE of S. Newport 
 
Figure 15a 
 
 
Macrorestriction profiling of S. Newport isolates with the enzyme XbaI. The percentage 
similarity between various pulsotypes is shown. The isolate number and source is 
specified. Cluster A was further divided by ribotyping; Cluster B and C refer to the 
ribotyping group 2 that was subdivided by PFGE.  S=susceptible, 1 class=R or I to only 
one class of antibiotic, MDR=Multidrug resistant to 2 or more classes of drugs. 
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Figure 15b 
endrogram of the macrorestriction profiling with the enzyme SpeI. The percentage 
 
Dice (Tol 1.0%-1.0%) (H>0.0% S>0.0%) [0.0%-100.0%]
PFGE Spe-1
10
0
959085807570656055504540
PFGE Spe-1
CBD 604, S.Newport
CBD 759, S.Newport
CBD 588, S.Newport
CBD 597, S.Newport 
CBD 584, S.Newport 
CBD 585, S.Newport
CBD 586, S.Newport
CBD 587, S.Newport
CBD 589, S.Newport
CBD 590, S.Newport
CBD 591, S.Newport
CBD 572, S.Newport
CBD 571, S.Newport
CBD 595, S.Newport
CBD 596, S.Newport
CBD 598, S.Newport
CBD 592, S.Newport
CBD 593, S.Newport
CBD 594, S.Newport
CBD 829, S.Newport
CBD 815,S.Newport
CBD 67, S.Newport
CBD 213, S.Newport 
CBD1058, S.Newport
CBD 30, S.Newport 
CBD 425, S.Newport 
CBD 426, S.Newport 
CBD 427, S.Newport 
CBD 428, S.Newport 
CBD 827, S.Newport
Human,FLDOH
Human,FLDOH
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Turkey Carcasses
Human,FLDOH
Human,FLDOH
Human FLDOH
Human FLDOH
ATCC
ATCC
Human, WADOH
Human, WADOH
Human, WADOH
Human, WADOH
Human,FLDOH
MDR
S
MDR
MDR
MDR
MDR
MDR
MDR
1 Class
MDR
MDR
MDR
MDR
1 Class
1 Class
MDR
MDR
MDR
1 Class
S
1 Class
S
1 Class
S
S
MDR
MDR
MDR
MDR
S
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
similarity between various pulsotypes is shown. The isolate number and source is 
specified. S=susceptible, 1 class=R or I to only one class of antibiotic, MDR=Multidrug 
resistant to 2 or more classes of drugs. 
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Figure 16. Antibiotyping of S. Newport 
 
endrogram showing the percentage similarity between isolates based on their 
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D
susceptibilities to 31 different antibiotics or antibiotic combinations. Each cell indicates 
the minimum inhibitory concentration (MIC) of the corresponding antimicrobial. The 
darker the cell, the greater the MIC value therefore the greater the resistance to that 
particular drug. S=susceptible, 1 class=R or I to only one class of antibiotic, 
MDR=Multidrug Resistant to 2 or more classes of drugs. Ampicillin (Amp), piperacillin 
(Pip), ticarcillin (Tic), amoxicillin/clavulanic acid (Aug), ampicillin/sublactum (A/S), 
piperacillin/tazobactum (P/T), ticarcillin/ clavulanic acid (Tim), amikacin (Ami), 
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gentamicin (G), kanamycin (K), streptomycin (Str), tobramycin (Tob), ceftriaxone (Axo), 
cephalothin (Cep), cefoxitin (Fox), ceftiofur (Tio), aztreonam (Azt), cefepime (Fep), 
cefoperazone (Fop), cefotaxime (Fot), ceftazidime (Taz), nalidixic acid (Nal), 
ciprofloxacin (Cip), levofloxacin (Levo), lomefloxacin (Lome), chloramphenicol (Ch), 
tetracycline (Tet), trimethoprim/sulfamethaxazole (Cot), sulfamethoxazole (Smx), 
sulfizoxazole (Fis), imipenem (Imi). 
 
Antibiotic Susceptibility Testing 
ental isolates and some of the ATCC control strains All the 100 clinical and environm
were tested for susceptibility to 32 antibiotics using two panels. All the isolates showed R 
or I to carbenicillin including the ATCC strains of Salmonella. Therefore, carbenicillin 
was not considered for further analysis. A complete list of the MIC values for all the 100 
isolates tested with both panels is in the Appendix (Tables A2 and A3). Isolates that 
showed any resistance to one or more drugs are shown in Tables 16 and 17. Of the 
isolates comprising of clinical sources, 24/60 were R or I to at least one drug (Table 16).  
A high percent (83%) of isolates obtained from WADOH were R or I.  Twenty nine 
percent of the clinical isolates from FLDOH were R or I to one or more antimicrobials. 
Twenty out of the 24 (80%) clinical isolates showed multidrug resistance to two or more 
classes of drugs. The four S. Newport isolates, CBD 425, 426, 427 and 428 from 
WADOH were R or I to 17 or more drugs. The five S. Typhimurium isolates CBD 438, 
746, 777, 816 and 823 showed pentadrug resistance to Amp, Ch, Str, Smx and Tet, 
which, is a characteristic of S. Typhimurium DT104. These isolates also were R or I to 
several other antibiotics including Fop, Tob and Tim. Out of the 40 environmental 
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isolates, 36 (90%) showed R or I to one or more antibiotics (Table 16). Seventy percent 
of the resistant environmental isolates from WADOH were multidrug resistant to 6 or 
more classes of drugs and 71% of resistant FLDOH were multidrug resistant to three or 
more classes of drugs.  The two S. Muenchen isolates have the same antibiotic resistance 
profile. Of the isolates obtained from turkey carcasses, 96% were R or I to one or more 
drugs, 86% of which were multiply resistant to two or more classes of drugs.  Overall, 
60/100 isolates from both clinical and environmental sources were R or I to at least one 
drug of which 52 were multi resistant to two or more classes of drugs. 
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Table 16. Antibiotic Resistance of Clinical Salmonella Isolates 
ntibiotic resistance of clinical isolates, Ch- Chloramphenicol, Aug- 
Tobramycin, Nal- Nalidixic acid 
213, S.Newport Ch
425, S.Newport AugAmpFoxTioAxoCepChStrSmxTetA/SAztFopFotTazPipTicTim
426, S.Newport AugAmpFoxTioAxoCepChStrSmxTetA/SAztFopFotTazPipP/TTicTim
427, S.Newport AugAmpFoxTioAxoCepChStrSmxTetA/SAztFopFotTazPipTimTob
428, S.Newport AugAmpFoxTioAxoCepChStrSmxTetA/SFopFotTazPiptTicTim
433, S.arizonae AugAmpFoxTioAxoCepChStrSmxTetA/SFopTazPipTic
434, S.Brandenburg AugAmpFoxTioCepChStrSmxTetTic
436, S.Paratyphi A Nal
437, S.Saintpaul AugAmpCepGKSmxTetA/SFopP/TTicTimTob
438, S.Typhimurium AmpChStrSmxTetA/SFopPipTicTimTob
439, S.Enteritidis ChStrSmxTet
603, S.Javiana AmpGKSmx
604, S.Newport AmpGKSmx
746, S.Typhimurium A/SFopChGPipTetTicTim
747, S.houtenae AmpChStrSmxTet
777, S.Typhimurium AmpChStrSmxTetA/SFopPipTicTim
810, S. Heildelberg Ch
815, S.Newport FoxCep
816, S.Typhimurium AugAmpChStrSmxTetA/SFopPipTicTim
817, S.Typhimurium A/S
823, S.Typhimurium AmpChStrSmxTetA/SFopPipTicTim
824, S.Tallahassee A/SFopChPipTetTicTim
825, S.Paratyphi AmpChNalSmxTetA/SFopPipTicTim
826, S.Javiana A/SFopChPipTetTicTim
Isolate Antibiotic Resistance Profile
 
A
Amoxicillin/Clavulanic acid, Amp- Ampicillin, Fox- Cefoxitin, Tio- Ceftiofur, Cep- 
Cephalothin, Str- Streptomycin, Smx- Sulfamethoxazole, Tet- Tetracycline, A/S- 
Ampicillin/Sublactum, Azt- Aztreonam, Fop- Cefoperazone, Fot- Cefotaxime, Taz- 
Ceftazidime, Pip- Piperacillin, Tic- Ticarcillin, Tim- Ticarcillin, Clavulanic acid, Tob- 
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Table 17. Antibiotic Resistance of Environmental Salmonella Isolates 
Isolate Antibiotic Resistance Profile
429, S.Oranienburg AugAmpFoxTioAxoCepChStrSmxTetA/SFopPipTicTim
430, S.apapa AugAmpFoxTioCepChStrSmxTetA/SAxoTim
431, S.Saintpaul AugAmpFoxTioAxoCepChStrSmxTetTim
432, S.arizonae AugAmpFoxTioCepChStrSmxTet
440, S.Muenchen A/SFopChGPipTetTicTimTob
441, S.Muenchen A/SFopChGPipTetTicTimTob
443, S.Hildgo AmpChStrSmxTet
569, S.Alachua GSmxTetTob
570, S.Anatum GSmxTetTob
571, S.Newport GTetTob
572, S.Newport GTetTob
573, S.Istanbul StrTetGTob
574, S.Istanbul StrTet
575, S.Istanbul GStrSmxTet
576, S.Kentucky Tet
577, S.Kentucky StrTet
579, S.Montvideo GKStrTob
580, S.Muenster AmpChGKStrSmxTetA/SPipTicTim
581, S.Muenster AmpGStrSmxTetA/SGPipTicTim
582, S.Reading AmpChGKStrSmxTetA/SPipTicTob
583, S.Reading ChGStrSmxTetA/SGPipTicTob
584, S.Newport A/SGPipTetTicTob
585, S.Newport GImi
586, S.Newport GSmxTet
587, S.Newport GTet
588, S.Newport GTet
589, S.Newport Tet
590, S.Newport StrSmxTet
591, S.Newport AugAmpStrSmxA/SFopPipP/TTicTim
592, S.Newport StrSmxTetA/SPiTicTim
593, S.Newport StrGTetTob
594, S.Newport AmpTet
595, S.Newport Ch
596, S.Newport Ch
597, S.Newport AmpCepGKStrSmxA/SFopPipTicTim
598, S.Newport AmpCepGKNalStrSmxA/SFopPipTicTim
120 
 Antibiotic resistance of environmental isolates, Ch- Chloramphenicol, Aug- 
Amoxicillin/Clavulanic acid, Amp- Ampicillin, Fox- Cefoxitin, Tio- Ceftiofur, Cep- 
Cephalothin, Str- Streptomycin, Smx- Sulfamethoxazole, Tet- Tetracycline, A/S- 
Ampicillin/Sublactum, Azt- Aztreonam, Fop- Cefoperazone, Fot- Cefotaxime, Taz- 
Ceftazidime, Pip- Piperacillin, Tic- Ticarcillin, Tim- Ticarcillin, Clavulanic acid, Tob- 
Tobramycin, Nal- Nalidixic acid, G- Gentamicin, K- Kanamycin, Imi- Imipenem 
 
Resistance Determinants 
PCR was carried out with primers targeting the entire integron on all the isolates
were R or I to at least one drug. The negative controls were two susceptible isolates CBD 
28 and CBD 30. Twelve out of the 100 isolates showed the presence of class-1 integrons. 
Eleven of the 52 multidrug resistant strains clearly showed the presence of
integrons, as shown in Figure 16. The twelfth isolate, S. Paratyphi (CBD 436), which was 
not MDR, had a 1.6 Kb integron (data not shown). The five S. Typhi
CBD 438, 746, 777, 816 and 823 showed the presence of two integrons (1.0 Kb and 1.2 
Kb) that is a characteristic feature of S. Typhimurium DT104 (Figure 17). S. Muenster 
and S. Reading had a 1 Kb fragment and a small 750 bp fragment. The two S. Newport 
isolates had one fragment of 1 Kb size. On the whole four integrons prof
fragments at 1.0 Kb and 1.2 Kb; 1.0 Kb and 0.75 Kb; 1 Kb; 1.6 Kb were observed among 
the 12 isolates. The negative controls did not show an amplification product. The other 
isolates when tested with PCR with primers directed against the 5’CS and 3’CS of the 
 that 
 
 class-1 
murium isolates 
iles with 
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integrons showed multiple non specific bands or no bands at all (data not shown).  These 
esults of the 
 11 
outhern 
 
 
 
 
 
 
 
 
 
 
 
 
 
isolates were further tested with the class-1 integrase gene as a target; the r
integrase genes PCR were similar to the integron PCR with multiple bands. The
isolates in Figure 17 were considered for further analysis by sequencing and S
blotting. 
Figure 17. Integrons in Multidrug Resistant Isolates 
Amplification of integrons of the MDR isolates. 438, 746, 777, 816, 823 belong to 
serotype Typhimurium. 580, 581- S. Muenster, 583, 584 - S. Reading, 597, 598 - S. 
Newport.  M- molecular weight standard, NTC- no template control 
 
 
 
 
 
M   NTC 438    746    777    816  823               580  581     582 583    597    598   M    
1 Kb
1.2 Kb
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Location of Integrons 
 
To determine if the integrons in the 11 isolates are present on plasmids or chromosomes, 
plasmids were purified and the product was subjected to amplification by PCR targeting 
the integron. The results of the plasmid prep are shown in Figure 18. All the isolates had 
a plasmid at approximately 23.1 Kb. These plasmids were not linearized, therefore it is 
ossible that there are supercoiled and relaxed plasmids. On the whole, a total of five 
Figure 18. Plasmid Profiling of Integron Positive Isolates 
 
 
 
 
lasmids extracted from the 11 isolates in Figure 16 that had integrons. M=Molecular 
eight standard, lane 1=CBD 438, lane 2= CBD 746, lane 3= CBD 777, lane 4=CBD 
16, lane 5= CBD 823, lane 6= CBD 580, lane 7= CBD 581, lane 8= CBD 582, lane 9= 
BD 583, lane 10= CBD 597, lane 11= CBD 598 
p
different plasmid profiles were noted. 
 
 
 
23. 1 Kb  
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 The plasmid DNA was amplified by using primers directed against the entire integrons to 
identify the location of the integrons and the results are shown in Figure 19. The plasmid 
prep of all the 11 isolates (data of CBD 581 not shown) was positive for the presence of 
integrons by PCR. These results suggest that the integrons are present on the plasmids of 
these isolates. However, to make sure that there is no possible chromosomal DNA 
contamination, real time PCR with the chromosomal marker gene, ompF was performed 
on the plasmid DNA. The results of the real time PCR were positive for all isolates, 
l DNA contamination in the 
plasmids extracted. Therefore the location of the integrons could not be conclusively 
determ
 
 
 
 
 
 
 
demonstrating that there was a possible chromosoma
ined based on these tests. 
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Figure 19. Detection of Integrons in Plasmids 
 
19a.     19b. 
 
       M       NTC     583   597    816    823    + M NTC 438  746  777 580 582  598   +  
PCR amplification of plasmid prep with int primers. The isolate numbers are given, 
NTC=no template control, + = positive control (chromosomal and plasmid DNA), M= 
olecular weight standard 
equencing of the Integrons 
 
The 1.0 Kb and 1.2 Kb fragments of the integrons of the 11 isolates (Figure 17) were 
sequenced to identify the nature of the genes located inside the integrons. The 1.6 Kb 
fragment of CBD 436 was partially sequenced. Each band of each isolate was sequenced 
repeatedly and the consensus was compared with the NCBI database. The consolidated 
results of the BLAST match of the isolates are given in Tables 18 and 19. The complete 
sequence of each fragment is shown in the Appendix (Figure A4). The 1.0 Kb band of all 
the S. Typhimurium isolates harbored the gene aadA2 conferring resistance to 
aminoglycosides including Str, G and K (Table 18). The 1.0 Kb integron of the 
M
 
S
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environmental isolates S. Muenster, S. Reading and S. Newport harbored genes including 
sul1 conferring resistance to 
sulfonamides. The 1.2 Kb band of the S. Typh
gene pse1 encoding resistance to β lactam
showed 96% similarity to Salmonella en
resistance to aminoglycosides. It is aadA2 
gene, did not show R or I to any of the am
aadA1 encoding resistance to aminoglycosides and 
imurium isolates showed the presence of 
ases (Table 19). The 1.6 Kb band of CBD 436 
terica class-1 integron, aadA2 gene encoding 
interesting to note that CBD 436 though had 
inoglycosides tested. 
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Table 18. Sequencing of 1.0 Kb Integron Fragments 
Isolate Resistance Integron 
bands
Number of 
bp 
 
Sequencing of the 1.0 Kb fragment of class -1 integron. The isolate names, source and 
their resistance patterns are shown. The actual size of the integron, the number of base 
pairs sequenced and their BLAST match is indicated. WADOH=Washington Department 
of Health, FLDOH= Florida Department of Health. Amp=ampicillin, 
sequenced
S.Typhimurium, SFopPipTicTimTob integron aadA2
FLDOH
 to S.Typhimurium Class1 
tegron aadA2 
816, S. 
Typhimurium 
FLDOH
AugAmpChStrSmxTe
tA/SFopPipTicTim
1.0 Kb 1.0Kb 99% to S.Typhimurium Class1 
integron aadA2 
823, S. 
Typhimurium 
AmpChStrSmxTetA/
SfopPipTicTim
1.0 Kb 1.0 Kb 98% to S.Typhimurium Class1 
integron aadA2 
580, S.Muenster, 
Turke
NCBI Blast results
438, 
WADOH
AmpChStrSmxTetA/ 1.0 Kb 975bp 98% to S.Typhimurium Class1 
746, 
S.Typhimurium 
FLDOH
A/SFopChGPipTetTi
cTim
1.0 Kb 1.0 Kb 99% to S.Typhimurium Class1 
integron aadA2
777, 
S.Typhimurium 
AmpChStrSmxTetA/
SFopPipTicTim
1.0Kb 1.0Kb 98%
in
1.0Kb 1.0Kb 97% to S.Typhimurium integron 
aadA1 , y farms
AmpChGKStrSmxTet
A/SPi spTicTim ul1
581, S.Muenster, 
Turkey farms
AmpGStrSmxTetA/S
PipTicTim
1.0Kb 1.0bp 98%to S.Infantis class1 integron 
aadA 1 
582, S.Reading, 
Turkey farms
AmpChGKStrSmxTet
A/SPipTicTob
1.0Kb 975 bp 97%to S.Infantis class1 integron 
aadA1 
583, S.Reading, 
Turkey farms
ChGStrSmxTetA/SG
PipTicTob
1.0Kb 1.0 Kb 99%to S.Infantis class1 integron 
aadA1  , 99% to S.Typhimurium 
sul1  gene
597, S.Newport, 
Turkey farms
AmpCepGKStrSmxA
/SFopPipTicTim
1.0Kb 994bp 98%to S.Infantis class1 integron 
aadA1  , 98% to S.Typhimurium 
sul1  gene
598, S.Newport, 
Turkey farms
AmpCepGKNalStrSm
xA/SFopPipTicTim
1.0Kb 1.0 Kb 98%to S.Infantis class1 integron 
aadA1 
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Ch=chloramphenicol, Str= streptomycin, Smx=sulfamethoxizole, Tet=tetracycline, A/S= 
 
 
Sequencing of the 1.2 Kb and 1.6 fragments of class-1 integron. The isolate names, 
source and their resistance patterns are shown. The actual size of the integron, the number 
of base pairs sequenced and their BLAST match is indicated. WADOH=Washington 
Department of Health, FLDOH= Florida Department of Health. Amp=ampicillin, 
Ch=chloramphenicol, Str=streptomycin, Smx=sulfamethoxizole, Tet= tetracycline, 
ampicillin/ sublactum, Fop=cefoperazone, Pip=piperacillin, Tic=ticarcilllin, Tim= 
ticarcillin/clavulanic acid, G=gentamicin, K=Kanamycin, Aug=amoxicillin/clavulanic 
acid, Tob=tobramycin, Cep=cephalothin, Nal=nalidixic acid. aadA=aminoglycoside 
adenyl transferase, sul1=sulfonamide resistance gene 
Table 19. Sequencing of 1.2 Kb, 1.6 Kb Integron Fragments 
Isolate Resistance Integron 
Bands
Number of 
bp 
Sequenced
NCBI Blast Results
438, S. 
yphimurium 
FLDOH
AmpChStrSmxTetA/
SFopPipTicTimTob
1.2 Kb 1.17 Kb 97% to S.Typhimurium pse 1, β-
lactamse gene, 95% to 
Salmonella  integron dfr gene
746, S.Typhimurium 
LDOH
A/SFopChGPipTetTi
cTim
1.2 Kb 1.2Kb 98% to S.Typhimurium pse 1, β-
lactamse gene
777, S.Typhimurium 
LDOH
AmpChStrSmxTetA/SF
opPipTicTim
1.2Kb 1.17Kb 98% to S.Typhimurium pse 1, β-
lactamse gene
816, S. Typhimurium 
LDOH
AugAmpChStrSmxTetA
/SFopPipTicTim
1.2Kb 1.2Kb 98% to S.Typhimurium pse 1, β-
lactamse gene
823, S. 
yphoimurium, 
LDOH
AmpChStrSmxTetA/Sfo
pPipTicTim
1.2 Kb 1.16 Kb 98% to S.Typhimurium pse 1, β-
lactamse gene
436, S. ParatyphiA, 
WADOH
Nal 1.6 Kb 553 Kb 96% to Salmonella enterica , 
aadA2 gene
T
F
F
F
T
F
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A/S=ampicillin/ sublactum, Fop=cefoperazone, Pip= piperacillin, Tic= ticarcilllin, 
Tim=ticarcillin/clavulanic acid, G=gentamicin, Aug=amoxicillin/clavulanic acid, 
Tob=tobramycin, Nal=nalidixic acid 
 
To see if the sequences of 1.0 Kb fragments of all
 
 the S. Typhimurium isolates are 
entical, the sequences were aligned using MegAlign program of the DNAstar® 
ragment of all the five S. 
 
least seven differences including insertions/deletions of base pairs were seen in a small 
region (260 bp) shown in (Figure 21). 
 
 
 
id
software. The results of the alignment of the 1.0 Kb f
Typhimurium isolates is shown in Figure 20. A very high similarity is seen in the 1.0 Kb 
bands of all the S. Typhimurium isolates as indicated by the red bar of the alignment in 
the Figure 20. Likewise, the 1.2 Kb integron fragments of the S. Typhimurium strains 
were very similar (data not shown). When the 1.0 Kb sequences of the environmental 
isolates (CBD 580, 581, 582, 583, 597 and 598) were aligned, similar results were 
observed (data not shown). These results indicate that all the 1.0 bands were similar
between all the S. Typhimurium strains and between the environmental isolates. To see 
the difference between the 1.0 Kb integron of S. Typhimurium, that harbored aadA2 gene 
and the 1.0 Kb integron of environmental isolates that had aadA1 genes, all the 11 
isolates were aligned. There were a number of differences between the two genes. At 
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Figure 20. Alignment of 1.0 Kb of Integrons of S. Typhimurium 
 
 
 
 
 
 
 
 
 
 
 
 
Alignment of the 1.0 Kb integron sequence of the 5 S. Typhimurium isolates. Sequence 
information from 1 bp to 840 bp is shown here. Sequences of CBD 438, 746, 777, 816 
and 823 are represented here. BLAST analysis of the sequence shows 98% to 99% match 
to aadA2 gene encoding resistance to aminoglycosides. The red bar represents 100% 
identity of the sequences between isolates, orange and green regions represent lower 
similarity. 
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Figure 21. Alignment of 1.0 Integrons of S. Typhimurium and Other Serotypes 
Alignment of 1.0 integron sequences of S. Typhimurium isolates with six environmental 
isolates including S. Muenster, S. Reading and S. Newport. Sequence information from 
230 bp to 490 bp is represented. The 1.0 Kb integron of S. Typhimurium harbors aadA2 
gene encoding resistance to aminoglycosides; 1.0 Kb integron of the other isolates has 
aadA1 gene that also encodes resistance to aminoglycosides. Red bar indicates 100% 
identity between sequences and blue bar shows lower similarity. 
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Association of Salmonella Pathogenicity Island (SPI) Genes and Integrons 
 
. The location of two islands, SPI-1 and SPI-
 was tested in the integron positive isolates. The five S. Typhimurium isolates have very 
milar macrorestriction profiling, except for CBD 777 (Figure 22a). The two S. 
uenster isolates: CBD 580 and 581 are identical (Figure 22b). Likewise, the two S. 
eading isolates (CBD 582, 583) and the two S. Newport strains (CBD 597, 598) showed 
entical PFGE profiles. The sitB gene, which is an iron transporter gene that is important 
r the virulence of Salmonella species is part of SPI-1, and is located on the 668. 9 Kb 
agment of XbaI gel in S. Typhimurium and S. Reading isolates (Figure 23a, 23b).  The 
t operon is present on the 173 Kb fragment in S. Muenster isolates and on the 104 Kb 
agment in S. Newport isolates (Figure 23b). The sitB gene is absent in the negative 
ontrol Proteus mirabilis.  The magA gene, which is a magnesium transporter gene and is 
ted S. Reading and S. 
ewport are not clear in this gel. Based on these results it is clear that the integron of S. 
uenster (CBD 580) is present on the chromosome. 
Southern hybridization of PFGE gels was carried out to identify the location of the SPI 
and the antibiotic resistance of the integrons
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located in SPI-3 was seen on the 104 Kb fragment of XbaI digested DNA in all the 
isolates tested including serotypes Typhimurium, Muenster and Reading (Figure 24a, 
24b). In S. Newport, however it was seen on the 173 Kb fragment (Figure 24b). The 
integrons in the S. Typhimurium isolates were observed at a band lower than 33 Kb. In 
CBD 580 (S. Muenster) the integron was located at 167 Kb band of the XbaI digested 
DNA (Figure 25). The results of the other two serotypes tes
N
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Figure 22. PFGE Gel of Integron Positive Isolates 
Figure 22a      Figure 22b 
 
 
 
 
 
 Figure 22a        Figure 22b 
 
 
 
 
 
 
 
 
 
 
XbaI digested PFGE of 11 integron positive isolates. 22a.  438, 746, 777, 816 and 823 = 
S. Typhimurium. 22b. 580, 581= S. Muenster, 582, 583= S. Reading, 597, 598= S. 
Newport, M= molecular weight standard 
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Figure 23. Southern Hybridization with sitB Probe 
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Southern blots of PFGE gel with sitB gene of Salmonella Pathogenicity Island 1 as a 
hybridized 
3c- dot blots, positive control= S. Typhimurium (CBD 746), Negative control= Proteus 
irabilis (CBD 554), M= molecular weight standard (S. Braenderup, CBD 321) 
 
igure 24. Southern Hybridization with magA Probe 
 
Figure 24a     Figure 24b 
 
 
probe. The isolate numbers and the sizes of the fragments where the probe 
with the DNA are shown. 23a- S. Typhimurium isolates, 23b – Environmental isolates, 
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    Figure 24c 
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ith the DNA are shown. 24a- S. Typhimurium isolates, 24b – Environmental isolates, 
4c- dot blots, positive control= S. Typhimurium (CBD 746), negative control= Proteus 
irabilis (CBD 554), M= molecular weight standard (S. Braenderup, CBD 321) 
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Figure 25. Southern Hybridization with 1 Kb Integron Probe 
 
 
 
 
outhern blots of PFGE gel with1.0 Kb integron band of CBD 746 as a probe. The isolate 
umbers and the sizes of the fragments and the location of integron are shown. M= 
olecular weight standard (S. Braenderup, CBD 321), which is also a negative control 
r integron 
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Chapter Four - Discussion 
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 this study, Salmonella species belonging to over 30 serotypes, and three subspecies 
elective enrichment.  
 
Primers targeting sopB, spvA and ompF genes were tested for rapid detection by real time 
PCR. The sopB gene was present in all the 106 isolates of Salmonella subspecies I tested 
but not in all of the isolates belonging to subspecies III and IV. The spvA gene was 
olecular or phenotypic typing techniques require pure Salmonella culture,
rst aim of this project was to rapidly detect and isolate Salmonella species fro
artificially contaminated ready to eat foods. The second aim of the project was to build a 
subtyping database with two DNA based typing techniques and a phenotypic typing 
technique and to see if there is a correlation between the two. The application of
database was to identify unknown Salmonella species received from local hospitals
to analyze the discriminatory ability of the three typing methods.  The third aim wa
ine the antibiotic susceptibility patterns of clinical and environmental Salmonella
isolates and study the underlying mechanisms of resistance. The last aim was to
whether there is an association between the antibiotic resistance determinants
pathogenicity island genes. 
In
were subjected to primer and probe testing, molecular typing and antibiotic resistance 
analysis. For rapid detection and isolation of Salmonella from food, eight food matrices 
were intentionally contaminated and subjected to detection by real time PCR and 
isolation by s
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detected in selected serotypes I  (Typhimurium, Enteritidis, 
ullorum and Choleraesuis) tested as expected and spvA gene was also present in half of 
the isolates tested that belonged to subspecies III and IV. ompF was present in all 114 
isolates belonging to Salmonella subspecies I, III and IV. The fact that the sopB gene was 
absent in certain isolates of subspecies III and IV and ompF was present in all the 
subspecies tested suggests that SPI-5 is not very conserved among all Salmonella 
subspecies whereas SPI-2 is relatively more conserved. Based on this data, PCR with 
ompF gene primers could be used for identification of Salmonella subspecies I, III and IV 
isolates. Whether this gene is present in subspecies II, V and VI remains to be tested. The 
sopB gene can be used for the identification of strains of subspecies I, and spvA for the 
specific detection of selected serotypes of subspecies I. All three genes were specific to 
Salmonella because they were absent in other foodborne organisms tested including E. 
coli, Shigella species, Listeria monocytogenes and Bacillus cereus. A number of studies 
ested including 33 serotypes of subspecies I and 
bspecies III and IV, we suggest that it is a good alternative to invA gene for 
 of Salmonella subspecies 
P
have targeted invA gene for the detection of Salmonella species (54, 62, 70, 177). Some 
studies have used other gene targets including sipA, and ttR for the detection of 
Salmonella species (67, 133). However, no study has tested the potential of ompF gene 
for identification of Salmonella species to our knowledge. Since ompF gene was present 
in all 114 Salmonella isolates t
su
identification of Salmonella species. Of course, more serotypes of subspecies I and other 
subspecies need to be tested.  
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Real time PCR with primers targeting the ompF gene was applied for identifying 
Salmonella in artificially spiked ready-to-eat-food samples. The samples were artificially 
contaminated with low counts of S. Typhimurium or S. Enteritidis (1-10 CFU) and also 
mixed spiked with low cell numbers of Salmonella along with other members of 
Enterobacteriaceae including E. coli, Citrobacter freundii and Proteus mirabilis. DNA 
extracted from two broth enrichments, general enrichment in BPW (6 hours) and 
selective enrichment (additional 4 hours in TT broth), was subjected to PCR. Overall, for 
the eight food groups tested, 34/45 reactions (75%) were positive after BPW enrichment 
and 31/45 (68%) were positive after the BPW and TT enrichment for the low and mixed 
spiked samples. This data suggests that additional enrichment in TT broth for four hours 
did not provide any additional benefit for the detection of Salmonella species in 
intentionally seeded food samples. A longer enrichment in TT broth might have been 
beneficial. Neither of the two broths tested provided 100% positive results for the 
samples tested. Most of the studies that successfully detected Salmonella from BPW 
enrichment have either incubated for a longer time period of up to 18 hours (70) or had a 
very high initial inoculum (106 CFU) (58). Knutsson et al. detected 1 CFU of Salmonella 
species after 8 hours of BPW enrichment. However, sterile BPW was inoculated and food 
samples were not tested in that study (102). Agrawal et al. detected 3 CFU of Salmonella 
species in artificially   inoculated food samples but only ten grams and not the standard 
25 grams of food samples were tested in that study (1).  A study by Ellingson et al. 
successfully detected 1 CFU of Salmonella species after 6 hours of BPW enrichment in 
rtificially seeded food samples (67). In that study 15 ml of the enriched BPW sample a
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was used for DNA extraction, which probably led to increased sensitivity of the assay. 
However, they did not test the detection limit in mixed culture samples. To our 
knowledge, our study is the first to detect very low amounts of Salmonella species from 
mixed backgrounds of food matrices using a very short preenrichment.   
 
Rapid isolation of S. Typhimurium and S. Enteritidis from low, mixed and unspiked food 
samples was verified on samples enriched by general enrichment (BPW) and selective 
enrichments (BPW+IMS and BPW+TT). Salmonella was not recovered from any of the 
unspiked foods. For the low spiked foods, significantly greater number of colonies were 
isolated after selective enrichment in IMS compared to BPW and BPW+TT. The results 
for the mixed spiking were slightly different, where both the selective techniques IMS 
and TT fared well and were better than BPW enrichment. However, this could be because 
of the isolation results after overnight incubation of cheese, where BPW+TT isolated 
TNTC Salmonella but IMS isolated only 31 CFU (Table 13). If the food group cheese is 
not considered for the mixed spike analysis then BPW+IMS is significantly better than 
BPW+TT (P=0.07). However, if cheese is included in the analysis the isolation results of 
BPW +IMS and BPW+TT are very close with a P value of 0.9.  The IMS technique was 
successful in isolation of Salmonella colonies from all the tested food groups except for 
cheese, which required an overnight incubation. This is possibly because of the high fat 
content of cheese interfering with the magnetic beads, which has been reported in other 
studies (95). Therefore, for foods with high fat content, a longer enrichment is suggested 
and IMS is not recommended, although further studies are needed to prove this.  
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 A number of studies have employed IMS for rapid isolation of Salmonella species from 
artificially inoculated foods. Although these studies have been rapid compared to the 
conventional protocol they are not very sensitive. For example Hanai et al. isolated 
almonella from artificially spiked food in 30 hours. However, the detection limit in that S
study was 103 CFU/gm (84). Other studies involved a long pre-enrichment of 18-20 hours 
prior to IMS (47, 136). In this study, we were successful in isolating numerous 
Salmonella colonies starting with low inoculum (1-10 CFU) from artificially 
contaminated food samples, which included foods contaminated with other members of 
Enterobacteriaceae, in 25 hours using the IMS technique. To our knowledge this is the 
first report on isolation of Salmonella, using a method that is both is very sensitive and 
rapid. This technique does not involve complex machinery and is very simple to perform. 
In conclusion BPW+TT did not provide any additional benefit for either detection by real 
time PCR or for isolation for most of the food groups tested. Therefore, we suggest that 
the general enrichment in BPW for detection and selective enrichment in IMS is adequate 
for rapid identification and isolation of Salmonella species from food samples. For foods 
with high fat content, however, further testing is needed. In this study, the application of 
isolated colonies directly from XLD agar plate for molecular typing and antibiotic 
susceptibility testing was shown. This technique is less time consuming especially for 
mixed cultures, as Salmonella colonies can be easily distinguished on XLD plates from 
other common food organisms.  
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A Salmonella fingerprinting database was created based on the ribotypes and pulsotypes 
 identification of a Salmonella serotype. The fact that 
botyping with EcoRI is appropriate for serotype level identification was demonstrated 
of known Salmonella serotypes obtained from ATCC, CDC, WADOH and turkey 
carcasses. The unknown Salmonella serotypes received from various hospitals in Tampa 
were typed by ribotyping and PFGE to validate the database. Based on the results of the 
two typing techniques (Table 15) it is clear that the ribotyping gives a closer match to the 
particular serotype compared to PFGE. The unknown S. Newport isolates demonstrated 
90 to 100% similarity to S. Newport isolates in the database, whereas PFGE similarity 
was only 65% to S. Newport. Similarly, the unknown S. Typhimurium isolates were 90 –
100% identical to the known S. Typhimurium in the database by ribotyping, whereas they 
were only 55-72% related to S. Typhimurium by PFGE clusters. This was not the case 
with S. Enteritidis, where both the techniques showed a high similarity of 80 – 95% 
relatedness to the known S. Enteritidis. This demonstrates that S. Newport and S. 
Typhimurium has a very diverse genome whereas S. Enteritidis has a homogenous 
genome. The fact that S. Enteritidis has a homogenous genome was observed in many 
studies (56, 118), therefore, it is not surprising that PFGE of S. Enteritidis generated a 
closely related cluster. The ribotyping and PFGE data of the unknown S. Newport and S. 
Typhimurium suggest that PFGE is more discriminatory compared to ribotyping for the 
serotypes with less well-conserved genomes. However, being more discriminatory is not 
necessarily an ideal feature for identification purposes, especially if the database has a 
limited number of known isolates. Therefore ribotyping, which is not as discriminatory as 
PFGE, could be used for initial
ri
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(56). Since ribotyping with the automated RiboPrinter® is more rapid (nine hours 
including sample preparation) than PFGE (26 hours), initial identification of Salmonella 
species by ribotyping is suggested in a foodborne outbreak situation. However, 
ribotyping by the RiboPrinter® is more expensive and may not be appropriate for use in 
public health laboratories. 
 
The discriminatory power of the two molecular typing methods including ribotyping and 
PFGE and the phenotypic method, antibiotic susceptibility profiling was tested on the 
100 wild type isolates from clinical and environmental sources. Manual ribotyping 
analysis by using the TIFF images was more discriminatory compared to the automated 
analysis by the RiboPrinter®. Manual analysis using BioNumerics® generated 62 types 
for the 100 isolates whereas the automated analysis generated 58 types; the major 
difference was seen in the closely related environmental isolates obtained from turkey 
farms. The manual analysis is worth considering for all analyses using the RiboPrinter® 
since it does not require a significantly longer time compared to the automated analysis.  
Macrorestriction digestion analysis with XbaI enzyme generated the highest number of 
profiles (74) compared to all the other typing techniques. A good correlation was seen 
between profiles using XbaI and SpeI enzymes; however XbaI is preferable, not only 
because it was slightly more discriminatory compared to SpeI but also because the bands 
of XbaI digested gels were spread apart and were easy to interpret compared to SpeI, 
bands. Dendrograms derived from antibiograms were the least discriminatory for the 100 
isolates tested generating only 42 profiles. This could be because of the greater number of 
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susceptible clinical isolates from FLDOH. The data in this study illustrates that PFGE is 
the most discriminatory compared to the other two techniques tested and this is consistent 
with previous studies (66, 81, 119). Ribotyping using a combination of enzymes has 
previously been shown to be more discriminatory than using one enzyme.  For example, 
ribotyping with PstI and SphI has proven to be very discriminatory for certain Salmonella 
rotypes including S. Enteritidis and S. Typhimurium (118, 120). A combination of se
macrorestriction patterns from PFGE, ribotyping and antibiotic resistance profiles will be 
very useful for rapid source tracking of Salmonella strains in an outbreak situation 
 
Out of the 100 isolates, strains belonging to S. Newport represented the highest number 
belonging to a single serotype. Therefore, these 30 isolates were analyzed in detail to 
assess the discriminatory ability of the molecular typing methods and antibiotic resistance 
profiling. This analysis was also done to see if there is any correlation between the DNA 
fragment patterns and their respective antibiograms as observed by two studies involving 
S. Newport (76, 213). PFGE with XbaI as well as SpeI generated 14 pulsotypes for the 30 
isolates, illustrating the consensus between the two enzymes. Likewise, ribotyping 
divided the isolates into fourteen types, clearly demonstrating that ribotyping using the 
RiboPrinter® can be equally discriminatory when compared to PFGE for typing S. 
Newport.  It is interesting to note again that ribotyping using the automated RiboPrinter® 
was more discriminatory when the fragment profiles were analyzed manually from TIFF 
files than when the patterns were normalized by the RiboPrinter®. Fourteen profiles were 
seen by manual analysis compared to the ten profiles obtained by the automated 
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normalization.  A greater discrimination was seen in the environmental isolates using the 
manual analysis compared to the automated analysis. Previous studies have shown that 
PFGE further resolved the ribogroups (10, 42). However, we observed that both PFGE 
and ribotyping further resolved groupings not differentiated by the other method. For 
example, ribotype cluster 2 (Figure 14a) was further discriminated by PFGE into two 
groups, B and C (Figure 15a). Likewise, PFGE cluster A (Figure 15a) was further divided 
into clusters 1 and 3 by ribotyping (Figure 14a). This is the first report to our knowledge 
that ribotyping using the automated RiboPrinter® with the enzyme EcoRI is as 
discriminatory as PFGE for S. Newport, when analyzed manually from TIFF files.  
 
All the environmental isolates from turkey carcasses formed a single major cluster using 
both the ribotyping and PFGE. With ribotyping, the environmental isolates clustered at 
92% or more similarity along with some clinical isolates (Figure 14a). With XbaI PFGE, 
all the environmental isolates formed a unique cluster at 88% or more relatedness (Figure 
15a). Similarly, PFGE performed on the environmental isolates with SpeI generated a 
distinct group at 90% or more similarity (Figure 15b). This demonstrates that all the 
environmental isolates are very closely related and PFGE clearly distinguished the 
environmental isolates from the clinical isolates, as opposed to ribotyping. The PFGE and 
ribotyping profiles of the four clinical isolates from WADOH were identical. These four 
isolates were obtained from different sources (Table 5), and the fact that they have the 
same molecular typing patterns suggests the possibility of an outbreak strain.  
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Two isolates, CBD 571 and CBD 572, which were previously serotyped as Salmonella 
enterica serotype Bardo (S. Bardo) by conventional methods, showed very high 
similarity with S. Newport using molecular subtyping methods. S. Newport and S. Bardo 
have very similar antigenic formulas and differ by the presence or absence of O: 6 
antigen. Ribotyping showed that CBD 571 was 96% similar to S. Newport (Figure 14a); 
PFGE with Xba-1 showed 92% similarity (Figure 15a) and the SpeI PFGE showed 95% 
relatedness (Figure 15b) to the S. Newport.  Similarly, ribotyping of CBD 572 showed 
100% identity with the S. Newport cluster (Figure 14a) and PFGE analysis with XbaI and 
SpeI displayed 93% (Figure 15a) and 100% identity (Figure 15b) with the S. Newport, 
spectively, prompting us to serotype the two putative S. Bardo isolates again. Both 
g & PFGE 
endrograms (Figure 14 and 15).  Therefore, there was no clear distinction of the 
re
strains typed as S. Newport, demonstrating that molecular techniques are not only rapid 
but are also very powerful tools for identifying Salmonella serotypes, provided the profile 
from the serotype is present in the database. Discrimination of these S. Newport strains 
also confirms that molecular typing methods are very useful for outbreak investigations.  
 
The typing of the strains based on their antibiotic susceptibilities, which gave rise to 23 
profiles, was more discriminatory than either ribotyping or PFGE.  When cluster analysis 
of the macrorestriction profiles and the ribotypes were compared to the antibiotic 
resistance dendrograms, no correlation was observed. The susceptible isolates, the 
multidrug resistant strains and the isolates that were R or I to only one class of antibiotics 
were distributed among various clusters as shown in the both the ribotypin
d
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susceptible isolates from the resistant ones with PFGE, contrary to the results observed 
(76, 213). Likewise, no such correlation was seen between the antibiotic resistance 
patterns and the ribotyping patterns. A greater selection of antimicrobials was used in this 
study and could be a factor contributing to the lack of correlation between PFGE and 
resistance profiles. Cluster analysis of antibiotic susceptibilities was more discriminatory 
compared to either of the molecular typing techniques and this could be because of very 
high resistance in most of the S. Newport isolates tested.   
 
Of the 100 clinical and environmental isolates tested, 60% were R or I to one or more 
antimicrobials of which the majority were multiply resistant to antimicrobials. Forty 
percent of the clinical isolates were R or I, of which, 83% belonged to isolates from 
WADOH. The isolates from Tampa hospitals obtained through FLDOH were relatively 
less resistant (29%). The cause of higher resistance among the clinical isolates of 
WADOH compared to FLDOH is not known, but depends on the nature of the serotype 
nd the year of isolation. A very large number of environmental strains (90%) were R or I a
to one or more antibiotics. The three environmental isolates, S. Oranienburg (CBD 429), 
S. Apapa (CBD 430) and S. arizonae (CBD 432) that were isolated from bearded dragon, 
lizard and snake respectively, showed R or I to nine or more drugs. Reptiles are not 
usually subjected to antibiotic treatment like food animals or humans and the fact that 
multidrug resistant Salmonella species were obtained from these sources is a cause for 
concern. It was not surprising that 96% of turkey carcass isolates comprised of eight 
serotypes were R or I to one or more drugs. These results imply that multiple antibiotic 
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resistance in Salmonella species is a major crisis especially in poultry farms as 
demonstrated in several studies (29, 39, 163).  The fact that the majority of the 
environmental isolates (75%) in this study were obtained from two turkey plants might 
have affected the antibiotic resistance distribution and possibly skewed the data. The high 
antibiotic resistance in poultry isolates is consistant with other studies (29, 50). We 
observed that the majority of resistant clinical isolates (70%) were R or I to Ch. Sixty two 
percent of the clinical isolates showed R or I to extended spectrum cephalosporins or 
ephams, which are a method of choice for treating salmonellosis in children (4). A high c
incidence of resistance to Str, Amp and Tet was also observed among the clinical and the 
environmental isolates. On the whole 86% (52/60) of the resistant isolates showed 
multiple drug resistant phenotype. 
 
The presence of integrons was tested by PCR to identify the basis for the high occurrence 
of multiple drug resistance among the resistant isolates. Integrons with four different 
profiles were seen in 21% of the multidrug resistant isolates and one isolate of the non-
MDR phenotype. Five S. Typhimurium isolates had two integrons (1.2 Kb and 1.0 Kb) 
harboring the genes pse1 and aadA2 respectively. This two-integron pattern is a 
characteristic feature of S. Typhimurium DT104 (11, 131). Whether these five isolates 
are DT104 is yet to be determined. The integrons of six environmental isolates from 
turkey farms were identical based on the sequencing results. Similarly, sequencing 
revealed that the 1.0 Kb integrons are identical and the 1.2 Kb integrons are identical 
among the five S.  Typhimurium isolates.  S. Paratyphi A (CBD 436) was R or I to only 
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Nal, and was susceptible to all aminoglycosides including Str, G, K and Tob tested. 
However, the 1.6 Kb integron of S. Paratyphi A had the aadA2 gene encoding resistance 
to aminoglycosides. This suggests that the aadA2 gene in this integron cassette is not 
expressed. Whether this is due to the lack of promoter in the 5’ region or mutation of the 
gene is yet to be determined. The presence of silent aadA2 or strA genes encoding 
resistance to streptomycin is not unusual (169, 206). aadA2 genes were seen on the 2 Kb 
integrons in three isolates that were susceptible to aminoglycosides in a study by White et 
al. (206).  
 
It was surprising to see no integrons in the multidrug resistant isolates that were R or I to 
ten or more antibiotics, including the four S. Newport isolates from WADOH. It was 
ssumed that the integron gene cassettes are of several Kb and therefore were not a
amplified by the primers targeting the entire integrons. Therefore, PCR with primers 
targeting only the integrase gene was performed. However, these results were not 
encouraging and were similar to the ones obtained with the primers targeting the 
integron. So it is possible that there are no integrons in those isolates, and integrons are 
probably not as prevalent as hypothesized in multiply resistant isolates. Overall, 12% of 
the 100 isolates had class-1 integrons, and this finding is consistent with other studies (2, 
83). However, further studies with more primers targeting integrons and subsequent 
sequencing is needed to conclude that the rest of the 39 multidrug resistant isolates do not 
have integrons. Also, the presence of integrons of other classes including class-2 and 
class-3 is possible and needs to be verified.  
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 To identify the location of the integrons, plasmid DNA was amplified with primers 
targeting the integrons in 11 isolates shown in Figure 17. The plasmid prep of all 11 
isolates tested was positive for integrons. However, further testing of the plasmid DNA 
with a chromosomal marker revealed contamination of the plasmid DNA with 
chromosomal DNA.   Southern hybridization of the XbaI digested PFGE gel isolates 
containing the 1.0 integron fragments revealed that the integrons are present below the 33 
Kb region in the four S. Typhimurium isolates and on the 173 Kb fragment in S. 
uenster, CBD 580. Based on this data it is clear that the integron of CBD 580 is in fact M
chromosomal as hypothesized. Also, chromosomal location of the integron of CBD 581, 
which is also a S. Muenster and appears to be a clone of CBD 580 is expected. Based on 
several studies and our data, it is reasonable to speculate that the integrons of the S. 
Typhimurium isolates are not located on plasmids, but are in fact on the 10 Kb band of 
XbaI digested gel which is a part of SGI (53, 64). The pentadrug resistance profiles 
(resistance to ACSuST), the two-integron pattern and also the location of the integrons 
suggest that the five clinical isolates S. Typhimurium (CBD 438, 746, 777, 816 and 823) 
are of phage type DT104. Further testing is needed to prove this. In general, resistance to 
sulfonamides is a characteristic feature of the presence of class-1 integrons, as integrons 
have sul1 gene on the 3’ end (185). However, out of 35 isolates that were R or I to Smx, 
only 11 had class-1 integrons. It is also possible that some of the isolates have partial 
integrons with only a functional 5’ end.  
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Association of integrons with two ion transporter genes belonging to SPI-1 and SPI-3 
ended for accurate identification of Salmonella 
ecies in food. Application of IMS for isolation of Salmonella species from foods with 
was verified. The integrons and the two ion transporter genes (iron transporter gene sitB 
and magnesium transporter gene magA) were located in different bands showing clearly 
that there was no association between the two. Studies in Shigella flexneri have shown 
the iron transporter system is located on a pathogenicity island and is associated with 
multiple antibiotic resistance genes encoding resistance to Tet, Ch and Amp (127, 195). 
This association of antibiotic resistance genes and pathogenicity island was also observed 
in the high pathogenicity island (HPI) of Yersinia. It was observed by deChamps et al. 
that the Klebsiella isolates that were resistant to Nal and Aug were more likely to possess 
the Yersinia HPI (57). However, in this study any physical association of the integrons 
with SPI-1 and SPI-3 genes (with iron and magnesium transport systems) was not 
observed. It is possible that other antibiotic resistance genes that are not on the integrons 
are associated with one of the five SPI. Further studies involving antibiotic resistance 
genes that are not associated with integrons but are chromosomal in location are needed 
to verify any association with SPI. 
 
In conclusion, ompF gene was shown to be the most reliable marker when compared to 
other genes for the rapid detection of Salmonella species by real time PCR. General 
enrichment in BPW is adequate for the detection for Salmonella from food by real time 
PCR; further enrichment in TT broth was not beneficial. However, a longer general 
enrichment of about 8 hours is recomm
sp
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low Salmonella inoculum was demonstrated to recover significantly greater numbers of 
colonies compared to TT broth enrichment. IMS was shown to be a superior enrichment 
for isolation of Salmonella compared to TT broth for most foods with mixed 
backgrounds. Since IMS takes three hours less than TT broth enrichment and provides 
pure colonies in 25 hours, it is the method of choice for Salmonella isolation for most 
food groups. As hypothesized, macrorestriction profiling with PFGE was the most 
discriminatory technique for typing of clinical and environmental Salmonella isolates. 
However, ribotyping with EcoRI by the automated RiboPrinter® that requires only 9 
hours is suggested for preliminary identification and typing of Salmonella species in case 
of an outbreak or a BT event. When the clinical and environmental isolates from three 
different geographical locations were tested for resistance to 31 antibiotics, 60% were R 
or I to one or more drugs and the majority showed multidrug resistant phenotype. It was 
interesting to observe that the clinical isolates from FL were the least resistant compared 
any other isolates. Class-1 integrons were noted in 12/60 (20%) resistant isolates. The 
location of the integrons seems to be chromosomal for at least five of the isolates as 
ypothesized. Contrary to our hypothesis, no physical association between the h
pathogenicity islands and the integrons was observed. 
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Chapter Five - Significance of the Research 
 
The gene ompF, which has not been previously used as a target by any study for the 
detection of Salmonella by PCR, was established to be a reliable marker for the detection 
of Salmonella subspecies I, III and IV. Primers for the gene ompF gene were also tested 
for the detection of Salmonella species form artificially contaminated food samples 
enriched in general enrichment and selective enrichment. It was shown in this study that 
further enrichment in TT broth was not required for detection of Salmonella from 
artificially contaminated food samples. A detection limit of 1-10 CFU of Salmonella in 
25 gm of food was achieved in 8 hours, 75% of the time by means of the real time PCR.  
Pure culture of Salmonella is a prerequisite to do any biochemical or molecular analysis 
for source tracking. Isolating pure Salmonella colonies in a rapid fashion is especially 
important during an outbreak or a BT event when time is the rate-limiting step. However, 
not many studies have focused on the rapid isolation of Salmonella species from food. 
We have shown for the first time that isolation of pure Salmonella colonies on selective 
agar is possible in 25 hours starting from contaminated food samples.  This accelerated 
isolation protocol yielded pure culture and could be applied for molecular subtyping, 
ntibiotic susceptibility testing and further serological and biochemical analyses. This 
rotocol could be applicable to other organisms or other matrices including stool or 
lood. In this study, a DNA fingerprinting database of more than 100 Salmonella strains 
as created. This database included both ribotyping and PFGE profiles of strains from 
linical and environmental sources. This database will be useful for identification of 
a
p
b
w
c
154 
unknown Salmonella  database could be 
ompared with the CDC PulseNet database in future to unravel any epidemiological links 
isolates received by FLDOH. The PFGE
c
between the Florida isolates and other isolates. The incorrect serotyping of two S. 
Newport isolates was determined by using the database. The antibiotic susceptibility 
patterns and the resistance mechanisms of 100 isolates from three different geographical 
locations were studied. Difference in the susceptibility patterns of Florida isolates and the 
isolates from two other locations was observed. A study probing the association of 
Salmonella virulence genes and antibiotic resistance genes was initiated. Southern 
hybridization probes for various antibiotic resistance genes (β-lactamase, tetracycline, 
and chloramphenicol) and virulence genes including invA, and phoP/Q were designed to 
study the association further.    
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Chapter Six - Future Directions 
 
Salmonella enterica isolates from subspecies II, VI, other serotypes of subspecies I and 
also Salmonella bongeri strains need to be tested for the presence of ompF gene to 
confirm that this target is applicable for the detection of all Salmonella isolates. For the 
detection of Salmonella species from spiked food, the samples were incubated for six 
hours in BPW, this resulted in positive PCR results only 75% of the time. To get 100% 
results, the samples need to be incubated for longer time. Therefore, in the future the 
DNA needs to be extracted and tested every two hours, after the six hour enrichment. In 
this study it was observed that enrichment in conventional selective broth (TT) provided 
a greater number of colonies compared to IMS for cheese. Further studies should verify if 
is is true for other foods with high fat content.  
he Salmonella isolates obtained from WADOH and turkey farms from the Midwest, 
owed a higher prevalence of resistance to antibiotics compared to the ones from 
LDOH. In future it will be interesting to observe if this represents a trend in these states. 
ntibiotic susceptibility testing of isolates from various geographical distributions will 
elp us understand if the isolates from FL are truly more susceptible compared to other 
gions. In this study the integrons of at least five isolates have been tentatively 
etermined to be present in the chromosomes; however, to prove the precise location of 
e integrons, conjugation experiments need to be performed. If the resistance is not 
ansferred it can be confirmed that the integrons are indeed chromosomal. A vast 
th
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majority of multidrug resist resence of integrons, it is 
ossible that these isolates have integrons with several gene cassettes and are not being 
ant isolates did not show the p
p
amplified using conventional PCR. A long PCR with primers directed against the entire 
integrons might elucidate the presence or absence of integrons. Also, it is possible that 
these isolates harbor other classes of integrons including class-2 or class-3. The 
association between integrons and SPI-1 and SPI-3 was verified in this study. The 
possible relationship between integrons and other SPIs, or between antibiotic resistance 
genes outside integrons and SPI needs to be tested. An alternative way to verify the 
association between virulence and antibiotic resistance would be to see if any of the 
antibiotic resistance genes are located on the Salmonella virulence plasmid as observed 
by Villa and Carotolli recently (199). 
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Appendix A 
 
Table A1. Detection and Isolation of Salmonella from Food 
  
Food and average PCR Number of CFU on 
CFU spiked Enrichments result XLD agar 
BPW 40, - 0 
BPW+IMS   0 C(Unspiked) 
hicken cuts 
BPW+TT 40, - 0 
BPW 39.16, - 1-S 
BPW+IMS   0 Chicken cuts (10 CFU 
BPW+TT 34.77, + 8-S 
of S.Typhimurium) 
BPW 35.26, + 38-S 
BPW+IMS   17-S Chickeof S.Typhi
+ 159-S 
n cuts (264 CFU 
murium) 
BPW+TT 29.1, 
BPW 40, - 0 
BPW+IMS   0 C(
BPW+TT 40, - 0 
hicken cuts 
Unspiked) 
BPW 39.0, + 70-S 
BPW+IMS   215-S Chicken cuts (4 CFU of S.T
BPW+TT 29.8, + 27-S 
yphimurium) 
BPW 39.4, + 164-S, 34-NS Chicken cuts (4 CFU of 
BPW+IMS   327-S, 34-NS S.Typhimurium, 73 
o
CFU of E.coli and 
CFU f Citrobacter, 74 
Proteus) 
BPW+TT 30.03, + 90-S, 20-NS 
BPW 40, - 0 
BPW+IMS   3-possible 
contamination 
C
(unspiked) 
BPW+TT 40, - 0 
hicken cuts 
BPW 33.29, + 111-S 
BPW+IMS   295-S Chicken cuts (5 CFU of S.Enteritidis) 
BPW+TT 33.8, + 14-S 
BPW 35.26, + 101-S, 193-NS Chicken cuts (5 CFU of
BPW+IMS   134-S, 71-NS 
 
S.Enteritidis, 99 CFU 
Citrobacter, 59 CFU 
of E.coli and Proteus) BPW+TT 33.68, + 22 
of 
192 
Food and average 
CFU spiked Enrichments result 
Number of CFU on 
XLD agar 
PCR 
BPW 40, - 0 
BPW+IMS   0 Egg salad (unspiked) 
BPW+TT 40, - 0 
B 2PW 6.52, + 82-S 
BPW+IMS  91-S  Egg salad (7 CFU S ) 
27  + 17-S 
.Typhimurium
BPW+TT .3,
BPW 3  600-S 1.5, +
BPW+IMS  1200-S  Egg salad (58 CFU 
23. , + 525-S 
S.Typhimurium) 
BPW+TT 03
BPW 40, - 0 
BPW+IMS   0 Egg salad (unspiked) 
4 - BPW+TT 0, 0 
BPW 36.71, + 42-S 
BPW+IMS  130-S  Egg salad (6 CFU S ) 
33. , + 29-S 
.Typhimurium
BPW+TT 47
BPW 3 40-S 3.42, +
BPW+IMS   270-S Egg salad (62 CFU 
N  
S.Typhimurium) 
BPW+TT D 181-S 
BPW 40, - 0 
BPW+IMS   0 Egg salad (unspiked) 
BPW+TT 4 - 0, 0 
BPW 29.4, - 44-S 
BPW+IMS   43-S Egg salad (7 CFU yphimuriuS.T m) 
TT 30.9,  13-S BPW+ +
BPW 39.7, - 128-S, 10-NS 
BPW+IMS   193-S 
Egg salad (7 CFU 
S.Ty
CFU Citrobacter, 167 
CFU -E.coli and 29.28, + 37-S, 2-NS 
phimurium, 12 
BPW+TT 
Proteus) 
BPW 4 - 0, 0 
BPW+IMS   0 Egg salad (unspiked) 
TT 40, BPW+ - 0 
BPW 34  + .8, 27-S Egg salad (7 CFU 
S.Typhimurium) BPW+IMS 56-S   
193 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
BPW+TT 40, 3-S - 
BPW 35  + 52-S .7,Egg salad (7 CFU 
BPW+IMS 0, 2-NS   S.Typhimurium, 12 
CFU Citrobacter, 167 TT 36.8, BPW+ + 46-S CFU -E.coli and 
Proteus) 
BPW 40, - 0 
BPW+IMS   0 Hamburger Patty 
4 - 
(unspiked) 
BPW+TT 0, 0 
BPW 36.3, + 36-S, Low background 
BPW+IMS 6-S, Low background   Hamburger patty (8 
30  + 56-S 
CFU S.Typhimurium) 
BPW+TT .0,
BPW 32, + 133-S, Low background 
BPW+IMS 57-S, Low background   
Hamburger Patty (8 
CFU S.Typhimurium, 8 
C  
Proteus) 
33  + FU Citrobacter, 82
CFU E.coli and BPW+TT .5, 1-S 
BPW 40, - 32 –NS 
BPW+IMS   46-NS Ha ) 
3
mburger (unspiked
BPW+TT 5.4, + 0 
BPW 3 230-S 4.07, +
BPW+IMS   800-S Hamburger (4 CFU of S.Typhimurium) 
3 50-S BPW+TT 8.24, +
BPW 3 212-S, 129-NS 4.04, +
BPW+IMS   352-S, 71-NS 
H f 
S
CF 3 12-S, 2-NS 
amburger (4 CFU o
.Typhimurium, 74 
U of Citrobacter, 4 BPW+TT 38.27, +CFU of E.coli and 
Proteus) 
BPW 4 - 0, 12-NS 
BPW+IMS   115-NS Ha d) 
BPW+TT 40, - 0 
mburger (unspike
BPW 39.72, - 13-S, 97-NS 
BPW+IMS   46-S, 188-NS Hamburger (5 CFU S.Enteritidis) 
3  50-S BPW+TT 6.2, +
BPW 38.0, + 64-S, 53-NS H
S.Enteritidis, 138 CFU 87-S, 68-NS 
amburger (5 CFU 
BPW+IMS   
194 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
Citrobacter, 71 CFU 
E
36.44 + 600-S, 30-NS BPW+TT 
.coli and Proteus) 
BPW  40, - High background 
BPW+IMS Low background   Tuna sushi (unspiked) 
BPW+TT  40, - Low background 
BPW 32.4, + 107-S, High background 
BPW+IMS   19-S, 6-NS Tuna sushi (6 CFU, 
29.4, + 49-S, 0-NS 
S.Typhimurium) 
BPW+TT 
BPW 31.9, + 260-S, High background 
BPW+IMS   230-S, Low background Tuna sushi (47 CFU, S.Typhimurium) 
BPW+TT 28.3, + 360-S, 0-NS 
BPW   Low background 
BPW+IMS   Low background Tuna sushi (unspiked) 
BPW+TT   0 
BPW 40, + 18-S, Low background 
BPW+IMS   39-S Tuna sushi (6 CFU, S.Typhimurium) 
TT 40, BPW+ - 1-S 
BPW 40, + 250-S, Low background 
BPW+IMS   560-S Tuna sushi (46 CFU, S.Typhimurium) 
TT 40, BPW+ + 9-S 
BPW 39.3, - Low background 
BPW+IMS Low background   salmon Sushi 
TT 40, 
(unspiked) 
BPW+ - 0 
BPW 34.5, + 12-S, Low background 
BPW+IMS   28-S Salmon sushi (7 CFU, S.Typhimurium) 
BPW+TT 40, + 2-S 
BPW 40, - 18-S, Low background 
BPW+IMS   5-S 
Salmon sushi (7 CFU, 
Citrobacter, 45 CFU 
E.coli and Proteus) 45-S 
S.Typhimurium, 3 CFU 
BPW+TT 40, - 
BPW 40, - 1-NS 
BPW+IMS   0 Blueberries (unspiked) 
TT BPW+ 40, - 0 
BPW 40, - 19-S, Low background Blueberries (13 CFU 
195 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
BPW+IMS   239-S S.Enteritidis) 
BPW+TT 40, - 9-S 
BPW 40, - 390-S 
BPW+IMS   8-S Blueberries (37 CFU S.Typhimurium) 
BPW+TT 40, - 280-S 
BPW 40, - 0 
BPW+IMS   0 Blueberries (unspiked) 
BPW+TT 40, - 0 
BPW 40, - 17-S 
BPW+IMS   19-S Blueberries (4 CFU S.Enteritidis) 
BPW+TT 40, - 17-S 
BPW 40, - 62-S 
BPW+IMS   162-S Blueberries (8 CFU S.Typhimurium) 
BPW+TT 40, - 21-S 
BPW 40, - 0 
BPW+IMS   0 Blueberries (unspiked) 
BPW+TT   0 
BPW 40, - 25-S 
BPW+IMS   10-S Blueberries (3 CFU S.Enteritidis) 
BPW+TT 40, - 6-S 
BPW 40, - 60-S 
BPW+IMS   136-S 
Blueberries (3 CFU S. 
En U 
Citrobacter
E.coli and Proteus) 
teritidis, 2 CF
, 48 CFU BPW+TT 40, - 19-S 
BPW 40, - 0 
BPW+IMS   0 Blueberries (unspiked) 
TT BPW+   0 
BPW 40, - 33-S, 1-NS 
BPW+IMS   61-S, 1-NS Blueberries (4 CFU S.Enteritidis) 
BPW+TT 40, - 16-S 
BPW 40, - 26-S, 1-NS 
BPW+IMS   22-S, 1-NS 
Blueberries (4 CFU S. 
Citrobacter, 48 CFU 
Enteritidis, 3 CFU 
BPW+TT E.coli and Proteus) 40, - 325-S 
  Blueberries (unspiked) BPW 40, - 
196 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
For PCR only BPW +TT 40, -   
  BPW + Low spiked (7 CFU of 
S. Typhimurium) TT BPW + +   
BPW +   Mixed Spiked (7 CFU 
f S. Typhimurium, o
Citrobacter, E.coli and 
BPW+TT +   
Proteus 
BPW 4 - 0, 0 
BPW+IMS   0 Cheese (unspiked) 
TT 40, BPW+ - 0 
BPW 4 - 0, 1-S 
BPW+IMS   0 Cheese (12 CFU of S.Typhimurium) 
TT 40, BPW+ - 0 
BPW 38.71, + 1-S, 28-NS 
BPW+IMS 1-S, 1-NS   
Cheese (12 CFU of 
Salmonella; 92 CFU of 
Citrobacter and 76 TT 40, BPW+ - 0 
CFU of E.coli, Proteus-
N/A 
BPW 4 - 0, 0 
BPW+IMS   0 Cheese (unspiked) 
BPW+TT 4 - 0, 0 
BPW 40, - 0 
BPW+IMS   0 Cheese (8 CFU of S.Typhimurium) 
BPW+TT 38  + .7, 0 
BPW 40, - 5-S, 9-NS Cheese (8 CFU 
BPW+IMS  4-S  S.Typhimurium, 83 
Proteus) 
4 - CFU of Citrobacter, 70 CFU of E.coli and BPW+TT 0, 0 
BPW 40, - 0 
BPW+IMS   0 Cheese (unspiked) 
BPW+TT 40, - 0 
BPW 3  6.4, + 0 
BPW+IMS   0 Cheese (5 CFU-S.Enteritidis) 
BPW+TT 40, - 0 
BPW 37.78, + 5-S, 9-NS Cheese (5CFU 
197 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
BPW+IMS   4-S S
TT 40, 
.Enteritidis, 90-
Citrobacter, 59-E.coli 
and Proteus) 
BPW+ - 0 
BPW 40, - 0 
BPW+IMS   0 Cheese (unspiked) 
BPW+TT 40, - 0 
BPW 40, - 0 
BPW+IMS   0 Cheese (5 CFU of 
36. , +
S.Enteritidis) 
BPW+TT 73 0 
BPW 38. 74, + 0 
BPW+IMS   0 
Cheese (5 CFU of 
S.Enteritidis, 94 CFU, 
C f 
E 34  + 
itrobacter, 48 CFU o
.coli and Proteus BPW+TT .6, 0 
BPW-O/N 40, - 0 
BPW+IMS   0 Cheese (unspiked) 
BPW+TT 38  - .8, 0 
BPW-O/N 1  TNTC-S 8.9, +
BPW+IMS   TNTC-S Cheese (2 CFU, S.Enteritidis) 
TT 16. 47, + TNTC-S BPW+
BPW-O/N 29.6,  + 0, high background 
BPW+IMS 31-S, 85-NS   
Cheese (2 CFU 
BPW+TT-O/N 17.45, TNTC-S +
S.Enteritidis, 130 CFU 
C  
S 450-S 
itrobacter, 67 CFU
E.coli and Proteus) BPW+TT+IM   
BPW 40, - 0 
BPW+IMS   0 M ) 
4 - 
ayonnaise (unspiked
BPW+TT 0, 0 
BPW 3  107-S 6.0, +
BPW+IMS   121-S Mayonnaise (5 CFU S.Typhi ) 
TT 40, 47-S 
murium
BPW+ - 
BPW 35.8, + 197–S, 18-NS 
BPW+IMS 400-S, 0   
Mayonnaise (5 CFU 
S.Typhimurium, 66 
CFU Citrobacter, 44 TT 228-S, 33-NS BPW+ 40, + 
CFU E.coli and 
Proteus) 
BPW 40, - 0 Mayonnaise (unspiked) 
IMS  BPW+  0 
198 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
BPW+TT 4 - 0, 0 
BPW 3  154-S 6.6, +
BPW+IMS  206-S  Mayonnaise (4 CFU S.Typhiumurium) 
102-S BPW+TT 40, - 
BPW 35.6, + 295-S, 19-NS 
BPW+IMS   339-S, 1-NS 
Mayonnaise (4 CFU 
S.Typhimurium, 79 
CFU 215-S, 35-NS Citrobacter, 47 CFU E.coli and 
Proteus) 
BPW+TT 40, - 
BPW 40, - 0 
BPW+IMS   0 Mayonnaise (unspiked) 
BPW+TT 39.7, - 0 
BPW 39.6, + 7-S 
BPW+IMS   19-S Mayonnaise (7 CFU, 
39  + 5-S 
S.Enteritidis) 
BPW+TT .9,
BPW 40, - 18-S, 20 -NS 
BPW+IMS   28-S, 6-NS 
Mayonnaise (7 CFU 
S.Enteritidis, 144 CFU 
C  
E.c s) 40, - 60-S, 6-NS 
itrobacter, 41 CFU
oli and Proteu BPW+TT 
BPW 40, - 0 
BPW+IMS   0 Orange juice (unspiked) 
BPW+TT 40, - 0 
BPW 36. , +01 24-S 
BPW+IMS  106-S  Orange juice (5 CFU of S.Typhimurium) 
34. , + 14-S BPW+TT 53
BPW 38.10, + 26-S, 21-NS 
BPW+IMS 40-S, 13-NS   
Orange juice (5 CFU of 
S. Typhimurium, 113 
C  40, - 27-S, 12-NS FU of Citrobacter, 59CFU of E.coli and 
Proteus) 
BPW+TT 
BPW 40, - 0 
BPW+IMS   0 Orange Juice (unspiked) 
BPW+TT 40, - 0 
BPW 37.92, + 11-S 
BPW+IMS  5-S  Orange juice (7 CFU of 
34. , + 13-S 
S.Typhimurium) 
BPW+TT 68
199 
Food and average 
CFU spiked 
PCR 
result 
Number of CFU on 
XLD agar Enrichments 
BPW 37.3, + 28-S, 6-NS 
BPW+IMS 21-S, 4-NS   
Orange juice (7 CFU of 
S. Typhimurium, 93 
C  
Proteus) 
35. , +FU of Citrobacter, 59
CFU of E.coli and BPW+TT 76 15-S 
BPW 40, - 0 
BPW+IMS   0 Orange juice (unspiked) 
3BPW+TT 9.5, - 0 
BPW 38.34, + 1-S 
BPW+IMS  6-S  Orange juice (5 CFU of S.Enteritidis) 
39  - 2-S BPW+TT .8.
BPW 39.12, - 4-S, 7-NS 
BPW+IMS 3-S, 15-NS   
Orange juice (5 CFU of 
S. Enteritidis, 100 CFU 
o  
of E us) 39.5,  +
f Citrobacter, 50 CFU
.coli and Prote BPW+TT 18-S 
 
 
 species from artificially seeded food samples. The 
or s  Salmonella E.coli and 
teus species was not determined.  BPW=Buffered 
Peptone Water, BPW+IM
PCR ind te the CT values. + = positive PCR 
tion. XLD -Lysin ate, S= Salmonella 
e . The PCR results 
for blueberries (Gray cells) were negative for four experiments because the samples were 
store  over ich m ve caused cell lysis and possible DNA 
degradation. 
 
 
Detection and isolation o
iginal spiking count i
f Salmonella
shown for each of the organism  species, 
Citrobacter. The viable count for Pro
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Figure A2. PFGE of Wild type Salmonella Isolates 
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Macrorestriction profiling of the 100 wild type Salmonella isolates with the enzyme 
XbaI. The serotype names and sources are indicated. The percent similarity between 
isolates is represented 
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Figure A3. Antibiotic Resistance Profiling of Wild type 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibiograms of the 100 wild type Salmonella for 31 drugs. The serotype names and 
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R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
4 S 1 
S 
.12 S .5 
S 
16 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
8 I 2 S 
CBD# 4 S 
580 
16 
I 
2S 25
6 R 
2 S 4 S 4 S 1 S 8 S .254 
S S 
8 I 1 .12 S .5 
S S 
64 
I 
8 6 
S 
25
S 
8 I 64 
I 
32 
I 
4 S .5 S 
CBD# 4 S 
581 
16 
I 
2S 25
6 R 
2 S 4 S 4 S 1 S 8 S .254 
S S 
8 I 1 .12 S .5 
S S 
64 
I 
8 
S 
256 
S 
8 I 64 
I 
32 
I 
4 S .5 S 
CBD#
(582 
 4 S 16 
I 
2S 25
6 R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
8 I 1 
S 
.12 S .5 
S 
32 
I 
8 
S 
256 
S 
8 I 64 
I 
16 
S 
8 I .5 S 
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 AM
I 
A/S AZ
T 
CA
R 
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P 
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P 
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T 
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Z 
A
X
O 
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L 
CIP GE
N 
IM
I 
LEVO LO
M 
PI
P 
P/
T 
FIS TE
T 
TI
C 
TI
M 
TO
B 
SX
T 
CBD# 
583 
4 S 16 
I 
2S 25
6 R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
8 I 1 
S 
.12 S .5 
S 
32 
I 
8 
S 
256 
S 
8 I 64 
I 
16 
S 
8 I .5 S 
CBD# 
584 
4 S 16 
I 
2S 25
6 R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
8 I 1 
S 
 
S 
.12 S .5 64 
I 
8 
S 
256 
S 
8 I 64 
I 
16 
S 
8 I .5 S 
CBD# 
585 
4 S 4 S 2 S 32 
I 
 2S 4S 4S 1S 4S 4S .25 
S 
1 S 8 I .12S .5S 8S 8S 256
S 
1S 16
S 
16
S 
1S .5S 
CBD# 
586 
4 S 4 S 2 S 32 
I 
2S 4S 4S 1S 4S 4S .25 
S 
1 S 1 
S 
.12S .5S 8S 8S 256
S 
1S 8S 16
S 
1S .5S 
CBD# 
587 
4 S 4 S 2 S 32 
I S 
2S 4S 4S 1S 4S 4S .25 
S 
1 S 1 .12S .5S 8S 8S 256
S 
1S 8S 16
S 
1S .5S 
CBD# 
588 
4 S 4 S 2 S 32 
I 
2S 4S 4S 1S 4S 4S .25 
S 
1 S 1 
S 
.12S .5S 8S 8S 256
S 
1S 8S 16
S 
1S .5S 
CBD# 
589 
4 S 4 S 2 S 32 
I 
 
S 
2S 4S 4S 1S 4S 4S .25 
S 
1 S 1 .12S .5S 8S 8S 256
S 
1S 8S 16
S 
1S .5S 
CBD# 
590 
4 S 4 S 2 S 32 
I 
2S 4S 4S 1S 4S    4S .25 
S 
1 S 1 
S 
.12S .5S 8S 8S 256
S 
1S 8S 16
S 
1S .5S 
CBD# 
591 
4 S 16I 2S 25
6 R 
2S 32 
I 
  4 S 1S 4S 4S .25
S 
1S 1S .12S .5S 64
I 
64
I 
256 
S 
1S 64I 128
R 
1S .5S 
CBD# 
592 
4 S 16I 2S 25
6 R S 
  2S 16 4 S 1S 4S 4S .25
S 
1S 1S .12S .5S 64
I 
8S 256 
S 
1S 64 
I 
64 
I 
1S .5 S 
CBD# 
593 
4S 2S 2S 32I 2S 4S 4S 1 S 4S 4S .25
S 
8 I 1S   .12S .5S 8S 8S 256
S 
8 I 8S 16
S 
8 I .5S 
CBD# 
594 
4S 2S 2S 32I 2S 4S 4S 1 S 4S    4S .25
S 
1 S 1S .12S .5S 8S 8S 256
S 
8 I 8S 16
S 
1S .5S 
CBD# 
595 
4S 4S 2S 64
R 
2S 4S 4S 1 S 4S 16I .25
S 
1 S 1S   .12S .5S 16
S 
8S 256
S 
2S 8S 16
S 
1S .1S 
CBD# 
596 
4S 2S 2S 32I 2S 4S 4S 1 S 4S    8S .25
S 
1 S 1S .12S .5S 8S 8S 256
S 
2S 8S 16
S 
1S .5S 
CBD# 
597 
4S 16I 2S 25
6R 
2S 32 
I 
4S 1  S 4S 8S .25
S 
8 I 1S  .12S .5S 64 
I 
16
S 
256
S 
1 
S 
64 
I 
64 
I 
4 S .5S 
CBD# 
598 
4S 16 
I 
2S 25
6 R 
2S 32 
I 
4S 1  S 4S 4S .25
S 
8 1 1S  .12S .5S 64 
I 
8S 256
S 
1 
S 
64 
I 
64 
I 
4 S .5S 
CBD 
#603 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 
S 
8 S 16 
S 
1S 0.5
CBD# 
604 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 
S 
8 S 16 
S 
1S 0.5
CBD# 
746 
4S 16 
I 
2S 25
6 R 
2S 32 
I 
4S 1  S 4S 16 I .25
S 
8 1 1S  .12S .5S 64 
I 
8S 256
S 
8 I 64 
I 
128 
R 
2 S .5S 
CBD 
#747 
4 S 4 S 2 S 64 
R 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1S 1 S 1S 0.5
S S 
.12 S .5 
S 
16 
S 
8 
S 
256
S 
1S 8 16 
S 
CBD 4 S 2 S 2 S 32 2 S 4 S 4 S 1 S 4 4 S .25 1S 1 .12 S .5 8 8 256 1S 8 S 16 1S 0.5
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I 
A/S AZ
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CA
R 
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P 
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O 
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L 
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I 
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M 
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P 
P/
T 
FIS TE
T 
TI
C 
TI
M 
TO
B 
SX
T 
#757 I S S S S S S S S S 
CBD 
#759 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1S 1 S 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 16 
S S 
CBD 
#775 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1S 1 S 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 16 
S S 
CBD 
#776 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 S 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 16 
S S 
CBD 
#777 
4 S 16I 2 S 25
6R 
2 S 32 
I 
4 S 1 S 4 
S 
16 I .25
S 
1 S 1 
S 
.12 S .5 
S 
64 
I 
8 
S 
256 
S 
8 I 64 
I 
128 
R 
1 S .5 S 
CBD 
#778 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
CBD 
#779 
4 S 4 S 2 S 32I 2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
CBD 
#780 
4 S 4 S 2 S 64 
R 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1 S 1 
S 
.12 S .5 
S 
16 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S 1 S 
CBD 
#781 
4 S 4 S 2 S 64 
R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1 S 1 
S 
.12 S .5 
S 
16 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S 1 S 
CBD 
#782 
4 S 4 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
4 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
CBD 
#805 
4 S 2 S 2 S 64
R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 .5 
S 
16
S 
8 
S 
256
S 
1S 8S 16 
S S 
CBD 
#806 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 .5 
S 
8S 8 
S 
256
S 
1S 16 
S 
16 
S S 
CBD 
#807 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 S 1S 0.5
S 
.12 S .5 
S 
8S 8 
S 
256
S 
1S 8 16 
S S 
CBD 
#808 
4 S 2 S 2 S 64 
R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 S 
S 
.12 S .5 
S 
16 
S 
8 
S 
256
S 
1S 8 16 
S 
2 S 0.5
S 
CBD 
#809 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 .5 
S 
8S 8 
S 
256
S 
2S 16 
S 
16 
S S 
CBD 
#810 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
16I .25 1S 1  S 2S 0.5
S S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
2S 8 16 
S S 
CBD 
#811 
4 S 2 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1  S 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 16 
S S 
CBD 
#813 
4 S 4 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8S .25 1S 1 1S 0.5
S S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 S 16 
S S 
CBD 
#814 
4 S 4 S 2 S 32 
I 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1  1S 0.5
S 
.12 S .5 
S 
16
S 
8 
S 
256
S 
1S 8 S 16 
S S 
CBD 
#815 
4 S 4S 2 S 64
RR 
2 S 4S 4 S 1 S 4 
S 
8 S .25
S 
1 S 1 
S 
.12 S .5 
S 
16
S 
8 
S 
256 
S 
1S 8S 16
S 
2 S 1 S 
CBD 
#816 
4 S 16I 2 S 25
6R 
2 S 32I 4 S 1 S 4 
S 
16I .25
S 
1 S 1 
S 
.12 S .5 
S 
64
I 
8 
S 
256 
S 
8I 64I 128
R 
1 S .5 S 
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M 
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T 
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C 
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B 
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T 
CBD 
#817 
4 S 16I 2 S 64 
R 
2 S 4 S 4 S 1 S 4 S 1 S .12 S  6 1 8 S  1 S S 4 
S 
.25
S 
1 
S 
.5 
S 
16
S 
8 
S 
25
S S 
16
S 
1 
CBD 
#818 
4 S 4 S 2 S 64 
R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 S .5 
S 
16
S 
8 
S 
256
S 
1S 8 S 16 
S S 
CBD 
#819 
4 S 4 S 2 S 64
R 
2 S 4 S 4 S 1 S 4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 S .5 
S 
16
S 
8 
S 
256
S 
1S 16 
S 
16 
S S 
CBD 
#820 
4 S 4 
S 
2 S 64
R 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1S 1  1S 0.5
S 
.12 S .5 
S 
8S 8 
S 
256
S 
1S 8S 16 
S S 
CBD 
#821 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 S .5 
S 
8S 8 
S 
256
S 
1S 8S 16 
S S 
CBD 
#822 
4 S 4 
S 
2 S 64
R 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1S 1  
S 
.12 S .5 
S 
16
S 
8 
S 
256
S 
1S 8S 16 
S 
2S 1S 
CBD 
#823 
4 S 16 
I 
2 S 25
6 
R 
2 S 32
I 
4 S 1 
S 
4 
S 
16 I .25
S 
1S 1 
S 
.12 S .5 
S 
64
I 
8 
S 
256
S 
8I 64I 128
R 
1S 0.5
S 
CBD 
#824 
4 S 16 
I 
2 S 25
6 
R 
2 S 32
I 
4 S 1 
S 
4 
S 
16 I .25
S 
1S 1 
S 
.12 S .5 
S 
64
I 
8 
S 
256
S 
8I 64I 128
R 
1S 0.5
S 
CBD 
#825 
4 S 16 
I 
2 S 25
6 
R 
2 S 32
I 
4 S 1 
S 
4 
S 
16 I .5S  1S 1 
S 
.5 S 2 S 64
I 
8 
S 
256
S 
8I 64I 128
R 
1S 0.5
S 
CBD 
#826 
4 S 16
I 
2 S 25
6 
R 
2 S 32
I 
4 S 1 
S 
4 
S 
16 I .25
S 
1S 1 
S 
.5 S 2S 64
I 
8 
S 
256
S 
8I 64I 128
R 
1S 0.5
S 
CBD# 
827 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
4 S .25
S 
1S 1 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 S 16 
S S 
CBD 
#828 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1S 1 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 S 16 
S S 
CBD 
#829 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
4 S .25
S 
1S 1 S 1S 0.5
S 
.12 S .5 
S 
8 
S 
8 
S 
256
S 
1S 8 16 
S S 
CBD 
#830 
4 S 4 
S 
2 S 64 
R 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1 S 1 
S 
.12 S .5 
S 
16 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
2 S 1 S 
CBD 
#831 
4 S 4 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
4 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8 
S 
8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
CBD 
#832 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
8 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8S 8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
CBD 
#833 
4 S 2 
S 
2 S 32 
I 
2 S 4 
S 
4 S 1 
S 
4 
S 
4 S .25
S 
1 S 1 
S 
.12 S .5 
S 
8S 8 
S 
256 
S 
1 
S 
8 S 16 
S 
1 S .5 S 
 
Table A i c s e b f la  u ng  p l. AMI- Am n S m ci , ZT zt nam, 
- e l  C p T ef ax T -C a im X - r on
ra nicol, CIP- Ciprofloxacin, E G ta Levofloxacin, LOME- Lome
rac n, - e ill Ta ba um
ulanic d, TOB obramy in, SXT- Trimethoprim ulpham oxazole. = resist , I Intermediately resistant. Gray 
in t  o T v s  i / . 
 
e A i tic Sus ng M -7 e
A2. ntib oti usc pti ility o  iso tes si  NF ane ikaci , A/ - A pi llin/Sublactum  A - A reo
CAR Carb nici in, FEP- efe ime, FOP- Cefoperazone, FO - C ot ime, AZ eft zid e, A O Ceft iax e, CHL- 
Chlo mphe G N- en micin, IMI- Imipenem, LEVO- floxacin, PIP- 
Pipe illi P/T Pip rac in/ zo ct , FIS- Sulfizoxazole, TET- Tetracycline, TIC- Ticarcillin, TIM- Ticarcillin/ 
Clav Aci - T c /S eth R ant = 
cells dica e R r I. he alue are n μg ml
 
Tabl A3. ntib o ceptibility Testi  C V  Pan l 
 
 
 AMI AUG AMP FOX TIO XO CEP CHL CIP EN KAN NAL STR X TET A  G SM COT 
CBD# 
32 
1S 1S S 1S .5S .25S  8S .01S .5S 8S 4S 32 S 64S 4S .12S 2
CBD# 
33 
1S 1S 1S 1S .5S 5S  .01S .25S 8S 4S  S 4S .2 8S 32 S 32 .12S 
CBD# 
67 
1S 5S 4S 1S 1S 2S .5S .2 2S 4S .01S .25S 8S 32S 32S 4S .12S 
CBD# 
69 
1 5S 4S S 1S 1S 4S .5S .2 2S 8S .01S .1S 8S 32S 32S 4S .12S 
CBD# 
213 
1S 5S 1S 4S 4S 1S .2 8S 16I .3S 5S 3 4S .2  8S 16S 2S 32S .12S 
CBD# 
222 
1S 5S 3  1S 2S 2S 1S .2 4S 8S 01S 1S 8S 8S 2S 16S 4S .12S 
CBD# 1S 
425 
32R 32R 16I 8R 16I 32R 32R .01S .25S S  8S 4 64R 512R 32R 2.1 S 
CBD# 1S 
426 
32R 32R 16I 8R 32R 32R 32R .01S .25S 4S  8S 64R 512R 32R 2.1 S 
CBD# 1S 
427 
32R 32R 16I 8R 32R 32R 32R .01S .25S 4S  8S 64R 512R 32R 2.1 S 
CBD# 
428 
1S 32R 32R 16I 8R 16I 32R 32R .01S .25S 8S 2S 64R 512R 32R .12S 
209 
210 
 AMI AUG AMP FOX TIO AXO CEP CHL CIP GEN KAN NAL STR SMX TET COT 
CBD# 2S 
429 
32R 32R 16I 8R 16I 32R 32R .01S .5S 8S 4S 64R 512R 32R .12S 
CBD# 
430 
1S 32R 32R 16I 8R 8S 32R 32R .01S .25S 8S 4S 64R 512R 32R .12S 
CBD# 
431 
2S 32R 32R 16I 8R 16I 32R 32R .01S 1 S 8S 4S 64R 512R 32R .12S 
CBD# 1S 
432 
32R 32R 16I 8R 8S 32R 32R .01S .5S 8S 2S 64R 512R 32R .12S 
CBD# 1S 
433 
32R 32R 16I 8R 16I 32R 32R .01S 1S 8S 2S 64R 512R 32R .12S 
CBD# 
434 
2S 32R 32R 16I 8R 8S 32R 32R .01S .5S 8S 4S 64R 512R 32R .12S 
CBD# 
435 
1S 1S 1S 4S .5S .25S 2S 8S .01S .5S 8S 4S 32S 16S 4S .12S 
CBD# 
436 
.5S 2S 2S 8S 1S .25S 8S 8S .5S .25S 8S 32R 32S 16S 4S .12S 
CBD# 2S 
437 
16I 32R 2S 1S .25S 32R 4S .01S 16R 64R 2S 32S 512R 32R .25S 
CBD# 2S 8S 
438 
32R 2S .5S .25S 2S 32R .01S 1S 8S 4S 64R 512R 32R .25S 
CBD# 
39 
1S 8S 
4
32R 2S .5S .25S 2S 32R .01S .25S 8S 4S 64R 512R 16R .12S 
CBD# 
440 
1S 1S 2S 2S .5S .25S 2S 4S .01S .25S 8S 4S 32S 32S 4S .12S 
CBD# 
441 
1S 1S 2S 1S .5S .25S  8S .01S .25S 8S 4S 32S 32S 4S .25S 
CBD# 
442 
1S 1S 2S 1S .5S .25S  8S .01S .25S 8S 4S 32S 32S 4S .25S 
CBD# 
443 
2S 8S 32R 2S .5S .25S 2S 32R .01S .5S 8S 4S 64R 512R 16R .12S 
CBD# 
444 
1S 1S 1S 2S .5S  .25S 2S 4S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
445 
1S 1S 1S 1S .5S  .25S 2S 8S .01S 1S 8S 4S 32S 16S 4S .12S 
CBD# 
446 
2S 1S 1S 1S .5S .25S 2S 4S .01S 1S 8S 4S 32S 16S 4S .12S 
CBD# 
569 
1S 1S 2S 2S .5S .25S 2S 4S .01S 16R 8S 4S 32S 512R 32R .25S 
CBD# 
570 
2S 1S 1S 4S .5S .25S 2S 4S .01S 8I 8S 4S 32S 512R 32R .12S 
CBD# 
571 
2S 1S 1S 4S .5S .25S 2S 4S .01S 4S 8S 4S 32S 16S 4S .12S 
CBD# 1S 1S 1S 1S .5S .25S  8S .01S .5S 8S 2S 32 S 32S 4S .12S 
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572 
CBD# 
573 
2S .5S .25S .01S .25S 4S 2S 1S 1S 8S  4S 64R 32S 32R .12S 
CBD# 
574 
2S .5S .25S 8S 2S 1S 1S 4S  4S .01S .5S 64R 32S 32R .12S 
CBD# 
575 
1S 1S .25S 1S 1S 4S 2S 4S .01S 8I 8S 4S 64R 512R 32R .12S 
CBD# 
576 
4S .5S .25S 8S 4S 1S 1S 2S 2S 4S .01S .5S 32S 128S 32R .12S 
CBD# 
577 
4S .5S .25S .5S 8S 4S 1S 1S 2S  8S .01S 64R 32S 32R .12S 
CBD# 
578 
1S .5S .25S 1S 1S 4S 2S 4S .01S 1S 8S 4S 32S 16S 4S .12S 
CBD# 
579 
4S 1S 1S 4S 4S 4S .5S .25S .01S 8I 64R 4S 64R 16S 4S .12S 
CBD# 
580 
2S 4S 32R 4S .01S 1S .25S 8S 8S 16R 64R 4S 64R 512R 32R .12S 
CBD# 
581 
2S 8S 32R 8S 1S .25S  8S .01S 16R 16S 4S 64R 265R 32R .12S 
CBD# 
582 
2S 4S 32R 8S 1S .25S 8S 16I .03S 16R 64R 8S 64R 512R 32R .25S 
CBD# 
583 
2S 2S 2S 8S 1S .25S  16I .01S 16R 8S 4S 64R 265R 16R .12S 
CBD# 
584 
1S 1S 2S 1S 2S 4S .5S .25S .01S .25S 8S 4S 32S 16S 4S .25S 
CBD# 
585 
1S 1S 2S 4S 8S 1S .25S  .01S 8I 8S 2S 128S 4S 32S .12S 
CBD# 
586 
2S 1S 2S 4S 8S 1S .25S  .01S 16R 8S 4S 32S 265R 16R .12S 
CBD# 
587 
2S 1S 2S 4S 1S .25S  4S .01S 16R 8S 4S 32S 64S 8I .12S 
CBD# 
588 
1S 1S 4S 4S 8S .5S .25S  .01S 8I 8S 2S 32S 64S 32R .25S 
CBD# 
589 
2S 1S 2S 2S .5S 8S 2S 1S .25S  8S .01S 32S 32S 16R .12S 
CBD# 
590 
1S 1S 2S 2S .01S .25S 8S 4S .5S .25S  4S 64R 256R 32R .12S 
CBD# 
591 
2S 16I 32R 4S .5S .25S  4S .01S .25S 8S 2S 64R 256R 4S .12S 
CBD# 
592 
1S 1S 2S 2S .01S .25S 8S 4S .5S .25S  4S 64R 256R 32R .25S 
CBD# 
593 
2S 2S 1S 2S .01S .25S 8S 2S .5S .25S  4S 64R 64S 4S .12S 
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CBD# 
594 
2S 2S 32R 2S .01S .5S .5S .5S  8S 8S 4S 32S 64S 8I .12S 
CBD# 
595 
1S 1S 4S 4S 4S 1S .25S 16I .03S 1S 8S 16S 32S 16S 4S .25S 
CBD# 
596 
4S 1S 4S 4S 4S 1S .25S 16I .03S .25S 8S 4S 32S 32S 4S .25S 
CBD# 
597 
1S 8S 32R 2S 1S .25S 32R 8S .03S 16R 64R 8S 64R 512R 4S .25S 
CBD# 
598 
2S 8S 32R 4S 1S .25S 16I 8S .03S 16R 64R 32R 64R 512R 4S .12S 
CBD# 
603 
1S 8S 32R 2S 8S .5S .25S 8S .01S 16R 64R 4S 32S 512R 4S .12S 
CBD# 
604 
2S 8S 32R 2S 1S .25S 8S 8S .03S 16R 64R 8S 32S 512R 4S .12S 
CBD# 
746 
2S 8S 32R 2S 1S .25S 2S 32R .015S 1S 8S 8S 64R 512R 16R .25S 
CBD# 
747 
2S 8S 32R 4S 1S .25S 4S 32R .03S 1S 8S 8S 64R 512R 16R .12S 
CBD# 
757 
1S 1S 2S 4S 015S .5S 1S 2S 2S .25S . 8S 4S 32S 16S 4S .12S 
CBD# 
759 
1S .5S S 1S 1S 4S .25S 2 4S .015S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
775 
1S 1S 1S 2S .5S 2S .25S 4S .015S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
776 
2S 1S 1S 2S 2S 4S 015S 1S .5S .25S . 8S 4S 32S 16S 4S .12S 
CBD# 
777 
1S 8S 32R 2S .5S 2S .25S 32R .015S .5S 8S 4S 64R 512R 16R .25S 
CBD# 
778 
1S 1S 1S 2S .5S 2S 4S 015S 1S .25S . 8S 4S 32S 16S 4S .12S 
CBD# 
779 
1S 1S 1S 2S 1S 4S 4S .25S .015S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
780 
1S 1S 1S 2S 2S 4S .5S .25S .015S .25S 8S 2S 32S 16S 4S .12S 
CBD# 
781 
1S 1S 2S 2S 1S 2S 8S .25S .03S .25S 8S 8S 32S 16S 4S .12S 
CBD# 
782 
2S 1S 1S 2S 2S 4S 015S 1S .5S .25S . 8S 4S 32S 16S 4S .12S 
CBD# 
805 
2S 2S 4S 1S 1S 1S .5S .25S .01S .5S 8S 4S 32S 16S 4S .12S 
CBD# 
806 
1S 1S 1S 1S 4S 4S .5S .25S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 1S 1S 1S 4S 4S 8S .01S 1S .5S .25S 8S 4S 32S 16S 4S .12S 
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807 
CBD# 
808 
2S .25S 2S 4S 4S 1S 1S 2S .5S .01S 1S 8S 4S 32S 16S .12S 
CBD# 
809 
1S 1S 1S 2S .5S 2S .25S 4S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
810 
1S 1S 2S 1S .5S 2S .25S 8S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
811 
2S .5S 4S 1S 2S 2S .25S 2S .01S 1S 8S 4S 32S 16S 4S .12S 
CBD# 
813 
1S .5S 4S 1S 1S 1S .25S 2S .01S .25S 8S 2S 32S 16S 4S .12S 
CBD# 
814 
1S 4S 8S 1S 1S 4S .5S .25S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
815 
.5S 1S 2S 16I 1S .25S 16I 8S .01S .25S 8S 4S 32S 16S 4S .12S 
CBD# 
816 
1S 16I 32R 2S .5S .25S 2S 32R .01S 1S 8S 4S 64R 512R 16R .12S 
CBD# 
817 
1S .5S S 1S 1S 1S .25S  8S .01S .25S 8S 4S 32 32S 4S .12S 
CBD# 
818 
1S 1S 1S 1S .5S 4S .25S  .01S .25S 8S 2S 32S 32S 4S .12S 
CBD# 
819 
2S 1S 1S 2S 4S .5S .25S  .01S .5S 8S 4S 32S 16S 4S .12S 
CBD# 
820 
1S 1S 2S 1S 8S .5S .25S  .01S .25S 8S 2S 32S 32S 4S .25S 
CBD# 
821 
1S 1S 2S 2S 8S .5S .25S  .01S .25S 8S 4S 32S 64S 4S .12S 
CBD# 
822 
1S 1S 1S 1S .5S .25S  4S .01S .25S 8S 2S 32S 16S 4S .12S 
CBD# 
823 
1S 8S 32R 2S .5S .25S  32R .01S .5S 8S 2S 64R 256R 16R .12S 
CBD# 
824 
1S 8S 8S 1S .5S .25S  16I .01S .5S 8S 2S 32S 64S 8I .12S 
CBD# 
825 
1S 4S 16I 2S .5S .25S  32R .5S .25S 8S 32R 32S 256R 16R .12S 
CBD# 
826 
1S 1S 2S 1S .5S 8S .25S  .01S .5S 8S 4S 32S 32S 4S .12S 
CBD# 
827 
1S 1S 1S 2S 4S .5S .25S  .01S .25S 8S 2S 32S 64S 4S .12S 
CBD# 
828 
1S 1S 1S 1S 4S .5S .25S  .01S .25S 8S 4S 32S 32S 4S .12S 
CBD# 
829 
1S 1S 1S 1S .25S 2S .25S  .01S .25S 8S 2S 32S 32S 4S .12S 
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CBD# 
830 
2S 1S 1S 2S .5S .25S  8S .01S 1S 8S 4S 32S 32S 4S .12S 
CBD# 
831 
1S 1S 1S 2S 4S .5S .25S  .01S .25S 8S 4S 32S 32S 4S .12S 
CBD# 
832 
1S 1S 1S 2S 8S .5S .25S  .01S .25S 8S 4S 32S 32S 4S .12S 
CBD# 
833 
1S 1S 1S 1S 4S .5S .25S  .01S .25S 8S 2S 32S 32S 4S .12S 
 
 
 
 
Table A3 Antibiotic susceptibil re s o  1 so s C 7 el. I- k  A P- icillin, AUG- 
Am
Cip xacin, COT-Trimethoprim/Sulfamethaxazole, FOX- Cefoxitin, GEN- Gentamicin, KAN- Kanamycin, NAL- Nalidixic 
tho ole TR e yc n, T Te c  T  Ce fu  ta = mediately 
resis t. Gray cells indicate R or I. Cep was not tested for al cks this antibiotic. The 
valu re in μg/ml.
ity sult f the 00 i late with MV- pan AM Ami acin, M Amp
oxicillin/Clavulanic Acid, AXO- Ceftriaxone, Tio- Ceftiofur, CEP- Cephalothin, CHL- Chloramphenicol, CIP- 
roflo
Acid, SMX- Sulfame xaz , S - Str ptom i ET- tracy line, IO- ftio r. R= resis nt, I Inter
tan l the isolates as the new CMV-7 panel la
es a
Figure A4 Sequencing data of 1.0 Kb and 1.2 Kb Integron Fragments  
 
 
438 1.0 Kb 
 
ACGCTTGTGGGTCGATGTTTGATGTTAT GCAGCAACGATGTTACGCAGC
C GTCGCCCT T TCATGAGGGTAGCGGTGACCAT
CAAAATTTCaGAAC T TAAGCGTCATTTGAGCGCCATCT
T ACGTTGC G CGGCTCCGCAGTGGATGGCGGC
CTGAAGCCATACAG A T GTTACTGTGGCCGTAAAGCTTGA
A ACGCGGC CCTTATGGAGGCTTCGGCTTTC
G AGAGCGAGAC T T GAAGTCACCCTTGTCGTGCATG
C CATCCCG T C AGCGCGAGCTGCAATTTGGAGA
C CGCAATG A T CTTCGAGCCAGCCATGATCGAC
ATTGATCTAGCTAT G T ATAGCGTTGCCTTG
G CGGCAGC A A C TCCTGAACAGGATCTAT
TCGAGGCGCTGAGGGAAACC A C TCGCAGCCCGACTGGGC
G GAGCGAA G C GTCCCGCATTTGGTACAGCGCA
ATAACCGGCAAAAT C GAAGGAT GCTGCCGACTGGGCAATAAAA
TACCTGCCCA G TTGAAGCTAAGCAATGCTTATC
TGGGACAAAAAGAA T C T AGATCACTTGGAAGAATT
C TTTGTGAA G AGTCAGTTGGTAAATGATGTCTA
T GTTCAAG CGCGGCGGtCTTAACTCCGGCGT
TAGA 
438 1.2 Kb 
GTAATGGAGCAGCAACGTATGTTACG
A GCAGTCG C GCCATATTATGGAGCCTCATGC
TTTTATATAAAATG G A A A ATGGGGTTACTTACATGAAGTTT
T CATTTTCG T A C CCGTGGTTTTTGCAAGTAGTTCAAAG
TTTCAGCAAGTTGA C T ATTGAAGTTTCTCTTTCTGCTCG
G GTTTCCGTTCTTGATACT A GGAGAATATTGGGATTACAATG
GCAATCAGCGCTTC A A C TTAAAACAATAGCTTGCGCTAAA
TATATGATGC G A A AGTTAATCCCAATAGTACAGTCGAGA
TA G AAGCAGAT A T C CTGTAATAGAAAAGCAAGTAGG
GCAGGCAATCACAC CGCAACTATGACTACAAGTGAT
C CGGCAAA T C A G G GTGGCCCCAAAGGCGTTA
CTGATTTTTTAAGA A CTCGTCTAGACCGTATTGA
GATTTAAATG A T GACAACTCCT
A C ATAGCCAG C G T A T TTGGTTCCGCGCTATCTGA
AGATCA A T T TGAACAATCAAGTCACTGG
GTTC T T GGCG A AACATTGCGGATCGCTCAG
GTGCTGGCGGATTT G C C AGTTGTGTGGAGTGAGCA
TCAAGCCCCAATTATTGTGAGCATCTATCTAGCTCAAACACAGGCTTCAATGG
CAGAGCGAAATGATGCGATTGTTAAATTATTGGTCATTCAATTTTTGACGTTT
GGA
AAAACAAAG TAGACA
CAACTATCAGAAG GC
TGGCCGTGCATTT TA
CG TATTGATTTG TG
GAGCATTGCTCAATGA
GC CCGCGC ATA
TGGCGT ATCCGG TA
AC TTC TGCGGGTAT
CCT CT ACAAAAGCAAAGAGAAC
GG GG ATT TTTGACCCGGT
TTG AG TATGGAAC
AT TAGTGCTTA GTT
CG GCC GTC
GTATCA CCCGTCTTAC
GA CA TTGGCC CACGCGC
AG GCGAGATCATCA
CCGtACCGtCGtCTACGt
CC TAAAACAAAGTTA
TGT AC ATC AA TT
CT TTA TA CAT
ACAAGA GT AAGGCA
CA AAT
CCGTTA CA GTA TT
TGA CA GG AA
CTTGTG CC ATT CC
TCGATGATGCGTGCTT
TA CAT CT AGT CT TAG
CAA TTGGGGACAAAGAGA
AAGGTA GC CGGTGATTTGAGGGATAC
TA TTT AA AA TTT TAT
AA TTAGAGTCT GGA GG
AG AT GCC GG TGG
GGT CT GGAGTATTA AGC
AGGG A
GGAA CA
TG
CC
AA
TG
CG
CG
AC
AT
GA
GG
AT
AG
GTAG TC
CGGC AT
CGCC
TA
AC
TT
AA
GC
TC
 
 
GTTACGCCTTTCGGGTCGATGTTTGAT
CAGC GG
TTAT GG
TATA GT
TA
T
AC
A A
AATA TG
GCCT
A
AA
TAATT
GG
TGA
A
ACC
TACTAC
215 
ATACATCACAGTCGCGCTGATAAGGCTAACAAGGCCATCAA AGTTG CGGCTT
TCCGTCGCTTGTTTTGTGGTTTAACGCTACGCTACCACAAAACAATCAACTC
AAAGCCGCAACTTATAGGCGGCGTTAGATGCATCTAAGCACATAATTGCTG
TATACT 
TGTCTAACAATTCGTTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAA
TTAGAAGCACTAAGCACATAATTGCTCACAA  
T
C
CACATGCC
 
580 1.0 Kb 
 
TAGCCTTGCGGTCGATGTTTGATGTAATGGAGCAGCAACGATGTTACGCAGC
AGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCG
CCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCT
CAAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGC
CTAGAAGCCACACAGTGATATTAGATTTGCCTGGTTACGGTGACCGTAAGGC
TTGATAGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGG
CTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGGTTGT
GCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTT
GGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCAGAGCCAGCCACG
ATCGACATTGATCTGGGCTATCTTTGCTTGACAAAAAGCAAGAGAACATAGC
GTTGCCTTGGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCCGGTTCCTGAA
CAGGATCTTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGGAACTCGCC
GCCCGACTGGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTT
GGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTG
GGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGA
CAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCCCGCGCAGATCAGT
TGGAAGAtATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCA
ATAAA
CTCAAGCG
 
581 1.0 Kb 
 
AGGCTGTGAGCAATTATTGTGCTTAGATaGCATCTAACGCTTGTAGTTGAAGC
CGCGCCGCGAAGCGGCGTCGGCTTGAAACGAATTGTTAGACATTATTTGCCG
ACTACCTTGGTGATCTCGCCTTTCACGTAGTGAACAAATATCTTCCAACTAGA
TCTGCGCGGGAGGCCAAGCGATCTTCTTCCTTGTCCAAGATAAGCCTGTCTAG
CTTCAAGTATGACGGGCTGGATACTGGGCCGGCAGGCGCTCCATTGCCCAGT
CGGCAGCGACATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATG
CGGGACAACGTAAGCACTACATTTCGCTCATCGCCAGCCCAGTCGGGCGGCG
AAGTTCCATAGCGTTAAGGTTTCATTTAAGCGCCTCAAATAGATCCTGTTCAG
GAACCGGATCAAAGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATG
TTCTCTTGCTTTTGTCAGCAAGATAGCCAGATCAATGTCGATCGTGGCTGGGC
TCGAAGATCCCTGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTC
GCGCTTAGCTGGATAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTG
ACTTCTACAGCGCGGAGAATCTCGCTCTCTCCAGGGGAAGCCGAAGTTTCCA
AAAGGTCGTTGATCAAAGCTCGCCGCGTTGTTTCATccAAGCCTTACGGTCAC
CGTAACCAGCAAATCAATATCACTGTGTGGCTTCAGGCCGCCATCCACTGCG
GAGCCGTACAAATGTACGGCCAGCAACGTCGGTTCGAGATGGCGCTCGATGA
CGCCAACTACCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTC
216 
ATGATGTTTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATACGTTGC
TGCTCCATAACATCAAACATAACCCGGCAAGTGAA 
 
582 1.0 Kb 
 
ATTATGTGCTTAGTGCATCTAACGCTTGATGTTAAtGCCGCGCCGCGAAGCGG
GTCGGCTTGAACGAATGTGTTAGACATTTATTATGCCGACTACCTTGAGTGA
GGGTGATGTTTGATGTTATGGAGCAGCAACGTATGTTACGCAGCA
GGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCC
C
ATACTCGCCATATACACAATAGATGAACAAATATCTTCCAACTGATCTGCGC
GGGAGGCCAAGCGATCTTCTTCTTGTCCAGAATAAGCCTGTCTAGCTTCAAGT
ATGACGGGCTGATACTGGGCCGGCAGGCGCTCCATTGCCCAGTCGGCAGCGA
CATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATGCGGGACAAC
GTAAGCACTACATTTCGCTCATCGCCAGCCCAGTCGGGCGGCGAGTTCTCAT
AGCGTTAAGGTTTCATTTAGCGCCTCAAATAGATCCTGTTCAGGAACCGGATC
AAAGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATGTTCTCTTGCTT
TTGTCAGCAAGATAGCCAGATCAATGTCGATCGTGGCTGGCTCGAAGATACC
TGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTCGCGCTTAGCTG
GATAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTGACTTCTACAGC
GCGGAGAATCTCGCTCTCTCCAGGGGAAGCCGAAGTTTCCAAAAGGTCGTTG
ATCAAAGCTCGCCGCGGTTTGTTTCATCAAGCCTTACGGTCACCGTAACCCAG
CAAATCTTAATATCACTGTGTGGCTTCTAGGCCGCCATCCACTGCGGAGCCGT
TACCCACATGTACGGCCAGCAACGTCGGTTCGAGATGGCGCTCGATGACGCC
AACTACCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTCATGC
ATGTTTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCT
CCATTACATCAAACATC 
 
583 1.0 Kb 
 
GCCTTGCT
G
GAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCG
AACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCT
GAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGAT
GAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCC
CTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGA
CGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAA
TGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATCGACA
TTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGT
AGGTCCAGCGGCGGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATT
TGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCT
GGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAG
TAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGC
GCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTTATCTT
GGACAAGAAGAAGATCGCTTGGCCTCCCGCGCAGATCAGTTGGAAGATATTT
GTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAA
CAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTACAAGCGTTA
GATGCACTAAGCACATAATGCTGCACAGCCTANACT 
217 
 
597 1.0 Kb 
 
GGCTTGTGAGCAATTATGTGCTTAGATGCATCTAACGCTTGAGTTAAGCCGCG
CGCGAAGCGGCGTCGGCTTGAACGAATTGTTAGACATTATTTGCCGACTAC
GATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGC
GGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCG
C
CTTGGTGATCTCGCCTTTCACGTAGTGAACAAATTCTTCCAACTGATCTGCGC
GGGAGGCCAAGCGATCTTCTTCTTGTCCAAGATAAGCCTGTCTAGCTTCAAGT
ATGACGGGCTGATACTGGGCCGGCAGGCGCTCCATTGCCCAGTCGGCAGCGA
CATCCTTCGGCGCGATTTTGCCGGTTACTGCGCTGTACCAAATGCGGGACAAC
GTAAGCACTACATTTCGCTCATCGCCAGCCCAGTCGGGCGGCGAGTTCCATA
GCGTTAAGGTTTCATTTAGCGCCTCAAATAGATCCTGTTTCAGGAACCGGATC
AAAGAGTTCCTCCGCCGCTGGACCTACCAAGGCAACGCTATGTTCTCTTGCTT
TTGGTCAGCAAGATAGCCCAGATCAATGTCGATCGTGGCTGGCTCGAAGATA
CCTGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGTTCGCGCTTAGC
TGGATAACGCCACGGAATGATGTCGTCGTGCACAACAATGGTGACTTCTACA
GCGCGGAGAATCTCGCTCTCTCCAGGGGAAGCCGAAGTTTCCAAAAGGTCGT
TGATCAAAGCTCGCCGCGTTGTTTTATCAAGCCTTACGGTCACCGTAACCAGC
AAATCAATATCACTGTGTGGCTTCTAGGCCGCCATCCACTGCGGAGCCGTAC
AAATGTACGGCCAGCAACGTCGGTTTGAGATGGCGCTCGATGACGCCAACTA
CCTCTGATAGTTGAGTCGATACTTCGGCGATCACCGCTTCCCTCATGATGTTT
AACTTTGTTTTCAGGGCGACTGCCCTGCTGCGTAACATACGTTGCTGCTCCAT
AACATCAAACATCAACCCAACAGGC 
 
598 1.0 Kb 
 
TCAGCCTGTGGGTT
A
CCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCT
CGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGC
CTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTG
ATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTC
CCCCTGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCA
CGACGACATCATTCCCGTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGG
AGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACGATC
GACATTGATCTGGCTATCTTGCTGACAAAAAGCAAGAGAACATAGCGTTGCC
TTGGTAGGTCCAGCGGCGGGAGGAACTCTTTGATCCGGTTCCTGAACAGGAT
CTATTTGAGGCGCTAAATGAAACCTTAACGCTTATGGAACTCGCCGCCCGACT
GGGCTGGCGATGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAG
CGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGCTGCCGACTGGGCAATG
GAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACAGGCTT
ATCTTGGACAAGAAGAAGATCGCTTGGCCTCCCGCGCAGATCAGTTGGAAGA
TATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATG
TCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTTCAAGC
GTTAGAGCATTAAGCACATAATGCTCACAGCCAAATA 
 
 
218 
746 1.0 Kb 
TTtGaGCTGTGAGCAATTATGTGCTTAGTGCATCTAACGCAGGAGTTAAGCCG
46 1.2 Kb 
CTACGACCTTTTGCGGTCAGATGTTGTGATGTAATGGAGACAGACAACGAT
ATAAGGCTAACAAG
CCATCAAGTTGACGGCTTTTCCGTCGCTTGTTTTGTGGTTTAACGCTACGCT
 
T
CCGCGCGTAGCGCGGTCGGCTTGAACGAATTGTTAGACATCATTTACCAACT
GACTTGATaGATCTCGCCTTTCACAAAGCGAATAAATTCTTCCAAGTGATCTG
CGCGTGAGGCCAAGTGATCTTCTTTTTGTCCCAGATAAGCTTGCTTAGCTTCA
AGTAAGACGGGCTGATACTGGGCAGGTAGGCGTTTTATTGCCCAGTCGGCAG
CGACATCCTTCGGCGCGATTTTGCCGGTTATTGCGCTGTACCAAATGCGGGAC
AACGTAAGCACTACATTTCGCTCATCGCCGGCCCAGTCGGGCTGCGAGTTCC
ATAGCTTCAAGGTTTCCCTCAGCGCCTCGAATAGATCCTGTTCAGGAACCGGG
TCAAAGAATTCCTCCGCTGCCGGACCTACCAAGGCAACGCTATGTTCTCTTGC
TTTTGTAAGCAGGATAGCTAGATCAATGTCGATCATGGCTGGCTCGAAGATA
CCCGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGCTCGCGCTTAGC
CCGGATAACGCCACGGGATGATGTCGTCATGCACGACAAGGGTGACTTCTAT
AGCGCGGAGCGTCTCGCTCTCGCCAGGGAAAGCCGAAGCCTCCATAAGGTCA
TTGAGCAAaTGCTCgGCCGCGTCGTTTCtATCAAGCTTTACGGCCACAGTAACC
AACAAATCttAATATCGCTGTATGGCTTCAGGCCGCCATCCACTGCGGAGCCG
TACAAATGCACGGCCAGCAACGTTGATTCCAGATGGCGCTCAATGACGCTTA
GCACCTCTGATAGTTGGTTCGAAATTTCGATGGTCACCGCTACCCTCATGATG
TCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTGACATCGTTGCTGCTCCA
TGTACATCTGTACATCTGACCCCACGGCTGATGCGGTCNGTAGGTNN 
 
7
 
T
GTTACGACAGCCAGGGACAGTCCGCCCCTAAAACAAAGTTAGACCATTATTA
TGGAGCCCTCATGACTTTTATATAAAATGTGTGACAATCAAAATTGTATGGGG
TTACTTACATAGAAGcTTgTTTATTGGCATATTCGCTTCTAATACCATCCGTGG
TTTTTGCAAGTAGTTCAAAGTTTCAGCAAGTTGAACAAGACGTTAAGGCAATT
GAAGTTTCTCTTTCTGCTCGTATAGGTGTTTCCGTTCTTGATACTCAAAATGGA
GAATATgTGGGATTACAATGGCAATCAGCGCTTCCCGTTAACAAGTACTTTTA
AAACAATAGCTTGCGCTAAATTACTATATGATGCTGAGCAAGGAAAAGTTAA
TCCCAATAGTACAGTCGAGATTAAGAAAGCAGATCTTGTGACCTATTCCCCTG
TAATAGAAAAGCAAGTAGGGCAGGCAATCACACTCGATGATGCGTGCTTCGC
AACTATGACTACAAGTGATAATACTGCGGCAaATATCATCCTAAGTGCTGTAG
GTGGCCCCAAAGGCGTTACTGATTTTTTAAGACAAATTGGGGACAAAGAGAC
TCGTCTAGACCGTATTGAGCCTGATTTAAATGAAGGTAAGCTCGGTGATTTGA
GGGATACGACAACTCCTAAGGCAATAGCCAGTACTTTGAATAGATTTTTATTT
GGTTCCGCGCTATCTGAAATGAACCAGATAAAAATTAGAGTCTTGGATGGTG
AACAATCAAGTCACTGGTAATTTACATACGTTCAGTATTGCCGGCGGGATGG
AACATTGCGGATCGCTCAGGTGCTGGCGGATTTGGTGCTCGGAGTATTACAG
CAGTTGTGTGGAGTGAGCATCAAGCCCCAATTATTGTGAGCATCTATCTAGCT
CAAACACAGGCTTCAATGGCAGAGCGAAATGATGCGATTGTTATATTATTGG
TCATTCAATTTTTGACGTTTATACATCACAGTCGCGCTG
G
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ACCACAAAACAATCAACTCCAAAGCCGCAACTTATAGGCGGCGTTAGATGCA
CTAAGCACATAATTGCTGCACATGCCTA 
ACGCG
AGATCACTTGGAAGTATTTATTCGCTTTGTGAAAGGCGAGATCATCAAGTCA
ATGATGTCTAACAATTCGTTCAAGCCGACCGCGCTACGtCGCGGC
GCTTAACTCCGGCGTTAGATGCATCTAAGCACATAATGCTgCACAGCCTANA 
GCAGAGCGAAATGATGCGATTGTTATAAATTGGTCATTCAATTTTTGACGTTC
T
 
777 1.0 Kb 
 
AAAAAAGCCCAAGACGCGTCATGCCGTGGGTCGATGTTTGATGTAATGGAGC
AGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGACATCA
TGAGGGTAGCGGTGACCATCGAAATTTCGAACCAACTATCAGAGGTGCTAAG
CGTCATTGAGCGCCATCTGGAATCAACGTTGCTGGCCGTGCATTTGTACGGCT
CCGCAGTGGATGGCGGCCTGAAGCCATACAGCGATATTAGATTTGTTGGTTA
CTGTGGCCGTAAAGCTTGATGAAACGACGCGGCGAGCATTGCTCAATGACCT
TATGGAGGCTTCGGCTTTCCCTGGCGAGAGCGAAGACGCTCCGCGCTATAGA
AGTCACCCTTGTCGTGCATGACGACATCATCCCGTGGCGTTATCCGGCTAAGC
GCGAGCTGCAATTTGGAgAATGGCAGCGCAATGACATTCTTGCGGGTATCTTC
GAGCCAGCCATGATCGACATTGATCTAGCTATCCTGCTTACAAAAGCAAGAG
AACATAGCGTTGCCTTGGTAGGTCCGGCAGCCGGAGGAATTCTTTGACCCGG
TTCCTGAACAGGATCTATTCGAGGCGCTGAGGGAAACCTTGAAGCTATGGAA
CTCGCAGCCCGACTGGGCCGGCGATGAGCGAAATGTAGTGCTTACGTTGTCC
CGCATTTGGTACAGCGCAATAACCGGCAAAATCGCGCCGAAGGATGTCGCTG
CCGACTGGGCAATAAAACGCCTACCCTGCCCTAGTATCTAGCCCGTCTTACTT
GAAGCTAAGCAAGCTTATCTGGGACAAAAAGAAGATCACTTGGCCTC
C
GTTGGTAA
G
 
777 1. 2 Kb 
 
NTAGCCTGTGGGTCGATGTTTGATGTAATGGAGCAGCAACGTATGTTACGCA
GCAGGGCAGTCGCCCTAAAACAAAGTTAGCCATATTATGGAGCCTCATGCTT
TTATATAAAATGTGTGACAATCAAAATGATGGGGTTACTTACATGAAGTTTTT
ATTGGCATCTTCGCTTTTAATACCATCCGTGGTTTTTGCAAGTAGTTCAAAGTT
TCAGCAAGTTGAACAAGACGTTAAGGCAATTGAAGTGTCTCTTTCTGCTCGTA
TAGGTGTTTCCGTTCTTGATACTCAAAATGGAGAATATTGGGATTACAATGGC
AATCAGCGCTTCCCGTTAACAAGTACTTTTAAAACAATAGCTTGCGCTAAATA
ACTATATGATGCTGAGCAAGGAAAAGTTAATCCCAATAGTACAGTCGAGATT
AAGAAAGCAGATCTTGTGACCTATTCCCCTGTAATAGAAAAGCAAGTAGGGC
AGGCAATCACACTCGATGATGCGTGCTTCGCAACTATGACTACAAGTGATAA
TACTGCGGCAAATATCATCCTAAGTGCTGTAGGTGGCCCCAAAGGCGTTACT
GATTTTTTAAGACAAATTGGGGACAAAGAGACTCGTCTAGACCGTATTGAGC
CTGATTTAAATGAAGGTAAGCTCGGTGATTTGAGGGATACGACAACTCCTAA
GGCAATAGCCAGTACTTTGAATCAAATTTTTATTTGGTTCCGCGCTATCTGAA
ATGAACCAGATACAAAATTAGAGTCTTGGATGGTGAACAATCAAGTCACTGG
TAATTTACTACGTTCAGTATTGCCGGCGGGATGGAACATTGCGGATCGCTCAG
GTGCTGGCGGATTTGGTGCTCGGAGTATTACAGCAGTTGTGTGGAGTGAGCA
TCAAGCCCCAATTATTGTGAGCATCTATCTAGCTCAAACACAGGCTTCACATG
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TATACATCACAGTCGCGCTGATAAGGACTAACAAGGCCATCAAGTTGACGGC
TTTTCCGTCGCTTGTTTTGTGGTTTATACGCTACGCTACCACAACACCATCGA
CTCCGAAGCCGCGAACTTATGGCGGCGTTAGATGCATCTAAGCACATAATG
CCTATA 
ATTCGTTCAAGCCGACCGCGCTACGCGCGGCGGCTTAACTCCGGCGTTAGA
GCACATAATGCGTCA 
A
CTCACAAG
 
816 1.0 Kb 
 
GCCTTGCGGTCGATGTTTGATGTAATaGGAGCAGCAACGATGTTACGCAGCAG
GGCAGTCGCCCTAAAACAAAGTTAGACATCATGAGGGTAGCGGTGACCATCG
AAATTTCGAACCAACTATCAGAGGTGCTAAGCGTCATTGAGCGCCATCTGGA
ATCAACGTTGCTGGCCGTGCATTTGTACGGCTCCGCAGTGGATGGCGGCCTG
AAGCCATACAGCGATATTGATTTGTTGGTTACTGGTGGCCGTAAAGCTTGATG
AAACGACGCGGCGAGCATTGCTCAATGACCTTATGGAGGCTTCGGCTTTCCCT
GGCGAGAGCGAGACGCTCCGCGCTATAGAAGTCACCCTTGTCGTGCATGACG
ACATCATCCCGTGGCGTTATCCGGCTAAGCGCGAGCTGCAATTTGGAGAATG
GCAGCGCAATGACATTCTTGCGGGTATCTTCGAGCCAGCCATGATCGACATT
GATCTAGCTATCCTGCTTACAAAAGCAAGAGAACATAGCGTTGCCTTGGTAG
GTCCGGCAGCGGAGGAATTCTTTGACCCGGTTCCTGAACAGGATCTATTTCGA
GGCGCTGAGGGAAACCTTGAAGCTATGGAACTCGCAGCCCGACTGGGCCGGC
GATGAGCGAAATGTAGtGCTTACGTTGTCCCGCATTTGGTACAGCGCAATAAC
CGGCAAAATTCGCGGCCGGAAGGAATGTCGCTGCCGACTGGGCAATAAAAC
GCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTG
GGACAAAAAGAAGATCACTTGGCCTCACGCGCAGATCACTTGGAAGAATTTA
TTCGCTTTGTGAAAGGCGAGATCATCAAGTCAGTTGGTAAATGATGTCTAAC
A
TGCACTAA
 
816 1.2 Kb 
 
TTACGCTTTTCGGGTCGATGTTTGATGTTATaGGAGCAGCAACGATGTTACGC
AGCAGGGACAGTCGCCCTAAAACAAAGTTAGCCATATTATGGAGCCTCATGC
TTTTATATAAAATGTGTGACAATCAAAATTATGGGGTTACTTACATGAAGTTT
TTATTGGCATTTTCGCTTTTAATACCATCCGTGGTTTTTGCAAGTAGTTCAAAG
TTTCAGCAAGTTGAACAAGACGTTAAGGCAATTGAAGTTTCTCTTTCTGCTCG
TATAGGTGTTTCCGTTCTTGATACTCAAAATGGAGAATATTGGGATTACAATG
GCAATCAGCGCTTCCCGTTAACAAGTACTTTTAAAACAATAGCTTGCGCTAAA
TTACTATATGATGCTGAGCAAGGAAAAGTTAATCCCAATAGTACAGTCGAGA
TTAAGAAAGCAGATCTTGTGACCTATTCCCCTGTAATAGAAAAGCAAGTAGG
GCAGGCAATCACACTCGATGATGCGTGCTTCGCAACTATGACTACAAGTGAT
AATACTGCGGCAAATATCATCCTAAGTGCTGTAGGTGGCCCCAAAGGCGTTA
CTGATTTTTTAAGACAAATTGGGGACAAAGAGACTCGTCTAGACCGTATTGA
GCCTGATTTAAATGAAGGTAAGCTCGGTGATTTGAGGGATACGACAACTCCT
AAGGCAATAGCCAGTACTTTGAATaGAAATTTTTATTTGGTTCCGCGCTATCT
GAAATGAACCAGATCAAAATTAGAGTCTTGGATGGTGAACAATCAAGTCACT
GGTAATTTACTACGTTCAGTATTGCCGGCGGGATGGAACATTGCGGATCGCTC
AGGTGCTGGCGGATTTGGTGCTCGGAGTATTACAGCAGTTGTGTGGAGTGAG
221 
CATCAAGCCCCAATTATTGTGAGCATCTATCTAGCTCAAACACAGGCTTCAAT
GGCAGAGCGAAATGATGCGATTGTTATTTTATTGGTCATTCAATTTTTGACGT
TTATACATCACAGTCGCGCTGATAAGGCTAACAAGGCCATCAAGTTGACGGC
TTTTCCGTCGCTTGTTTTGTGGTTTAACGCTACGCTACCACAACACAATCAAC
CCAAAGCCGCAACTTATAGGCGGCGTTAGATGCATCTAAGCACATAATTGC
CCTANA 
AATTTAGATGGTCACCGCTACCCTCATG
TGTCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCGTTGCTGCT
ATCAACCCAAGGCT 
T
TGCACATG
 
823 1.0 Kb 
 
ATATAAGGCTGTGAAGCAATAATGTGCTTAGTGCATCTAAACGCCGGAGTTA
AGCCGCCGCGCGTAGCGCGGTCGGCTTGAACAAATTGTTAGACATCATTTAC
CAACTGACTTGATGATCTCGCCTTTCACAAAGCGAATAAATACTTCCAAGTGA
TCTGCGCGTGAGGCCAAGTGATCTTCTTTTTGTCCCAGATAAGCTTGCTTAGC
TTCAAGTAAGACGGGCTGATACTGGGCATGTAGGCGTTTTATTGGCCCAGTC
GGCAGCGACATCCTTCGGCGCGATTTTGCCGGTTATTGCGCTGTACCAAATGC
GGGACAACGTAAGCACTACATTTCGCTCATCGCCGGCCCAGTCGGGCTGCGA
GTTCCATAGCTTCAAGGTTTCCCTCAGCGCCTCGAAATAGATTCTGTTCAGGA
ACCGGGTCAAAGAATTCCTCCGCTGCCGGACCTACCAAGGCAACGCTATGTT
CTCTTGCTTTTGTAAGCAGGATAGCTAGATCAATGTCGATCATGGCTGGCTCG
AAGATACCCGCAAGAATGTCATTGCGCTGCCATTCTCCAAATTGCAGCTCGC
GCTTAGCCGGATAACGCCACGGGATGATGTYGTCATGCACGACAAGGGTGAC
TTCTATAGCGCGGAGCGTCTCGCTCTCGCCAGGGAAAGCCGAAGCCTCCATA
AGGTCATTGAGCAATGCTCGCCGCGTCGTTTCATCAAGCTTTACGGCCACAGT
AACCAACAAATCAtATATCGCTGTATGGCTTCAGGCCGCCATCCACTGCGGAG
CCGTACAAATGCACGGCCAGCAACGTTGATTCCAGATGGCGCTCAATGACGC
TTAGCACCTCTGATAGTTGGTTCGA
A
CCATTACATCAAAC
 
823 1. 2 Kb 
 
TTAGCCTGTCGGGTCGATGTTTGATGTAATGGAGCAGCAACGTATGTTACGCA
GCAGGGCAGTCGCCCTAAAACAAAGTTAGCCATATTATGGAGCCTCATGCTT
TTATATAAAATGTGTGACAATCAAAATTATGGGGTTACTTACATGAAGTTTTT
ATTGGCATTTTCGCTTTTAATACCATCCGTGGTTTTTGCAAGTAGTTCAAAGTT
TCAGCAAGTTGAACAAGACGTTAAGGCAATTGAAGTTTCTCTTTCTGCTCGTA
TAGGTGTTTCCGTTCTTGATACTCAAAATGGAGAATATTGGGATTACAATGGC
AATCAGCGCTTCCCGTTAACAAGTACTTTTAAAACAATAGCTTGCGCTAAATT
ACTATATGATGCTGAGCAAGGAAAAGTTAATCCCAATAGTACAGTCAAGATT
AAGAAAGCAGATCTTGTGACCTATTCCCCTGTAATAGAAAAGCAAGTAGGGC
AGGCAATCACACTCGATGATGCGTGCTTCGCAACTATGACTACAAGTGATAA
TACTGCGGCAAATATCATCCTAAGTGCTGTAGGTGGCCCCAAAGGCGTTACT
GATTTTTTAAGACAAATTGGGGACAAAGAGACTCGTCTAGACCGTATTGAGC
CTGATTTAAATGAAGGTAAGCTCGGTGATTTGAGGGATACGACAAccTCCTAA
GGCAATAGCCAGTACTTTGAATAAATTTTTATTTGGTTCCGCGCTATCTtGAAA
TGAACCAGAACAAAATTAGAGTCTTGGATGGTGAACAATCAAGTCACTGGTA
222 
ATTTAAAAACGTTCTAGTATTGCCGGCGGGATGGAACATTGCGGATCGCTCA
GGTGCTGGCGGATTTGGTGCTCGGAGTATTACAGCAGTTGTGTGGAGTGAGC
ATCAAGCCCCAATTATTGTGAGCATCTATCTAGCTCAAACACAGGCTTCAATG
GCAGAGCGAAATGATGCGATTGTTAATTTATTGGTCATTCAATTTTTGACGTT
TATACATCACAGTCGCGCTGATAAGGCTAACAAGGCCATCAAGTTGACGGCT
TTTCCGTCGCTTGTTTTGTGGTTTAACGCTACGCTACCACAAAACAATCAACT
CAAAGCCGCAACTTATAGGCGGCGTTAGATGCATCTAAGCACATAAT 
BD 436- 1.6 Kb 
C
 
C
 
TGGTGCTTAAATGCATCTAACGCCGTGTAGTTAAGCCGCCGCGCGTAGCGCG
GTCGGCTTGAACGAATTGTTAGACATCATTTACCAACTGACTTGATGATCTCG
CCTTTCACAAAGCGAATAAATTCTTCCAAGTGATCTGCGCGTGAGGCCAAGT
GATCTTCTTTTTGTCCCAGATAAGCTTGCTTAGCTTCAAGTAAGACGGGCTGA
TACTGGGCAGGTAGGCGTTTTATTGTCCCAGTCGGCAGCGACATCCTTCGGGC
GCGATTTTGCCGGTTATTGCGCTGTACCAAATGCGGGACAACGTAAGCACTA
CATTTCGCTCATCGCCGGCCCAAGTTCCGGGCTGCGTATGTTCCATAGCTTCA
AGGTTTCCCTCAGCGCCTCAAATAGATCCTGTTTCAGGAACCGGGGTCAAAG
AATTCCTCCCGCTGCCGGACCTACCAAAGGCAACGCTATGTCCTCTTGCTTTG
TTAAGCAAGGATACCTAANATCAATGTTTCAATCATGGGCTGGCTCCAAA 
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